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A standardized pipeline for analysis of RNA-seq dataset from human skeletal
muscle was developed. For pre-processing of data, trimmomatic was found
to be a better choice than trim galore. For read alignment and quantification,
RSEM proved to be a better tool having less variation between replicates and
increased biological relevance. In addition, the effects of using different
normalization strategies for analysing and interpreting skeletal muscle trans-
criptome responses to resistance training was explored. Analysis of data from
this model showed that the choice of the normalization model affected down-
stream data interpretations. While all normalization models arguably remove
technical biasness, our results suggest that it may be necessary to account
for biological biasness caused by global changes in total RNA population
(i.e., total RNA per tissue mass) to increase the biological relevance of tran-
scriptome analyses from resistance-trained skeletal muscle. This perspective
and considerations is applicable to all sequencing technologies to have
results with better biological relevance. In addition, the vitamin D3 supple-
mentation and chronic obstructive pulmonary disease diagnosis during
training linked to some molecular change in skeletal muscle seen in transcrip-
tome responses with improvement in lung function but does not account for
significant phenotypic change as muscle growth.
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Summary in English 
Lifestyle-related diseases are widespread, and their incidences are increasing at an alarming 
rate in the human population. These diseases are associated with ageing, a sedentary lifestyle 
and/or poor diet and are usually accompanied by loss of muscle strength, muscle mass, and 
changes in muscle biology. The latter may be treated and prevented by weight-bearing training 
exercises (resistance training), which stimulates growth and maintain the health of the human 
skeletal muscle, the largest organ in the body.  
RNA-seq is a widely used method to study cellular characteristics and changes thereof 
(including muscle plasticity) under different conditions at a given time point. It produces a large 
amount of data, and many tools and different pipelines have been used to facilitate analysis. 
Several studies have focused on comparing different tools for RNA-seq data analysis. However, 
currently, there is no pipeline specific for analysing skeletal muscle data or transcriptome 
response to resistance training. Therefore, it is crucial to identify tools specifically for resistance 
training-induced growth in skeletal muscle. Moreover, each dataset is different and needs 
careful evaluation of tools to decide which is best for a given project.  
The main aim of the thesis was to develop RNA-seq data analysis strategies to analyse 
skeletal muscle transcriptome responses to resistance training and to employ these to study two 
different datasets. YOUNG dataset (18 – 40 years) – RNA-seq data from muscle biopsies 
collected from participants trained for 12 weeks with two different training volumes. For this 
dataset, the aim was to investigate the impacts of training volume for transcriptome responses. 
OLDER dataset (56 - 77 years) – RNA-seq from muscle biopsies collected from participants, 
both healthy and with chronic obstructive pulmonary disease diagnosis, which were trained for 
13 weeks with two different training loads and provided with either vitamin D3 or placebo 
supplementation. This dataset aimed to investigate the impact of vitamin D3 supplementation 
and COPD diagnosis for transcriptome responses. 
The YOUNG dataset was used to develop the standardised RNA-seq pipeline. 
Bioinformatic tools were selected based on read quality, observed gene counts, methodological 
variation between paired observations, and correlations between mRNA abundance and protein 
expression of myosin heavy chain family proteins. Based on exploring the effects of using 
different normalisation strategies, our results suggest that it may be necessary to account for 
biological biasness caused by global changes in the total RNA population (per tissue mass) to 
increase the biological relevance of transcriptome analyses. 
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This developed pipeline was used on the YOUNG and OLDER datasets to understand 
better muscle transcriptome responses to the above-mentioned resistance training interventions. 
In the YOUNG dataset, the two different resistance training volumes were associated with 
differential expression of 21 genes at week 2, mostly related to extracellular remodelling. In 
contrast, no readily explainable dose-dependencies were observed at Week 12. In the OLDER 
dataset, neither vitamin D3 supplementation nor COPD diagnosis affected transcriptome 
responses to training, as estimated at the single-gene level. However, enrichment analyses 
revealed that both conditions were associated with slight effects on response patterns. For 
example, vitamin D3 was associated with increased expression of gene sets involved in 
endothelial proliferation and blood vessel morphogenesis compared to placebo (Week 13). 
COPD was associated with more pronounced decreases in gene sets relating to oxidative 
phosphorylation and myogenesis.  
The results from this study could potentially help understand transcriptomic changes of 
training and factors affecting training response, which could help design better training 





Sammendrag på Norsk 
 
Livsstilsrelaterte sykdommer er utbredt, og forekomsten øker i en alarmerende hastighet i den 
menneskelige befolkningen. Disse sykdommene er forbundet med aldring, en stillesittende 
livsstil og/eller dårlig kosthold, og er vanligvis ledsaget av tap av muskelstyrke, muskelmasse 
og endringer i muskelbiologi. Sistnevnte kan behandles og forhindres av vektbærende 
treningsøvelser (motstandstrening), som stimulerer vekst og opprettholder helsen til 
menneskelig skjelettmuskel, det største organet i kroppen.  
RNA-seq er en mye brukt metode for å studere cellulære egenskaper og endringer derav 
(inkludert muskelplastisitet) under forskjellige forhold på et gitt tidspunkt. Den produserer en 
stor mengde data, og mange verktøy har blitt brukt for å lette analysen. Flere studier har fokusert 
på å sammenligne forskjellige verktøy for RNA-seq analyse. Imidlertid er det for øyeblikket 
ingen pipeline spesifikk for å analysere skjelettmuskeldata eller transkriptomrespons på 
motstandstrening. Derfor er det avgjørende å identifisere verktøy spesielt for 
motstandstreningsindusert vekst i skjelettmuskulatur. I tillegg er hvert datasett annerledes og 
trenger grundig evaluering av verktøy for å bestemme hvilket som er best for et gitt prosjekt.  
Hovedmålet med oppgaven var å utvikle RNA-seq dataanalyse strategier for å analysere 
transkriptomresponser av skjelettmuskulatur på motstandstrening og å bruke disse til å studere 
to forskjellige datasett. YOUNG datasett (18 - 40 år) - RNA-seq data fra muskelbiopsier samlet 
fra deltakere trent i 12 uker med to forskjellige treningsvolumer. For dette datasettet var målet 
å undersøke virkningene av treningsvolum for transkriptomresponser. OLDER datasett (56 - 77 
år) - RNA-seq fra muskelbiopsier samlet fra deltakere, både friske og med kronisk obstruktiv 
lungesykdomsdiagnose (KOL), som ble trent i 13 uker med to forskjellige treningsbelastninger 
og utstyrt med enten vitamin D3 eller placebo tilskudd. For dette datasettet var målet å 
undersøke virkningen av vitamin D3-tilskudd og KOL-diagnose for transkriptomresponser.  
Det YOUNG datasettet ble brukt til å utvikle den standardiserte RNA-seq pipeline. 
Bioinformatiske verktøy ble valgt ut fra lesekvalitet, observerte gentall, metodologisk variasjon 
mellom parede observasjoner og korrelasjoner mellom mRNA-overflod og proteinuttrykk av 
myosin tungkjede familieproteiner. Basert på å utforske effekten av å bruke forskjellige 
normaliseringsstrategier, antyder våre resultater at det kan være nødvendig å ta hensyn til 
biologisk skjevhet forårsaket av globale endringer i den totale RNA (per vevsmasse) for å øke 
den biologiske relevansen av transkriptomanalyser.  
Denne utviklede pipeline ble brukt på de YOUNG og OLDER datasettene for å gi en 
bedre forståelse av muskeltransskriptomresponser. I det YOUNG datasettet var de to 
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forskjellige motstandstreningsvolumene assosiert med differensial uttrykk av 21 gener i uke 2, 
hovedsakelig relatert til ekstracellulær remodellering. I motsetning ble det ikke observert noen 
lett forklarbare doseavhengigheter i uke 12. I det OLDER datasettet påvirket verken vitamin 
D3-tilskudd eller KOL-diagnose transkriptomresponsene på trening, når estimert på 
enkeltgenivå. Anrikningsanalyser viste imidlertid at begge forholdene var forbundet med små 
effekter på responsmønstre. For eksempel var vitamin D3 assosiert med økt uttrykk av gensett 
som er involvert i endotelproliferasjon og blodkarmorfogenese sammenlignet med placebo (uke 
13), og KOL var assosiert med mer markante reduksjoner i gensett knyttet til oksidativ 
fosforylering og myogenese.  
Resultatene fra denne studien kan potensielt bidra til å forstå transkriptomiske endringer 
i trening og faktorer som påvirker treningsrespons, noe som kan bidra til å designe bedre 
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1. Background of the study 
Lifestyle-related diseases involving dysfunction of metabolic, cardiopulmonary, neuronal and 
immune systems are increasingly prevalent in the human population. The progression of these 
diseases tends to be associated with life-long malnutrition or a lack of exercise and leads to 
personal suffering and substantial socioeconomic costs [1]. A sedentary lifestyle and poor 
dietary decisions cause muscle mass loss and/or obesity. In order to maintain regular healthy 
muscle mass, some lifestyle modifications along with the right amount of exercise are required 
[2].  
Skeletal muscle is the voluntary muscle, making up 40% of the body weight [3]. Healthy 
skeletal muscle mass is associated with longer life expectancy, a healthy life, and healthy ageing 
[4]. In the last couple of decades, training techniques have been optimised to help rehabilitate 
people living a sedentary lifestyle or with related diseases to lead a healthy life and have healthy 
ageing [5, 6]. Muscle mass can be affected by various factors, including training type, training 
volume, diet, sleep, supplementation of micro and macromolecules (vitamins and proteins) and 
physiological conditions [7-14]. The same training protocol could lead to a different response 
in different individuals, which suggests the need for a personalised rehabilitation programme. 
To design these protocols, we need biomarkers to determine health and training protocols for 
an individual. During the exercise condition, an individual could experience increased oxidative 
and inflammatory stress, altered transcription and coordinated stress response due to multiple 
molecular changes such as phosphocreatine and muscle glycogen breakdown, regulation by 
transcription factors and DNA hypomethylation [15]. With age, physical activity becomes 
limited, leading to muscle atrophy. Also, various chronic diseases like chronic obstructive 
pulmonary disease (COPD), cancer, arthritis, diabetes and obesity might impair physical 
activity and exacerbate muscle atrophy [16].  
COPD is the third most prevalent cause of death worldwide [17] [18]. COPD causes 
irreversible loss of lung function induced by smoking, air pollution, and direct contact with 
certain chemicals [19]. Muscle loss and dysfunction during COPD is the compounded result of 
inflammatory cytokines, oxidative stress, growth and anabolic hormones, nutritional status, and 
physical activity [20, 21]. Exercise seems to be the effective rehabilitation approach with and 
without clinical drugs targeting TNFα, IL-6 and reactive oxygen species (ROS) [22]. But the 
loss of lung function prevails fatigue, causing low motivation towards training. However, 
specific measures should be taken for a healthy lifestyle, like reducing contact with chemical 
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smoke and increasing lung function by training. Training is directly associated with muscle 
growth. Also, it has been stipulated by previous studies that vitamin D3 affect muscle growth 
[23-26]. Vitamin D3 indirectly regulates glucose uptake of skeletal muscle through calcium 
pathway cascade and elevated plasticity [27]. This suggests that vitamin D3 supplementation 
could benefit rehabilitation programmes for the elderly, healthy ageing and the COPD-affected 
population.  
To study muscle growth as a response to training volume, RNA sequencing (RNA-seq) can 
reveal the complete information about the presence and quantity of RNA in a biological sample 
at a given time [28]. The basic steps of RNA-seq data analysis include quality filtering, 
alignment, quantification, differential gene expression and gene ontology. However, the tools 
and algorithms for RNA-seq analysis keep evolving. Since the beginning of RNA-seq 
application, data analysis has been performed by different sets of tools with varying 
performance reports [29-32]. Each data set is different and needs careful evaluation of tools to 
decide which is best for a given project. 
Additionally, normalisation of RNA-seq is a critical, decisive step, which adjusts the data 
according to several factors (e.g., the run time difference between the samples, position of 
sample on the plate, sequencing plate usage, handling of samples), which prevents biases in 
comparison of quantified expression. Therefore, it is critical to compare different perspectives 
to normalise data and remove technical bias from the data, which can affect downstream 
analyses [33]. Different normalisation methods are associated with a different set of stable 
genes and differentially expressed (DE) genes. In addition, it is often ambiguous whether the 
selected stable genes are stable in expression or not [34]. Therefore, careful consideration is 
needed to decide on a standardised RNA-seq pipeline. This pipeline will be used to observe 












2. Introduction – Biological Background 
2.1. Muscle Tissue 
Muscles are contractile tissue found in animals, which function to produce motion and are a 
source of power and as a reservoir for protein. There are two types of muscles, i.e., striated and 
non-striated. Striated muscles are defined as having visible banding within muscle cells to 
ensure the constant direction of tension, whereas non-striated muscles lack this banding and are 
spindle-shaped. 
Striated muscles are also categorised into two types: skeletal muscle and cardiac muscle 
(Table 1). Skeletal muscle is the largest organ in the body [3] and contracts only when there is 
a signal from the somatic motor neuron. Skeletal muscle is connected to bone by a flexible joint 
called flexor/tendons to facilitate physical activity. Cardiac muscle, also known as the 
myocardial, comprises two types of contractile cells (99% of atria and ventricles) and generates 
spontaneous action and myocardial conducting cells make a conduction system of the heart. 
This tissue account for the unique ability of the heart to contract without any outside signal, 
instead of from auto-rhythmic cells/pacemaker cells. Cardiac muscle can be further 
differentiated from skeletal muscle by the presence of intercalated discs, which control the 
synchronised contraction of cardiac tissues. Non-striated or smooth muscles are mainly found 
in the digestive system, urinary bladder and respiratory system. They play an essential role in 
regulating the flow of material in and out of the body, for example, in aiding the movement of 
food through the digestive system via peristalsis. 
2.2. Skeletal Muscle  
Skeletal muscle is a set of innervated, non-voluntary muscle cells. It exhibits fatigue with high-
energy requirements during high physical activity. The role of skeletal muscles includes 
maintaining posture and all physical activity, maintaining basal energy levels, bone density, 
helping in recovery during disease, and acting as a reservoir for amino acids and carbohydrates 
for other organs and longevity [3, 35, 36]. Skeletal muscles consist of several long cylindrical 
striated muscle fibres (Figure 1A), which are made up of thousands of myofibrils with hundreds 
of nuclei arranged at their longer axis (Figure 1C). It contains the following: contractile and 
elastic proteins  - myosin and actin; regulatory proteins - tropomyosin and troponin; accessory 
proteins - titin and nebulin [3]. Every skeletal muscle is constrained by connective tissue – 
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epimysium and each bundle of fibre are surrounded by perimysium (Figure 1B); within this, 
every muscle fibre is surrounded by sarcolemma.  
Table 1. Comparison of the different muscle tissue type’s characteristics. 
  Smooth Muscle Cardiac Muscle Skeletal Muscle 
Appearance Non-striated Striated Striated  
Function 
Maintain the flow of 
fluids and solids along 
hollow structures 
Pumping blood through 
the heart chambers into 
blood vessels 
Body posture and 
locomotion, joint stability 
and heat generation 
Location 
iris, erectors of hairs, 
walls of hollow organs  Heart 
Directly attached to the 
skeleton by tendons 
Cell shape Short and fusiform Branching Long and cylindrical 
Nucleus 
Single nucleus, centrally 
located 
Single or bi-nucleated 
centrally located 
Multinucleated periphery 














Excitation or inhibition Excitation or inhibition Excitation 
 
 The ability of the skeletal muscle to change its structural and functional 
properties to adapt to imposed conditions is known as plasticity. Muscle plasticity adapts for 
continuous mechanical stress imposed on the body and leads to muscle gain known as muscle 
hypertrophy. Disuse of muscle for a more extended time can lead to loss of muscle mass, which 




Figure 1. A) Skeletal muscle is connected to the bones via flexor; each skeletal muscle tissue is 
covered by epimysium. B) Muscle fibre has nerve, artery and vein to transport glucose and 
proteins, and a nerve to control the movement of muscle C) Each subunit of muscle fibre is 
made up of several myofiber bundles. Each bundle is enveloped by endomysium. (Adapted from 
Human Physiology, Silverthorn DU, Copyright © Pearson Education, Inc. (reproduced with 
permission from Pearson Education Inc.) [3]. 
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2.2.1. Skeletal Muscle contraction proteins 
Myosin is a motor protein, which helps in the ability to create movement. Different 
isoforms of myosin are present in different muscle types; myosin decides contraction speed 
[37]. Myosin structures consist of the long tail and two tadpoles-like heads clustered together 
to make a thick filament.  
Actin is a family of globular multi-functional proteins that form microfilaments in the 
cytoskeleton and the thin filaments in muscle fibrils. Multiple globular proteins (G-actin) 
linearly polymerise to make filament proteins (F-actin) and further polymerising into double-
stranded beads to make thin filament with troponin, nebulin, and tropomyosin. Under the light 
microscope, the thick and thin filament has a repeating pattern of alternating dark and light 
bands (Figure 2A). Most of the thin and thick filament of myofibril are connected by myosin 
cross-bridges. (Figure 2B). Cross-bridges connect both the thin and thick filament to make 
sarcomere. Each G-actin has a myosin-binding site and an ATP binding site. Muscle contraction 
is the process of sliding of actin and myosin filaments. It is initiated by calcium signalling. Ca2+ 
binds to troponin and exposes myosin-binding sites on thick filaments, and the myosin head 
then binds to the active site of actin. This binding or cross-bridge is broken by adenosine 
triphosphate (ATP), as ATP hydrolysis changes the orientation of myosin heads. The myosin 
head again binds to actin and releases adenosine diphosphate (ADP). Myosin repositioning 
pushes thin filaments to the centre of the sarcomere, causing muscle contraction by transmitting 
both longitudinal and radial forces, which reinforce the dystrophin-glycoprotein complex and 
the integrin complex provide mechanical linkage between myofilament and Extracellular 






Figure 2. A) A repeating pattern of thin and thick filament making up the sarcomere can be 
seen under the microscope. A zigzag pattern where two sarcomeres are connected is called the 
Z-disk. The region where the Z-disk is present is called the I-band, and in this region, there is 
no thin filament present. Similarly, the region where the thin filament is present with and 
without thick filament overlapping is called A-band. If a thick filament is absent, that region is 
called the H-zone. The linear line where thin filaments are connected to each other is called 
the M-line. B) Thin filament joined to each other through the M-line and made up of myosin, 
slides between actin proteins facilitated by titin protein. (Adapted from Human Physiology, 
Silverthorn DU, Copyright © Pearson Education, Inc. (reproduced with permission from 
Pearson Education Inc.) [3]. 
 
2.2.2. Skeletal muscle Plasticity and Hypertrophy 
The ability of muscle tissue to modify its structure, function and metabolism in response to 
mechanical stress and numerous physiological changes is known as plasticity [40]. Repetitive 
resistance training acts as external stimuli or mechanical stress, activating adaptation and 
increasing muscle mass and strength with endurance or contractile speed. Muscle growth refers 
to an increase in muscle mass called hypertrophy. Training exercises act as stimuli for an 
increase in muscle volume. This adaptation takes time and depends upon the fitness goals of 
the individual. There are many factors affecting muscle hypertrophy, i.e. training type [13], 
training volume [10, 12, 41], sleep [42, 43], and supplements including macronutrients [9], 




 Training type 
Endurance exercise signals transcriptional upregulation of many genes involved in the response 
of structure genes enabling the muscle to function at a higher level of metabolic activity. The 
Ca2+ signalling cascade and high skeletal muscle energy status activate AMPK (Activated 
protein Kinase) by glycogen content. ROS/redox signalling sense hypoxia muscle. Exercise-
induced epinephrine initiation of angiogenesis takes place through cAMP pathways. PGC-1α 
activates multiple transcription factors and nuclear receptors and recruits chromatin 
remodelling complexes that facilitate transcription and post-transcriptional processes through 
splice proteins. PGC-1α expression is proportional to muscle tissue growth and also activates 
its antagonist, RIP140, a transcriptional corepressor that targets similar transcription factors and 
nuclear receptors such as PGC-1, but oppositely. On the other hand, resistance training 
enhanced translation. Mechanical stress activates AKT-dependent and AKT-independent 
pathways. This modulates mTOR, which controls most of the signalling cascade and increases 
translation and elongation. mTOR is negatively regulated by low energy metabolism and 
myostatin. Significant growth in muscle is not facilitated by stem cell type cell “satellite cells” 
that present themself in the basement membrane of muscle fibre, whose proliferation and 
differentiation are led by Notch and WNT signalling and MyoG, MyoD and Myf3 regulatory 
factors. [40] 
 Training volume 
The total number of lifts and sets per exercise is called training volume. High training volume 
might lead either to high muscle mass growth or to muscle damage [44]. In studies on health 
and performance improvement studies, inter and intraindividual variability can vary the results. 
However, to reduce or remove the interindividual effects, studies need to consider it in 
experimental design [45]. No previous studies have reported molecular changes at the wholistic 
level to explain the effect of training volume while accounting for the intraindividual effect.  
 Supplementation  
Skeletal muscle hypertrophy is the balance between muscle protein synthesis and breakdown. 
For good muscle mass growth and maintenance, there is a need for an adequate amount of 
nutrition. Several supplements are proposed for good or high muscle mass gain and 
maintenance. Usage of these supplements has grown by tenfold a decade [46]. Different goals 
need different dietary proportions and a different supplementation mix. Research on Vitamin 
D3 has recently received attention from several focus areas. It has been proposed to play a 
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prominent role in cancers, cardiovascular diseases, diabetes, neurological and psychiatric 
disorders and autoimmune diseases [47, 48]. Halfon et al. reported that calcium and phosphorus 
supplementation helps the frail elderly and positively affects muscle growth [49]. However, 
another study has noted otherwise [23], which throws doubt on the role of vitamin D3 in muscle 
hypertrophy.  
 Loss of skeletal muscle - Muscle atrophy 
Muscle loss or wastage is known as atrophy. It is caused by a sedentary lifestyle, low muscle 
movement, ageing, malnutrition, alcohol, burns, and diseases, leading to early fatigue and 
demotivation to perform physical activity. However, these can be treated by medicine and/or 
rehabilitation programmes. Due to all these reasons, COPD affects the population adversely 
and leads to mortality in the elderly. The effects of COPD cannot be reversed but can be stopped 
by rehabilitation programmes by increasing lung capacity, which is directly related to training 
and muscle mass. 
  Chronic Obstructive Pulmonary Disease (COPD) 
Emphysema and chronic bronchitis are covered under the term COPD. COPD is a chronic 
lung disease that causes progressive damage to airways and lung parenchyma, causing airflow 
obstruction. It is estimated that worldwide, 210 million people suffer from COPD, and it was 
the third leading cause of death (3.23 million) in 2019 [18, 19]. Exposure to cigarette smoking, 
biomass smoke and chemicals [50-52] contributes to the destruction of parenchymal, which 
leads to airway lumen narrowing through smooth muscle hypertrophy, inflammation and elastic 
recoil loss. This results in a loss of alveolar surface area, ventilation-perfusion mismatch, 
airflow limitation and gas trapping. All these complications contribute to dyspnoea (difficult or 
laboured breathing) and fatigue. The pathological mechanism of COPD is still not well 
understood. But it is evident that alteration of the protease or antiprotease balance is mediated 
by an increase in neutrophils and macrophages, increased oxidative stress, autoimmune 
dysfunction and dysfunction of lung development and maintenance pathways like the retinoic 
acid pathway and hedgehog signalling pathway [53-56]. However, not all smokers get COPD, 
so genetics plays an important role too, which needs to be better understood.  
COPD causes skeletal muscle weakness, and with age, it becomes more severe, causing 
mortality in one-quarter of the affected population [57-59]. Weakness is usually caused by the 
limitation of exercise and physical movement due to fatigue, systemic inflammation, oxidative 
stress, genetic susceptibility and loss of motivation.  
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Several studies have found an association between vitamin D3 and the measure of muscle 
strength [60, 61], which suggests that vitamin D3 supplementation could positively affect the 
rehabilitation of the COPD population [57-59] [57]. In contrast, a few studies show no effect 
of vitamin D3 on the COPD diagnosed population [25, 26]. This indicates that there is a 
contrasting view of the usefulness of vitamin D3 supplementation on the COPD population. 
Moreover, there is a need for a detailed molecular study to understand this issue further. 
 
2.3. Transcription  
All organisms share the foundational mechanism of life: “the central dogma” (Figure 3), which 
describes the central component of life and how they are related [62]. The first component of 
the central dogma is deoxyribonucleic acid (DNA). DNA stores the information for an organism 
to develop, grow, function and reproduce. DNA is transcribed into ribonucleic acid (RNA) by 
a process called transcription. RNA was only known as a transitional step containing protein 
information until recent years, but RNA itself has many essential functions, such as gene 
regulation [63]. The stretch of DNA, transcribed into an RNA molecule encoding a protein, is 
called messenger RNA (mRNA). Other stretches of DNA transcribed into RNA molecules are 
called non-coding RNAs, including transfer RNA (tRNA), small nucleolar RNA, ribozymes, 
ribosomal RNA (rRNA), long non-coding RNA, etc.  
 Figure 3. The central dogma of molecular biology. It is the explanation of the flow of genetic 
information within a biological system. In this DNA makes RNA, and RNA makes Proteins 
facilitated by different enzymes.   
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The process by which mRNA information is used to make protein is known as 
translation. Proteins act as active components and facilitate the function of an organism. The 
abundance of mRNA is directly proportional to protein abundance, which leads to different 
phenotypic and physiological results/outcomes. In other words, transcription of DNA is the key 
regulatory step in managing functional molecules [64]. Commencement of transcription is 
mainly regulated by sequence-specific transcription factors (TFs). The promoter region has a 
transcription start site (TSS) possessing many transcription factor binding sites (TFBS) at the 
enhancers region, which are present far away from the gene, and are what regulate the 
transcription process [65]. 
Furthermore, DNA is divided into multiple loci known as exons, separated by introns 
[66]. These exons accumulate mRNA by a splicing event or an alternative splicing event, 
forming different products/mRNAs from a single gene [67]. The final step towards mRNA 
formation is terminating the transcription, facilitated by transcription termination sites (TTS), 
a conserved sequence motif in emerging RNA sequences [68]. These mRNA sequences are 
translated into protein resulting in phenotypic changes. High throughput approaches are used 
to study overall gene expression at a condition and a given time.  
2.4. Training induced changes in expression profile 
A single bout of exercise can alter gene expression in both exercised and non-exercised 
muscles, promoting upregulation of gene expression. This expression profile at different time 
points can provide a clear picture of molecular changes [69]. Previously, when high-throughput 
technology was not available, it was challenging to calculate these changes. The only method 
was PCR and multiplex PCR, which is only for one gene or a set of genes at any one time. With 
advances in technology including RNA-seq, and microarray, it has become possible to study 







3. Introduction – Technological Background 
 
3.1. High-throughput transcriptomic/whole transcriptome technologies  
Transcriptome analysis is the study of the transcriptome, which is the complete set of RNA 
transcripts produced by the genome, under specific circumstances or in a particular cell, using 
high-throughput methods. Although many methodologies have been developed for 
transcriptome profiling, two of these methods have revolutionised gene expression profiling, 
i.e., microarray and RNA-seq technology.  
3.1.1. Microarray  
Since the 1990s, microarray has been the choice for genome-wide transcriptomic studies. This 
method enables the simultaneous examination of thousands of transcripts. In this technology, a 
large set of short (typically 20 to 70 bp long) single-stranded DNA probes are attached to a 
fixed plate/sheet, complementary to cDNA sequences, followed by labelling it with fluorescent 
dye. Fluorescence from each probe cDNA complex is then observed by measuring fluorescence 
with a  fluorescent scanner [70]. However, with the emergence of the high throughput next-
generation sequencing technology RNA-seq, the usage of microarray has become limited. In 
microarray, probes need to be complementary to the target sequence, and therefore these have 
to be defined in advance. In contrast, RNA-seq does not require any prior knowledge about 
nucleotide sequence. Microarray is a good choice if one is interested in analysing known targets 
due to its low cost, cheaper data storage, and lower complexity than RNA-seq [71]. RNA-seq, 
on the other hand, brings an advantage when high throughput data are needed, and unknown 
targets are considered.  
3.1.2. RNA-seq 
Sanger sequencing was the very first whole-genome sequencing technology. It is expensive and 
has low throughput as each reaction gives out only one sequence. To overcome this limitation, 
a tag-based method was developed, which is used in cap analysis of gene expression (CAGE), 
serial analysis of gene expression (SAGE) and massively parallel signature sequencing (MPSS) 
[72-74]. These technologies provide less expression sensitivity than microarrays, and tags can 
be mapped to several places on the reference genome. High throughput sequencing overcame 
these limitations.  
RNA-seq is a high throughput sequence-based transcriptome analysis method to survey, 
characterise and quantify the transcriptome at the whole genome level [28]. In contrast to 
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previous methods, RNA-seq utilises sequencing by synthesis technology to define the 
nucleotide sequences and to quantify RNA molecules in a sample. RNA-seq can process this 
data in hours to days with high fidelity, making it the preferred technique for RNA analysis 
amongst many researchers. Currently, RNA-seq from Illumina is the leading technology for 
performing high throughput sequencing. RNA sequencing can identify differential expression 
of genes (DEGs), mutated genes and gene isoforms in disease states. 
A typical RNA-seq experiment (Figure 4) starts with isolating the whole RNA and 
purifying subset RNA from total RNA. The majority of RNA species consist of rRNA. The 
mRNAs are enriched either by selecting poly-A molecules using poly-T oligo attached 
magnetic beads or by the rRNA depletion method [75-77]. The enriched mRNA is then 
fragmented via RNA hydrolysis or nebulization, or it can be performed after cDNA conversion 
by DNase I treatment or sonication (100-300 bp). The cleaved mRNA fragments are then 
converted into cDNA using reverse transcriptase and random primers. Following this adaptor, 
sequences are ligated using ligase enzymes. Adenine bases are added to the 3’ end to prepare 
cDNA for ligation to adaptors, containing a single T base overhang at the 3’ end. Later, cDNA 
molecules are split into different sizes. The desired range of cDNA length is purified using the 
gel extraction method to select molecules of a similar size, which removes un-ligated adaptors 
and dimers of adaptors. The process is followed by the amplification of collected DNA 
fragments by PCR. Double-stranded cDNA is then denatured in single-stranded molecules. 
These single-stranded molecules are hybridised with forward and reverse primers (adapter 
complimenting primers) fixed on a sequencing plate. After hybridisation, fragments loop over 
to the hybridised sequence to the adjacent primer, and DNA polymerase copies the template 
forming double-stranded DNA bridges, which are denatured to obtain a single-stranded 
template population. Then, reverse strands are removed by base-specific cleavage, and the 3’ 
end of the forward strand is blocked to prevent interference in the sequencing process. This 
process is repeated several times until dense clusters containing at least 1000 fragments per 
cluster are procured/achieved. The final step is sequencing by synthesis, where clusters are 
amplified in rounds. 
In each round, fluorescence-labelled nucleotides are added. Separate dyes are used for 
dATPs, dCTPs, dTTPs and dGTPs. Additionally, these nucleotides are blocked on the 3’-end, 





Figure 4. The first step in RNA sequencing is to select suitable mRNA molecules from the total 
RNA by poly-A tail, and then it is fragmented into the required length. The RNA of interest is 
then filtered out by gel electrophoresis.  Then it is converted into cDNA by reverse transcriptase 
in step 2 (primer annealing) and step 3 (elongation). cDNA has blunt ends, so A base is added 
to it at step 4 and step 5. At step 6, the ends of the cDNA chain are blunted, and A base is added 
to it. To this product, the adaptor sequence is hybridised with inserted A base. The adaptor-
ligated product is purified and amplified using PCR at step 7. Step 8 is to hybridise it to a fixed 
plate with a complementary adaptor sequence. These strands are amplified using bridge 
amplification at step 9 and are clustered by repeating this process at step 10. The reverse strand 
is cleaved and washed away the sequencing primers (complementary to the adaptor sequence 
attached to the plate) at step 11. This is followed by the sequencing-by-synthesis process at step 
12. After the hybridisation of the sequencing primers, four labelled reversible terminators and 
DNA polymerase are added; one nucleotide is added to the nucleic acid chain, and after laser 
excitation, the colour of its fluorescent label is observed and recorded. The fluorescent label 
and the blocking group are then washed away, and the described process is repeated until the 
length of interest is achieved.  Adapted from Illumina.com  [81]. 
unincorporated nucleotides are washed, and the sequencing plate is excited by a four-channel 
laser to record to which clusters which nucleotides were added. Next, fluorescence dyes and 
blocking groups are removed, and the next sequencing round starts. This process is repeated 
200-300 times (for small RNAs a lesser number of times). The output of this step is a 
sequencing image; one each has information of a newly incorporated nucleotide, combining it 
to form sequences, and each base has its quality score based on the fluorescence levels. This 
information is saved as text using the fastq file format, which contains a unique ID for each 
sequence and quality score for each base. 
3.2. RNA-seq application in sports and training  
Advances in high throughput sequencing technology, algorithms, machine learning and data 
science have enabled researchers to explore genomic transposition with exercise [78]. This has 
led to important discoveries related to sports and health genomics. Progression in this field 
promises to deliver more precise, personalised health care and rehabilitation programmes to 
benefit the population [79]. However, this progression can only be expected by more 
coordinated research. As such, meta-analysis of several studies reported by the metamex.eu 
database has revealed that most studies have statistical ascendency, are oblique towards male 
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volunteers and have no contemplation towards individual effect. [80].  Exercise and sports 
genomics experiments need to be innovative to accommodate inter and intraindividual effects 
while protecting privacy and avoiding misuse of genomic information. These experiments have 
the potential to contribute to designing rehabilitation programmes for improving health and 
for healthy ageing  
3.3. RNA-seq data analysis 
3.3.1. RNA isolation and sequencing 
RNA isolation can be performed using standard protocol or by a commercial kit. The quality of 
these samples needs to be observed to select only high-quality samples for sequencing (RNA 
integrity score RQI >7 is preferred). Sequencing libraries are prepared for each sample (1000 
ng RNA) using TruSeq Stranded Total RNA Library Prep (Illumina, San Diego, CA USA). 
And sequencing is performed using any Illumina Sequences, e.g., HiSeq. The files retrieved 
from the sequencer are called raw data, and sequences in it are called reads. Although Illumina 
has high-quality reads, it still needs to be preprocessed followed by basic steps for RNA-seq 
analysis.  
 
Figure 5. Overview of RNA-seq data analysis for detecting differential gene expression. 
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3.3.2. Quality filtering 
The NGS platform provides data in fastq format; it is similar to the fasta format with two 
additional lines reporting the header or the id of the sequence and starting with the + sign.  The 
third line is left blank in the new platform, and the fourth line represents base quality score 
values using an ASCII character, one for each base. The quality of sequence is shown by the 
Phred score, which is the probability of the base being wrong (Q = -10log10P). P is the 
probability of a nucleotide being incorrectly identified. For example: if Q = 10, then P = 0.1 
and estimate correctness is 90%; if Q = 20, then P = 0.01 and estimated correctness is 99%; and 
if Q = 30, then P = 0.001 and estimated correctness is 99.9%.  
Sequencing bias can be caused by calling the wrong base due to poor sequencing quality 
during the sequencing reaction. In addition, when fragments are smaller than the sequencing 
length, adaptor sequence contamination can adversely affect downstream analysis [82]. Before 
downstream analysis, quality control of read sequences is important to remove short and/or 
low-quality reads/bases and trim out the adaptor sequence. The two most cited tools for these 
steps are Trim Galore (https://github.com/FelixKrueger/TrimGalore) and trimmomatic [83].  
Trim Galore is a wrapper tool for Cutadapt [84] and FastQC [85]. Cutadapt is an adaptor and 
quality filtering tool, and FastQC calculates and visualises the quality of reads in each fastq file. 
It uses the first 13 bases of the adaptor sequence for its identification. Users can define a Phred 
score cut off where any base below the cutoff would be trimmed. The default Phred score 
threshold is 20. Cutadapt calculates the Phred score for each base, subtracts the default score 
from each base score and then partially sums all positive values and keeps the negative score 
as it is. Next, it removes all the bases with a negative Phred score. Cutadapt also removes the 
sequences, which are smaller than a pre-defined cut-off after filtering. The pre-defined cut off 
for sequence length is 20 bp.  
Trimmomatic uses an alignment-based score and sliding window methods to 
identify/remove the adaptor sequence and for quality filtering, respectively. In the sliding 
window method, the average of the base quality for a specific length is taken. If the average is 
less than the specified threshold (default is 25), it removes the afterwards bases. After that, it 
selects the sequences on maximal information quality filtering, which is based upon three rules, 
i.e., length threshold, sequence coverage and error rate. Then these filtered out files were 
observed for overall quality using FastQC. FastQC produces a report file for each file 
separately. To collectively tabulate and visualise the quality reports,  MultiQC [86] is used, 
which provides a summary of all files as graphs and tables.  
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3.3.3. Alignment and quantification 
After removing low-quality reads and trimming the adaptor sequences, high-quality reads are 
aligned on the reference genome (e.g., human genome). The main goal of alignment is to find 
loci of each read on the reference genome and quantify their expression (i.e., counting the 
number of reads that align to each gene/transcript [read count]). In recent years, alignment tools 
have evolved, and reads can be aligned directly to transcripts, and it does not need to be aligned 
to the genome. Hence, alignment tools are divided into two main groups, i.e. genome-based 
aligners, e.g. STAR [87] and HISAT2 [88, 89] and transcript based aligners. Transcript based 
aligners are further divided into two groups:  alignment-based, e.g. RSEM [90], and pseudo-
aligners, e.g. Kallisto [91] and Salmon [92]. STAR and HISAT2 need a quantification tool like 
htseq2 [93], while Kallisto and Salmon tools have their own quantification algorithm. Teng et 
al. suggested using standard deviation between the samples within the group as a measure of 
comparing better alignment tools, as it is expected to have a similar expression in samples in 
similar conditions [94].  
STAR: Spliced Transcripts Alignment to a Reference (STAR) was designed for non-
contiguous sequences. The alignment process using STAR consists of two steps. First is seed 
search, where Maximal Mappable Prefix (MMP), i.e. the longest matching sequence loci/s, is 
identified on the reference genome, and this MMP becomes seed1. Then the algorithm will 
search for an unaligned portion of the sequence to find the next longest match on reference 
genomes, which is seed2. If it does not find the exact match due to a mismatch or indel, MMPs 
will be extended (Figure 6). Second, this is followed by clustering, stitching and scoring. In this 
step, seeds are clustered together by similarity to selected anchor seeds. Then the seeds are 
stitched together based on alignment score [87]. 
HISAT2: Hierarchical Indexing for Spliced Alignment of Transcripts 2 (HISAT2) uses a graph-
based approach. It uses Burrows-Wheeler transformation (BWT) (Siren et al. 2014) to generate 
a new Graph Ferragina Marnzini index (GFM). A large set of small GFM indexes collectively 
covers a whole genome. These small indexes combine, which enables rapid alignment. This 
strategy is called the Hierarchical Graph Ferragina Marzini index (HGFM) and is used to index 
the whole genome[89] 
HTseq: STAR and HISAT2 provide SAM/BAM files as output, which need to be quantified. 
HTseq uses GFF (General Feature Format) or GTF (General Transfer Format) files to assign 
aligned reads to exon or genes [95]. It only counts uniquely assigned reads as count. The tools 
listed below have their own quantification algorithm.  
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RSEM: RNA-seq by expectation maximisation (RSEM) consist of two steps. The first is to 
generate a transcript index, which is created by using the transcript sequences provided. The 
second step is to align reads on this index to estimate the abundance and their credibility 
interval. It is based on collecting all alignments and not just the best alignment. It allows two 
mismatches in the seed sequence of input read, usually the first 25 bases, and then it collects all 
loci where the sequence is aligned. After alignment, RSEM computes maximum likelihood 
abundance estimate using an expectation maximisation algorithm [90, 96]. A different aligner 
generates RSEM process alignment files. Bowtie2 is suitable for both short read alignment and 
produces multiple alignments with a user-defined gap and mismatches. 
Bowtie2: It makes the FM index of reference genome or transcript to align reads. It uses the 
vectorised Smith-Waterman or Needleman-Wunsch algorithm, which enable it to perform 
alignment with mismatches and gaps [97].  
Kallisto: It is based on the unique idea of pseudo-alignment to determine the match between 
reads and the transcript [91]. In this approach, an index is created by the transcript sequence 
provided, making a transcriptome De Brujin graph of k-mers. K-compatibility class lookup is 
done for each fragment if it is a paired-end read. To quantify the pseudo-alignment, Kallisto 
uses the following likelihood function (Equation 1). In this, yf,t is the compatibility matrix, f is 
the set of fragments, t is the set of transcripts, Lt is the effective length, and α is the probability 
of selecting fragments from the transcript:  
(Equation 1) 
Salmon: Salmon uses a quasi-alignment approach to quantify reads aligned to the transcript 
index having a hash table of k-mers. In the quasi-alignment approach, the read is scanned from 
left to right until matching k-mer is identified in the hash table. Then all suffixes available in 
the SA matrix are retrieved, and the maximum matching prefix is identified using the next k-
mer until the end of the read is reached. The final set is determined by consensus formation by 
all MMPs in that read. In Salmon, an expectation maximisation model is used to estimate 
abundance.   
3.3.4. Normalisation 
The quantified result from the alignment tools provides raw sequences, which need to be 
normalised for technical and biological bias, reducing redundancy. There are three sources of 
technical bias: i) normalisation for library size, i.e. TC (Transcript count), Median, UQ (Upper 
Quantile) and TMM (Trimmed Mean of Median); ii) normalisation for gene length, i.e. TPM 
(Transcript Per Million) and FPKM (Fragment Per thousand Million) and iii) normalisation for 
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known and unknown artefacts, i.e. housekeeping/stable genes and spike-in [96, 98-102]. 
Additionally, it has been shown that data normalisation accounting for the number of cells leads 
to more accurate analysis (tissue-offset) [33]. Furthermore, a spike-in sequence can also be 
added during RNA isolation and is subject to the stable expression [103, 104]. Below is a brief 
of the most commonly used normalisation methods: 
TC (Total count): the number of transcript counts remained after removing transcript with zero 
counts.  
Library size: the total number of reads aligned on the reference genome.  
UQ (Upper Quantile): Upper quantile is a scaling factor calculated as the ratio of counts of 
each sample divided by mean 75th percentile in all samples. If it is done for the 50th percentile, 
it is known as the median.  
TMM (Trimmed Mean on M-values): TMM normalisation is based on weighted trimmed 
mean log gene expression ratios. It is used by edgeR. 
TPM (Transcript Per Million): In TPM normalisation, the raw count is the length of a gene 
in kilobase and then scaled by per million scaling factor.  
FPKM (Fragment Per Thousand Million): In FPKM, the raw count is normalised for 
sequencing depth (per million reads) and then the gene length (in kilobases).  
RLE (Relative Log Expression): In this, the median library is calculated from the geometric 
mean of all columns, and the median ratio of each sample to the median library is taken as the 
scale factor. It is used by edgeR and DESeq2. 
Tissueoffset: It is assumed that each cell produces the same amount of RNA [101], which is 
not necessarily true [105]. For a biologically relevant count, the raw count needs to be scaled 
by tissue weight used in RNA isolation [33]. 
Spike-in normalisation 
RNA spike-in is RNA with a known reference sequence, acting as a negative control for the 
experiment used in a hybridisation assay. It is added to the sample according to the proportion 
of the total RNA before sequencing library preparation. The sequence and quantity of spike-in 
are known for the sample. It was initially made to normalize qPCR data, but later it was used 
in RNA-seq too. In this approach, the read count of the spike-in sequence is observed, and raw 
counts are scaled accordingly.  
3.3.5. Stable transcripts  
Reference transcripts or housekeeping transcripts are transcripts that express stably irrespective 
of condition and tissue. They are also used to normalise data. In some studies, it has been 
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observed that the expressions of these transcripts are not stable [106-109]. Therefore, it is not 
viable to call them housekeeping transcripts or reference transcripts, but they can be called 
stable genes for a specific condition. Little is known about stable genes/transcripts for skeletal 
muscle in training conditions, which thus need to be investigated. It has been suggested that 
both B2M and GAPDH can be considered as housekeeping genes by qPCR in resistance 
training based skeletal muscle. There are different ways of identifying stable transcripts. The 
classical way to identify stable genes is based on differential gene expression analysis and 
identification of genes/transcripts with less than 20-40% change in expression with significant 
p-value and gene ontology [110]. However, this method cannot provide a constant answer if 
the normalisation approach is changed. Another method is based upon CV value (ratio of mean 
and standard deviation), calculated from different count files generated from different 
normalisation approaches. Before that, low and very high expressing transcripts are removed, 
and transcripts with a fold change of more than 0.2 are filtered out. With the emergence of new 
statistical algorithms, it is understood that this selection does not account for systemic effect 
across groups and interclass correlation across samples [33, 111].  
3.3.6. Differential gene expression 
Genes having altered expression between conditions are known as differential expressed genes. 
To determine these genes, normalised gene counts are arranged into an expression matrix, and 
statistical analysis is performed to discover significant differences between expression levels in 
experimental groups. The significance of DE genes is calculated by p-values which are then 
corrected for multiple testing using, e.g. FDR. DESeq2 [98] and edgeR [99, 101] are the two 
most cited tools for differential gene expression. Both approaches are based on the negative 
binomial approach. These methods are based on sample size calculation and power estimation 
and have been developed for experiments with independent measurements. RNA-seq 
experiments that have a complex design with repeated measures need different approaches in 
identifying DE genes, which can include. Normal pairwise comparison for complex design 
cannot be relied upon, as they do not consider data arising from such experiments should be 
analysed by generalised linear mix model approach, which allows for random effect [112, 113]. 
The selection of DE genes is done by log-fold changes (logFC > 1) and significant value 
(Adjusted p-value < 0.05).  
Few studies are performing the comparison of different tools [29-32]. Each study 
reports different tools as outperforming others, which indicates that each dataset requires a 
specific pipeline. An absence of an RNA-seq pipeline for a skeletal muscle dataset motivated 
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this work. In this work, we aimed to standardize a data analysis pipeline for the correct analysis 
of the data.  
3.3.7. Gene ontology (GO) analysis 
The biological domain and knowledge relating to gene and gene product attribute, functions, 
assimilations and disseminations are annotated into ontologies provided by numbers or IDs. It 
covers three domains: cellular component, molecular function and biological process [114]. It 
is vital to know which functions or pathways are changed in differential expression analysis 
between the condition(s). It provides further insight into genes expression change with the 
condition and provides associated pathways, co-regulating genes and signals. Therefore, if 
anyone wants to design a drug target or identify genes affected in a pathway and want to 








4. Materials and Methods 
Only a few transcriptomic studies related to health and sports [80, 115, 116]. This study is 
undertaken to understand the training responses on muscle growth of low and moderate training 
volume, vitamin D3 supplementation and COPD diagnosis. To achieve this, two datasets were 
used.  
4.1. Datasets  
4.1.1. Resistance training in young adults (YOUNG dataset) 
The YOUNG dataset comprised 16 male and 18 female non-smoking participants between 18 
- 40 years enrolled in the study. Participants were excluded who had an intolerance to local 
anaesthetic, a training history of more than one weekly resistance-exercise session during the 
last 12 months leading up to the intervention, impaired muscle strength due to any type of injury 
or an intake of prescribed medication that could affect adaptations to training, were excluded. 
Seven participants were excluded due to not completing the scheduled training sessions for 
differing reasons: discomfort, pain or injury. Each participant performed a standardised warm-
up routine consisting of 5 mins of ergometer cycling and ten repetitions of bodyweight 
exercises, including push-ups with individually adjusted leverage, sit-ups, back-extensions and 
squats. One set of 10 repetitions at ∼50% of the one-repetition maximum (1RM) for each 
resistance exercise was performed. Leg resistance exercises were performed in the following 
order: unilateral leg press, leg curl and knee extension. They were performed as either one set 
(single set) or three sets (multiple sets) per exercise for alternate legs selected randomly [117, 
118]. Biopsies were collected from the musculus vastus lateralis before and after the training 
intervention and at the week two training session.  
4.1.2. Resistant training in older adults with or without COPD (OLDER dataset) 
The OLDER dataset comprised 44 male, and 51 female participants (age 56 – 77) enrolled in 
the study. Participants had a  consumption of < 400 international units (IU) of vitamin D3 per 
day for the two months leading up to the study, and either normal lung function or a medical 
diagnosis of COPD (GOLD grade II or III, FEV predicted between 80% - 30%, 
FEV/FVC < 70% (Forced Expiratory Volume/Forced Vital Capacity) after reversibility testing 
with inhalation of salbutamol and ipratropiumbromid Due to incompletion of the training 
protocol, 17 participants were excluded from the study.  All participants performed unilateral 
leg press, unilateral knee extension, unilateral knee flexion, chest press and leg pulldown. Leg 
exercises were performed as three sets of 10 repetitions (high-load) and another of 30 repetitions 
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(low-load) or to exhaustion. All three sets for one leg were conducted before the other leg was 
exercised [119]. Biopsies were collected from m. vastus letralis before supplementation, before 
and after the training intervention and at 3.5 weeks mark of the training intervention. 
4.2. Biopsy collection 
Muscle tissue was obtained bilaterally from m. vastus lateralis using a 12-gauge needle 
(Universal-plus, Medax, San Possidonio, Italy) under local anaesthesia (Xylocaine, 
10 mg×ml−1mg×ml−1 with adrenaline 5 μg × ml−1, AstraZeneca AS, Oslo, Norge).  
4.3. RNA isolation 
Approximately 10 – 20 mg of wet muscle tissue was homogenised in a total volume of 1 mL 
TRIzol reagent (Invitrogen, Carlsbad, CA, USA) using 0.5 mm RNase-free zirconium oxide 
beads and a bead homogeniser (Bullet Blender, Next Advance, Averill Park, NY, USA), as 
previously described [117]. To enable an analysis of target gene expression per unit tissue 
weight, an exogenous RNA control (λ polyA External Standard Kit, Takara Bio Inc., Shiga, 
Japan) was added at a fixed amount (0.04 ng/mL of Trizol reagent) per extraction before 
homogenisation [120, 121]. Following phase separation, 450 μL of the upper phase was 
transferred to a new tube and RNA was precipitated using isopropanol. The resulting RNA 
pellet was washed three times with 75% ethanol, eluted in 30 μL TE buffer and diluted to 100 ng 
RNA/μL, following quantification of total RNA concentration using μDrop plate and the 
Multiskan GO microplate spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA). 
RNA integrity was assessed using capillary electrophoresis (Experion Automated 
Electrophoresis Station using RNA StdSens Assay, Bio-Rad, Hercules, CA, USA) with an 
average integrity score <7. 
4.4. RNA-Seq 
mRNA sequencing libraries were prepared from 1000 ng of total RNA using TruSeq Stranded 
Total RNA Library Prep (Illumina, San Diego, CA, USA). Paired-end sequencing (150 bp) was 
performed using an Illumina HiSeq 3000 (Illumina, San Diego, CA, USA) at the Norwegian 
Sequencing Centre, Oslo, Norway. 
4.5. Bioinformatics tools 
4.5.1. Data Preprocessing 
Trim Galore (version 0.6.5, https://github.com/FelixKrueger/TrimGalore) and Trimmomatic 
(version 0.39) [122] were used to discard low-quality reads and to trim poor-quality bases 
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before alignment, using default settings. The quality of filtered files was calculated by FastQC 
(version 0.11.4) and summarised using MultiQC (version 1.8) [86]. 
4.5.2. Mapping to reference human genome  
Filtered reads were aligned to the human genome (GRCh38 release-97 downloaded from 
ftp.ensemble.org) using the alignment-based methods HISAT2 (version 2.1.0) [123] , STAR 
(version 2.7.2) [87]  and RSEM (version 1.3.1) [90] and were used together with Bowtie 2 
(version 2.3.4.3) [97] and non-alignment methods including Kallisto (version 0.44.0) [91] and 
Salmon (version 0.13.1) [92]. For HISAT2 and STAR, SAM files generated as alignment 
results were used by HTSeq to generate a quantified expression of features [93]. RSEM, 
Kallisto, and Salmon have in-built quantification functions. 
4.5.3. Normalisation 
Normalisation accounts for bias due to sequencing depth, gene length was performed [124, 
125]. It also aims to remove systemic technical effects and ensure that it has no or negligible 
effect on results [126].  
4.5.4. Sequencing for Spike-in sequence 
Commercial spike-in control (λ polyA External Standard Kit, Takara Bio Inc., Shiga, Japan) 
was added before preparing samples for sequencing. For propriety reasons, the sequence of 
spike-in control was confidential and therefore was not shared by the vendor. Sequencing was 
performed on spike-in control using Illumina HiSeq 3000. Filtered reads were assembled using 
Spades v3.15.2 [127]. The scaffolds were blast searched against the NCBI reference genome 
database (phage genome). The reference genome was identified, and a longer scaffold was 
made by manually joining the reads aligned on the genome perfectly. Expression for this 
sequence was identified for all the files by alignment and quantification by RSEM and was used 
as the normalisation factor.  
4.5.5. Differentially expressed (DE) genes 
Three different normalisation strategies were compared based on negative binomial and 
GLMM, i.e. DESeq2 [98], edgeR [101] and the GLMM approach [112].  
4.5.6. Gene ontology  
Enrichment analyses of gene ontology (GO) gene sets were performed using three different 
approaches. First, a non-parametric rank test which is described in Yamaguchi et al. [128] and 
implemented in the tmod package v.0.40 [129], was performed based on gene-specific 
minimum significant differences (MSD). MSD was defined as the lower limit of the 95% 
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confidence interval (CI, based on estimated standard errors) around the log fold-change (FC) 
when log(FC) > 0 and the negative inverse of the upper 95% CI when log(FC) < 0. This metric 
has been shown to have lower false-positive rates compared to other metrics applied during 
enrichment analyses [130]. As the MSD metric is positive when the CI does not overlap 0 and 
negative when overlap occurs, the rank test does not discern between up and downregulated 
gene sets. A second approach, gene set enrichment analysis (GSEA) [131], was used to quantify 
the directional regulation of the gene set. GSEA was performed using the fgsea package [132] 
with Log (FC) as the gene level metric. Thirdly, over-representation analysis (ORA) was 
performed to assess if genes identified as DE (|Log2 fold-change|> 0.5 and adjusted p-
values < 0.05; DE-genes) belonged to specific gene sets. ORA was performed using the 
enrichGO function in the clusterProfiler package [113] (version 3.16.0). GO gene sets 
(biological process, cellular component and molecular function) were retrieved from the 




5. Knowledge gaps and aim of the thesis 
Primary aim: To develop RNA-seq data analysis strategies to analyse skeletal muscle 
transcriptome responses to resistance training and to employ these to study two different 
datasets.  
Sub-objective 1 
Background: In recent years, several benchmarking studies have shown strong disagreement 
with each other on which tool or method performs best for the analysis of the RNA-seq data. 
The reason for this disagreement may lie in the usage of different datasets and/or simulated data 
to evaluate these tools. It is possible that each dataset type requires its own data analysis 
pipeline. The normalisation of technical bias is one of the crucial steps in data analysis. 
However, biological biasness is also needed to be considered.  
Aim: To develop a pipeline for analysis of RNA-seq dataset from skeletal muscle training using 
the following secondary objectives: 
 To establish a bioinformatic pipeline specific for the analysis of RNA-seq data from 
skeletal muscles. (Paper I) 
 To explore the effects of using different normalisation strategies for analysing and 
interpreting skeletal muscle transcriptome responses to resistance training. (Paper I and 
II) 
Sub-objective 2 
Background: Resistance training is a potent driver of skeletal muscle plasticity, and the degree 
of plasticity can be affected by training volume, vitamin D3 supplementation and physiological 
condition like COPD. However, little is known about the interplay between skeletal muscle 
plasticity and these variables.  
Aim: The standardised RNA-seq pipeline was employed to analyse skeletal muscle 
transcriptome data from two human interventions, including (i) young and healthy adults 
performing 12 weeks of resistance training with two different volumes; and (ii) older 
participants with and without COPD condition performing 13 weeks of resistance training, with 
and without Vitamin D3 supplementation.  
 
This was achieved using the following secondary objective: 
 To explore the effects of resistance training with low and moderate volume for 
transcriptome responses in skeletal muscle in young adults.  (Paper I) 
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 To explore the impact of vitamin D3 supplementation and COPD diagnosis for skeletal 




6. Results and Discussion 
6.1. Standardisation of RNA-seq pipeline for skeletal muscle  
NGS has become a valuable tool for gene expression studies in precision medicine, diagnostics 
and population studies during the past few decades [133]. The data generated from such studies 
represent gene expression of the whole mRNA population at a given condition with remarkable 
detail. Despite a wealth of available data and studies focused on comparing different tools for 
RNA-seq data analysis [30, 32, 94], there is no pipeline specific for analysis of skeletal muscle 
data or transcriptome response to resistance training. Moreover, reports on which tools are best 
for such analyses vary from dataset to dataset. Therefore, it is crucial to identify tools 
specifically for resistance training-induced growth in skeletal muscle. The YOUNG dataset was 
used to compare different tools to obtain a skeletal muscle specific pipeline. 
6.1.1. Tools for preprocessing of data  
Before the analysis, raw sequencing data needs to be quality filtered, and sequencing adaptors 
should also be removed. Trimming and quality filtering affect downstream analysis by 
removing low-quality and ambiguous reads before alignments. Such steps, collectively referred 
to as data pre-processing, apply to all sequencing technologies where sequence quality needs to 
be monitored [134]. These steps are collectively referred to as data preprocessing. As there is 
no single answer for the generic question “Which tool is best for preprocessing?”; we decided 
to test the most frequently cited tools data pre-processing, trimmomatic and trim galore. 
Trimmomatic and trim galore are cited in more than 27100 and 11600 articles, respectively 
(listed on Google Scholar on 15 October 2021). Before and after preprocessing, quality was 
assessed by FASTQC and summarised by multiQC (Paper I: Figure 1G). Based on this quality 
assessment, trim galore failed to filter out low-quality data, whereas trimmomatic was more 
effective in removing low-quality bases for the YOUNG dataset. This is because adaptor 
sequence search in trimmomatic is more effective than trim galore [135]. Although trim galore 
retained a higher number of sequences after filtering, their average quality was lower. In 
addition, trimmomatic was fast in processing; it took 12 minutes 12 seconds per million reads, 
while trim galore took 19 minutes 13 seconds per million reads. These run times are similar 
(trimmomatic – 8 minutes and trim galore 23 minutes) to what has been earlier reported [135]. 
Using data without preprocessing can lead to alignments with a low score which can be dropped 
if they have many mismatches due to the presence of adaptor sequences [136]. Therefore, we 
used trimmomatic to do the preprocessing before performing the read alignment step. 
42 
 
6.1.2. Selection of alignment tool 
Filtered reads were aligned on the Human Genome GRCh38 using three different alignment-
based methods (STAR, HISAT2 and RSEM) and two non-alignment-based methods (Kallisto 
and salmon). RSEM, Kallisto and Salmon identified more features than STAR and HISAT2 
(Figure 6). Transcript based methods aligned around ten times the number of reads and 
identified 50% more features as compared to the genome-based methods. The average reads 
aligned by STAR, HISAT2 were less than two million reads, and less than 15000 features were 
identified. In contrast, Kallisto and salmon aligned, more than 12 million reads, and RSEM 
aligned with over 8.5 million reads. 
All transcript-based aligners identified more than 22000 features/genes. However, a 
higher number of genes is not a good criterion for assessing the performance of alignment tools. 
Instead, variability in replicates can be used as a measure of alignment performance [94]. RSEM 
had the lowest standard deviation between technical replicates in resting samples before the 
training protocol, followed by Salmon and Kallisto (Paper I: Figure 1J). In addition, alignment 
performance can be assessed by mRNA to protein expression correlations. To compare 
alignment performance between tools, we specifically used mRNA and the protein profile of 
the main myosin heavy chain genes. The myosin heavy chain protein profile and RNA-seq 
based myosin heavy chain family mRNA show a higher degree of correlation with RSEM 
count, which was lowest in HISAT and STAR (Paper I: Figure 2a).  
 
Figure 6. The average number of reads identified after preprocessing and the average number 




































6.1.3. Total RNA concentration changes with resistance training 
Before identifying DE genes, count data need to be normalised to reduce the effects of technical 
bias and variation. TMM and RLE, which are the most used RNA-seq data normalisation 
strategies are based on the assumption that all cell produces an equal amount of RNA at a given 
condition [33]. In contrast to this assumption, increased total RNA per unit tissue weight was 
seen in the samples obtained after resistance training [117]. Samples obtained at weeks 2 and 
12 had higher total RNA concentrations than resting samples (week 0). Total RNA 
concentrations were also affected by training volume. As a fixed amount of total RNA was used 
in all preparations, these effects resulted in lesser amounts of tissue used in library preparations 
in trained compared to non-trained samples and in high-volume samples compared to low-
volume samples (Paper I: Figure 3a and 3b). The mRNA volume has also increased with total 
RNA, which is evident from larger library sizes during the training intervention and suggests 
that it is not feasible to ignore total RNA changes. Previous studies by Lin et al. and Nie et al. 
in tumour cells and stem cells, respectively, found that proto-oncogene c-Myc, which plays a 
role in cell cycle progression, increases the total RNA as an effect of c-MyC [105, 137]. This 
changes the assumption that the cell produces a similar amount of total RNA, which is needed 
to account for better biologically correct normalisation factors (Paper I and II). Moreover, 
spike-in was added in all the samples in equal ratio with total RNA, acting as a negative control 
to normalize the count matrix.  
6.1.4. Spike-in sequence identifications 
Raw sequence files were filtered for quality and de novo assembled by Spades, which resulted 
in 26 contigs with lengths larger than 200 bp. The maximum contigs size was 837 bp. These 
selected contigs were blast against the NCBI non-redundant nucleotide database, and the 
sequence was found to match against the EA22 CDS of Enterobacteria phage lambda genome 
(NC_001416.1).  Three of the contigs aligned with 99% sequence identity. After joining these 
contigs based on the alignment on the lambda genome resulted in a 954 bp long consensus 
sequence. This sequence was treated as the spike-in transcript for downstream analysis. Based 
on our previous analysis of standardising the analysis pipeline alignment tool, RSEM was 
selected to perform the alignment and quantification.  The above selected spike-in transcript 
was aligned to the RNA-seq data to get the spike-in expression for all the biopsy samples. 
6.1.5. Normalisation strategies and their effects on RNA-seq data  
Different normalisation methods can lead to different results for identifying stable and DE 
genes [29, 138-140]. In this study, four different normalization methods were compared, i.e. 
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mRNA (TMM), total RNA (raw), tissue size (tissue offset) and spike-in. Figure 7 represents 
the difference in expression of all the expressed genes by the coefficient of variance (CV) value 
calculated by the ratio of standard deviation and mean. Library size normalization and mRNA 
(TMM) normalization showed similar CV values, while high CV values are observed in spike-




6.1.6. Selection of stable transcripts 
In many studies, CV value and logFC have been used to identify stable genes from the 
normalised count, and to account for differences in various normalisation techniques, common 
genes were taken using count data generated by different normalisation strategies [111, 141-
144]. However, CV value does not account for systemic effect and intraclass correlation, which 
is defined as the amount of variance attributed to between-participant variation relative to the 
total variance. A cutoff of 1.5 t-value is used to filter for potential stable genes. These transcripts 
were ranked by ascending interclass correlation (ICC). TMM and spike-in normalised count 
data reported 1266 and 1337 transcripts, respectively (Figure 8), and the selected stable genes 
have high ICC value and rank.  
High ICC value transcripts represent the most stable genes across the samples (Paper 
II: Figure 1) and (Figure 8). Total RNA (raw) and tissue-offset normalised count identified 90 
and 19 transcripts, respectively; selected transcripts having high ICC scores are coloured (Fig. 
Figure 7. Coefficient of variance by different normalisation strategies, including - library 
size, TMM, tissue offset and Spike-in. 
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8). Transcripts selected by these methods are compared for their expression change by 
normalizing with normalisation factors calculated by shortlisted transcripts (Figure 9), which 
shows a slight change in transcript expression (of transcripts listed in Table 2 and Paper II: 
Table 1) while comparing to each other. Comparing the average ratio of fold changes with time 
and volume between normalisation strategies (Figure 9), the least differences were identified 
between spike-in and tissue normalised data compared to any other comparison. It shows a 10% 
fold change difference at week 2 and 5% at week 12 for multiple set data, and single set training 
has less effect as muscle growth have less difference between fold changes. The similarity 
between tissue weight and spike-in normalised fold changes is due to the spike-in control 
sequence being added in accordance with tissue weight. Even if spike-in and TMM normalised 
counts reduced technical biasness, it could not account for biological biasness of tissue weight 
usage during RNA isolation. This suggests that tissue weight should be used to normalise the 
count. One of the advantages of tissue weight normalisation is that there is no additional cost 
for external spike-in purchase and sequencing.  
 
 
Figure 8. Genes were selected by different normalisation methods based on the intraclass 
correlation among genes with systemic effect (< 1.5). Selected stable transcripts are coloured 




Figure 9.  The ratio of normalisation factors over time and volume condition. 
 
Table 2. Genes selected as stable reference genes from each normalisation scenario. 
Transcript ID Gene Symbol Gene biotype Intraclass correlation 
ENST00000457540 MTND2P28 pseudogene 0.8859148 
ENST00000361681 MTND6 Protein coding 0.8574938 
ENST00000346365 NUDT2 Protein coding 0.8479227 
ENST00000522543 ANK1 Protein coding 0.8186528 
ENST00000295955 RPL9 Protein coding 0.809337 
ENST00000361227 MTND3 Protein coding 0.7973469 
ENST00000445193 RPP14 Protein coding 0.7885435 
ENST00000520612 MTND6P3 pseudogene 0.7837061 
ENST00000342751 SDHC Protein coding 0.783665 
ENST00000370474 SDHAF4 Protein coding 0.7792214 
 
6.1.7. Differential gene expression by different tools  
Two different approaches were tested for DE analysis - negative binomial models (DESeq2 and 
edgeR) and negative binomial Generalised Linear Mixed Model (GLMM). The advantage of 
using GLMM is that, unlike negative binomial models, this method allows for incorporating 
both random and fixed effects, which is not possible in DESeq2 and edgeR. For comparing the 
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simplest experimental design, a subset of data (weeks 0 and 2) from the YOUNG dataset was 
used to look for DE genes. EdgeR identified 1689 genes and DESeq2 identified 943 DE genes, 
having 920 overlapping genes with each other. In comparison, GLMM identified 340 DE genes 
and 319 genes common in all methods. DESeq2 and edgeR are based on sample size calculation 
and power estimation at the marginal or dataset level to test DE genes. However, these methods 
cannot be applied to correlated expression data, as they can lead to biased estimates and fail on 
error rate control and increase false-positive results [145-147]. To overcome this, the GLMM 
approach was considered for experimental design with a diverse correlation structure. This 
(GLMM) procedure can be applied to multifactorial design and allow multiple random effects 
[112, 147]. So, even though observing a higher number of DE genes, edgeR and DESeq2 were 
not considered for further analysis. 
 
Figure 9. Venn diagram comparing DE genes identified by each method in comparing week 0 
and week 2. 
 
6.1.8. Transcriptomic changes related to training volume  
We found 21 genes with higher expression in the moderate- compared to the low-volume 
condition at week 2. At weeks 0 and 12, there were no DE genes (Paper I: Figure 3D and 3H). 
Functional analysis of these DE genes revealed a gene ontology relationship with an ECM 
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(Paper I: Figure 3F ad Table 2). Different ECM changes induced by different training volumes 
have been reported in a few studies ([148] and Paper I). During systematic and repeated 
exercise, cells undergo changes in their mRNA and protein pool, specifically more in ECM 
related genes [148]. The formation of new fibre tubulin, signalling, cell size is related to ECM 
related gene ontologies [148]. Genes related to ECM function are upregulated during the early 
stages of resistance training and during prolonged endurance and resistance training, which has 
a beneficial effect on high-volume resistance training [149-156]. This is a novel finding, as 
before this, ECM remodelling gene changes for different training volumes has not been 
identified. Also, requiring fifty-three 1 (RFT1) gene showed a 6-fold increase in expression in 
moderate vs low volume resistance training. GO analysis of the RFT1 gene showed that it was 
linked with lipid transport, carbohydrate transport and is located in the endoplasmic reticulum 
membrane. Previously, Pillion et al. have reported a decrease in RFT1 immediately after 
training [157]. 
6.1.9. Transcriptomic changes with time during training 
3923 genes were upregulated, and 77 genes were downregulated at week 2. In addition, at week 
12, 1733 genes were upregulated, and two genes were downregulated (Paper I: Figure 4). GO 
terms associated with these genes belonged to ECM remodelling, which is expected as we have 
seen an increase in muscle mass and training act as stress [158]. 
6.2. Application of standardised RNA-seq pipeline on the OLDER dataset 
6.2.1. Vitamin D3 effect on muscle growth 
Vitamin D3 supplementation showed a remarkable increase in (25(OH)D) and (1,25(OH)2D) 
(Paper III: Figure 2 B and C), and with 12 weeks of resistance training showed increased 
muscle strength (Paper III: Figure 6A) and muscle mass (Paper III: Figure 7A). Vitamin D3 
itself did not exhibit any effect on muscle mass (Paper III: Figure 6B and 7B). However, minor 
gene expression changes have been observed in the transcriptome profile due to vitamin D3 
supplementation (Paper III: Figure 5A) as we identified 27 upregulated and 27 downregulated 
genes. This included increased expression of B-cell lymphoma 6 (BCL6) and prolyl 4-
hydroxylase subunit alpha-1 (P4HA1), both of which are known to oppose accumulation of 
ROS, and decreased expression of angiopoietin-like protein 4 (ANGPTL4), which is closely 
correlated with levels of mitochondrial respiration. This was supported by gene enrichment 
analysis, which showed a general reduction in the expression of genes related to oxidative and 
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glycolytic metabolism in the vitamin D3 arm altered expression of genes related to 
mitochondrial function (Paper III: Figure 5B).  
 Besides, vitamin D3 supplementation had no effect on training-associated changes in 
gene expression, either at 3.5 weeks or at 13 weeks (Paper III: Figure 11D and E). This 
suggests that no single gene was differentially affected by combined vitamin D3 
supplementation and resistance training and resistance training-only. In contrast, enrichment 
analyses showed minor vitamin D3-sensitive changes in expression at both 3.5 and 13 weeks 
(Paper III: Figure 11F). After 3.5 weeks of training, there was DE of genes involved in cell 
junctions, blood vessel morphogenesis and muscle cell differentiation. After 13 weeks, the 
vitamin D3 arm showed increased expression of genes involved in endothelial proliferation and 
blood vessel morphogenesis compared with placebo. 
However, the role of vitamin D3 cannot be denied, as it increases total lean mass by 
1.4% and reduces lipid level and fat mass (Paper III: Table S11). Vitamin D3 controls calcium 
metabolism to increase calcium uptake and reduce intestinal fatty acid absorption [123]. Also, 
our results suggest that vitamin D3 supplementation reduced lung function by approximately 
3% (Paper III: Table S2), which is in contrast to a previous study that reported vitamin D3 
deficiency is associated with reduced lung function [159].  
6.2.2. Muscle mass change in COPD diagnosed vs healthy individuals 
With decreased lung function and sarcopenic condition, COPD diagnosed participants exhibited 
impaired training capabilities (Paper IV: Table 1) [160]. During training, COPD participants 
exhibited a higher increase in muscle strength than healthy participants (Paper IV: Figure 4). 
However, joining both high and low load training modalities reported similar outcomes. Both 
groups averagely exhibited similar improvement in muscle mass gain, but overall improvement 
was better in COPD participants. A baseline baseline-level transcriptome profile between 
COPD diagnosed participants and healthy participants displayed 227 genes being DE (151 
upregulated and 76 downregulated). However, no transcript showed differential responses at 
the single-gene level at either time point, despite clear differences in transcriptome profile at 
the baseline. In contrast, the enrichment analysis revealed minor increases in expression of 
genes relating to oxidative phosphorylation after 3.5 weeks and decreases in genes associated 









7. Conclusion  
A standardized pipeline for analysis of RNA-seq dataset from human skeletal muscle was 
developed based on the YOUNG dataset. For pre-processing of data, trimmomatic was found 
to be a better choice than trim galore. For read alignment and quantification, RSEM proved to 
be a better tool having less variation between replicates and increased biological relevance. 
Also, the effects of using different normalisation strategies for analysing and interpreting 
skeletal muscle transcriptome responses to resistance training was explored. Analysis of data 
from this model showed that the choice of the normalization model affected downstream data 
interpretations. While all normalization models arguably remove technical biasness, our results 
suggest that it may be necessary to account for biological biasness caused by global changes in 
total RNA population (i.e., total RNA per tissue mass) to increase the biological relevance of 
transcriptome analyses from resistance-trained skeletal muscle. It is further suggested that 
assumptions of specific standardised RNA-seq pipelines are explicitly tested in each dataset.  
The developed RNA-seq pipeline was employed to analyse skeletal muscle 
transcriptome data from the YOUNG and the OLDER human interventions. Firstly, in the 
YOUNG dataset, the effects of resistance training with low and moderate volume for 
transcriptome responses in skeletal muscle in young adults were explored. At week 2, the two-
volume condition was associated with DE of 21 genes, mostly related to ECM remodelling. In 
contrast, at Week 12, no readily explainable dose-dependencies were observed.  
Secondly, in older participants, the impact of vitamin D3 supplementation and COPD 
diagnosis for skeletal muscle transcriptome responses to resistance training was explored. 
Overall, resistance training improved muscle functions and increased muscle mass, but there 
was no additional effect of vitamin D3 supplementation. COPD participants showed hitherto 
largely unrecognized responsiveness to resistance training as they improved muscle functions 
and increased muscle mass to a similar or larger extent than healthy participants. After 3.5 
weeks of resistance training, enrichment analysis showed that COPD participants had a greater 
increase in expression of genes related to oxidative phosphorylation than healthy participants. 
After 13 weeks of resistance training, COPD showed more pronounced decreases in genes 
related to myogenesis.  
In conclusion, the developed RNA-seq data analysis protocol to analyse skeletal muscle 
transcriptome responses to resistance training was successfully employed to study the YOUNG 






8. Future work 
This study was based on a comparative analysis of different tools and strategies used in RNA-
seq. Our results present an RNA-seq data analysis pipeline for resistance training-induced 
growth skeletal muscles data. It is suggested to perform similar comparison/s using additional 
tools and models for analysis and to use different datasets.  
Transcriptome analysis has been altered by resistance training, but gene expression is 
not the only aspect that needs investigation. Small ncRNAs (e.g. miRNA, siRNA) also 
regulated transcription. Small RNA sequencing can be done to find the relationship between 
small RNA and mRNA. There have been studies for myo-MIRs (micro RNAs). However, a 
joined experiment is needed to explore mRNA and small RNA changes together. A study design 
consisting of four different training modules involving no training, low, moderate and very high 
training is needed. This can be achieved by studying data of these contrast, which could lead to 
improved training protocols for healthy ageing. Additionally, it can also aid in designing 
miRNA-based medication for the population with critical muscle mass.  
Moreover, personalised training interventions can be designed using transcriptome 
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Increased biological relevance 
of transcriptome analyses in human skeletal 
muscle using a model‑specific pipeline
Yusuf Khan1,2† , Daniel Hammarström2,3† , Bent R. Rønnestad2, Stian Ellefsen2,4  and Rafi Ahmad1,5* 
Abstract 
Background: Human skeletal muscle responds to weight-bearing exercise with 
significant inter-individual differences. Investigation of transcriptome responses could 
improve our understanding of this variation. However, this requires bioinformatic 
pipelines to be established and evaluated in study-specific contexts. Skeletal muscle 
subjected to mechanical stress, such as through resistance training (RT), accumulates 
RNA due to increased ribosomal biogenesis. When a fixed amount of total-RNA is used 
for RNA-seq library preparations, mRNA counts are thus assessed in different amounts 
of tissue, potentially invalidating subsequent conclusions. The purpose of this study 
was to establish a bioinformatic pipeline specific for analysis of RNA-seq data from skel-
etal muscles, to explore the effects of different normalization strategies and to identify 
genes responding to RT in a volume-dependent manner (moderate vs. low volume). 
To this end, we analyzed RNA-seq data derived from a twelve-week RT intervention, 
wherein 25 participants performed both low- and moderate-volume leg RT, allocated 
to the two legs in a randomized manner. Bilateral muscle biopsies were sampled from 
m. vastus lateralis before and after the intervention, as well as before and after the fifth 
training session (Week 2).
Result: Bioinformatic tools were selected based on read quality, observed gene 
counts, methodological variation between paired observations, and correlations 
between mRNA abundance and protein expression of myosin heavy chain fam-
ily proteins. Different normalization strategies were compared to account for global 
changes in RNA to tissue ratio. After accounting for the amounts of muscle tissue used 
in library preparation, global mRNA expression increased by 43–53%. At Week 2, this 
was accompanied by dose-dependent increases for 21 genes in rested-state muscle, 
most of which were related to the extracellular matrix. In contrast, at Week 12, no read-
ily explainable dose-dependencies were observed. Instead, traditional normalization 
and non-normalized models resulted in counterintuitive reverse dose-dependency for 
many genes. Overall, training led to robust transcriptome changes, with the number of 
differentially expressed genes ranging from 603 to 5110, varying with time point and 
normalization strategy.
Conclusion: Optimized selection of bioinformatic tools increases the biological 
relevance of transcriptome analyses from resistance-trained skeletal muscle. Moreover, 
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normalization procedures need to account for global changes in rRNA and mRNA 
abundance.
Keywords: RNA-seq, Skeletal muscle, Bioinformatics pipeline, Normalization
Background
Skeletal muscle is a highly adaptable tissue that responds to environmental stress by 
altering growth rates and differentiation processes. During resistance training, signaling 
cascades that stimulate muscle plasticity are triggered. Upon repeated exposures, this 
facilitates growth and a phenotypic shift in a metabolically active direction [1], with the 
opposite happening during inactivity [2]. Despite this generalized view, muscle respon-
siveness and plasticity vary, both in response to different resistance-training protocols 
[3] and, perhaps more importantly, between individuals [4, 5]. Selected individuals show 
a near-complete absence of muscle growth after prolonged resistance training, which 
markedly reduces the beneficial outcomes of such interventions for muscle function 
and overall health [4, 5]. Currently, little is known about the etiology of this variation. 
However, it is usually associated with phenotypic traits of skeletal muscle [6–8], which 
implies interactions with environmental factors, genetics, epigenetics, and composites 
of the intra physiological milieu [9, 10]. This multifaceted origin makes the training-
response-spectrum difficult to study directly, with each of the underlying factors offer-
ing limited explanatory value alone [11]. Instead, a more indirect approach is necessary, 
whereby the combined effects of the factors are targeted by studying global patterns of 
mRNA, protein expression, and skeletal muscle biology.
Previous studies have investigated transcriptome responses to acute resistance exer-
cise [12–14] and chronic resistance training [12, 13, 15–18], as well as described asso-
ciations between transcriptome characteristics and degrees of muscle growth [18, 19], 
and function [20, 21]. Whereas these studies have merited interesting findings, they lack 
clear coherences in terms of differential expression events, even for classical exercise-
inducible genes such as PGC1α [22]. This lack of clear coherence is potentially due to a 
combination of issues such as differences in study design and methods for synthesis and 
analysis of transcriptome data. First, biologically founded variability can be attributed to 
differences in exercise protocols (e.g., differences in exercise-volume or intensity). This 
makes it difficult to discern a general transcriptome exercise response, as training vari-
ables are not standardized between studies. Biological heterogeneity is also caused by 
differences between research participants, affecting signal-to-noise ratios and making it 
difficult to discern the effects of single independent factors such as training variables. 
Design stage decisions such as the use of within-participant designs [3, 23] are likely to 
reduce this variation and to provide transcriptome data with increased biological mean-
ingfulness. Second, technical variability can be attributed to decisions made during the 
bioinformatical treatment of data. As described by Concea et al. [24], there is no optimal 
pipeline for sequencing technology as new tools keep evolving and emerging, different 
tools should be explored to an optimum pipeline for the specific type of data. To exploit 
the potential of any study design, there is a need for identifying an appropriate pipe-
line for transcriptome analyses to ensure a biologically valid interpretation of data. This 
entails identifying potential violations of common assumptions caused by the experi-
mental model at hand, relating to, for example, data normalization [25, 26].
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For transcriptome data to provide adequate biological information about a given 
experimental set-up, numerous bioinformatic steps need to be adopted in a custom-
ized manner [24, 27]. Of these steps, data normalization is particularly decisive [26], as 
it aims to transform naïve transcript counts into biologically meaningful results. This 
essentially means expressing them as per-cell abundances [28]. For most experimental 
models, this is equivalent to providing transcript-to-total RNA ratios, given the fulfill-
ment of the assumption that total RNA levels remain stable between conditions on a 
per-unit-cell or per-unit-tissue basis [28]. In cell models that exhibit high degrees of 
plasticity, gene expression events result in increased amounts of total RNA and mRNA 
transcripts per cell [29], specifically violating the assumption that most genes are not dif-
ferentially expressed [25, 28]. We are not aware of any study that has addressed the need 
to account for such perspectives during transcriptome analyses of skeletal muscle sub-
jected to mechanical stress, such as resistance training. Indeed, this assumption can be 
expected to be violated, as total RNA content increases markedly on a per-unit-weight 
basis [3], with potential global changes also occurring for the mRNA pool, though 
this remains unknown. The extent to which total RNA, and therefore ribosomal RNA, 
increases, coincides with the increase in muscle mass [3, 7], underlining its importance 
for cellular growth but also its inevitable presence as a potential confounding factor in 
RNA sequencing experiments.
In this study, we aimed to (1) establish a bioinformatic pipeline specific for analysis of 
RNA-seq data from skeletal muscles, (2) explore the effects of using different normaliza-
tion strategies for analyzing skeletal muscle tissue subjected to resistance training, and 
(3) identify genes responding to moderate versus low resistance exercise volume, while 
simultaneously identifying genes whose expression changes with time. To achieve these 
aims, we utilized RNA-seq data generated from a within-participant study, comparing 
the effects of low and moderate resistance training volume, as previously described [3]. 
Also, myosin heavy chain protein expression, quantified using immunohistochemistry, 
was used to validate RNA quantification tools.
Results
For the RNA-seq analyses presented here, a subset of participants was selected based on 
RNA quality measurements from a previously reported study comparing the functional 
and biological efficacy of low- and moderate-volume resistance training [3] (Fig.  1a). 
Twenty-five participants (out of 34) had a full set of RNA-samples with RNA quality 
indicator (RQI) scores ≥ 7 , which were subjected to bioinformatic data analysis (Fig. 1b). 
RQI scores were not associated with RNA yield (Fig. 1c). In these participants, twelve 
weeks of training with moderate volume led to greater increases in limb lean-mass than 
low volume (3.5% vs. 2.0%, pre-training MOD mean (SD) 8.9 (2.2), to post-training 9.2 
(2.3) kg; pre-training LOW 8.9 (2.2), to post-training 9.0 (2.2) kg, Fig. 1d), corresponding 
well with MRI-based muscle cross-sectional area data from the full data set [3]. Similar 
responses were seen in the excluded participants (Fig. 1d). This coincided with greater 
strength gains (~ 25% vs. ~ 19%, Fig. 1f ), which also agrees with observations made in the 
full cohort, accompanied by greater changes in muscle fiber proportions (type IIX fibers 
↓ ) [3].
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Fig. 1 Study overview and RNA-seq analysis pipeline. Forty-one participants performed twelve weeks of 
resistance training with low- (one set per exercise, LOW) and moderate-volume (three sets per exercise, MOD) 
in a contralateral manner (2–3 sessions week-1) (a). Pre- and post-training testing included strength and 
muscle lean-mass assessments. Muscle biopsies were collected from m. vastus lateralis at four time-points, 
prior to and after the intervention (Week 0 and 12) and before and after the fifth training session (Week 2). 
Biopsies from participants who completed > 85% of prescribed sessions were used for RNA extraction (n = 34; 
A). RNA quality was assessed (b), and participants with RNA quality indicator (RQI) scores > 7 were submitted 
for RNA-seq (n = 25). RNA quality was not associated with muscle tissue weight (c), and participants included 
in RNA-seq experiments did not differ from excluded in terms of limb lean-mass gains (d). Higher training 
volume led to greater gains in limb lean mass (e) and strength (f) in the lower extremities (n = 25). RNA-seq 
data were quality filtered using trimgalore and trimmomatic and reads were compared to unfiltered reads (g). 
Read alignment was performed using five tools of which RSEM, kallisto, and Salmon showed greater fractions 
of genes with robust expression after removing low-abundance genes (expression filtering; H) compared to 
HISAT2 and STAR. RSEM, kallisto and Salmon also showed less Log2-differences between biological replicates 
in a subset of genes with known robust expression (see text for details, i)
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Bioinformatic pipeline for analysis of RNA‑seq data from skeletal muscles
To select the most appropriate tools for bioinformatic analyses, we first compared 
quality filtering using Trimmomatic and Trim Galore, both of which are commonly 
used [30, 31]. Quality scores were generally better with Trimmomatic (Fig. 1g). Trim 
Galore did not improve scores over non-filtered data (Fig.  1g). Filtered reads were 
then aligned to the human genome using three alignment-based methods (includ-
ing HISAT2, STAR, RSEM, all used together with Bowtie 2) and two non-alignment-
based methods (kallisto and Salmon). RSEM, Salmon and kallisto all showed similar 
characteristics in terms of gene counts, resulting in the expected bimodal distribution 
of counts and a larger subset of detected genes after expression filtering compared 
to STAR and HISAT2 (Fig. 1h). For a selection of genes with known robust expres-
sion across tissues [32], Salmon, kallisto, and RSEM resulted in higher proportions 
of genes with high count numbers (Fig.  1i). RSEM was found to be associated with 
lower technical variation than Salmon, kallisto, HISAT2, and STAR expressed as 
log-differences in the expression of these genes between bilateral biopsies sampled 
prior to the intervention (Fig. 1j). For HISAT2 and STAR, this distorted correlations 
between RNA-seq based myosin heavy chain family mRNA and myosin heavy chain 
protein profiles (Fig. 2a and b), with the latter identified in Hammarström et al. [3], 
which are established hallmarks of skeletal muscle biology [33–35]. Overall, RSEM, 
kallisto, and Salmon thus displayed superior technical performance than HISAT2 and 
STAR, resulting in data with lower degrees of technical variation and higher degrees 
of biological validity. RSEM displayed slightly lower average variation between paired 
samples and was thus chosen for downstream analyses.




























































































Fig. 2 Correlations between myosin heavy chain mRNA and protein abundance. mRNA abundances of 
myosin-heavy chains in m. vastus lateralis estimated using RSEM, kallisto, and Salmon showed stronger 
correlations with immunohistochemistry-determined protein expression than HISAT2 and STAR (a, b). mRNA 
and protein abundances of MYH7/Type I, MYH2/Type IIA, and MYH1/Type IIX were calculated as percentages 
of overall myosin-heavy chain mRNA and protein expression, analyses unbiased by normalization [34, 46]
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Effects of normalization strategies on transcriptomic data analysis 
from skeletal muscle under hypertrophic stress
In the selected participants, similarly to what has been reported in the full cohort [3], 
resistance training led to an increase in total RNA per-unit tissue weight that was larger 
in response to moderate- versus  low-volume training (Week 2, low 15% vs. moderate-
volume 24%, mean difference 7.7%, 95% CI [1.1, 14.8]; Week 12, low 15% vs. moderate-
volume 24%, mean difference 7.7%, 95% CI [1.1, 14.8]). As equal amounts of total RNA 
were used for preparing RNA-seq libraries, the amounts of muscle tissue used for library 
preparations decreased from baseline to Week 2 and 12 in both legs (low volume, − 13% 
and − 9%; moderate volume − 20% and − 15%). This decrease was subsequently more 
pronounced in the moderate volume condition, resulting in lower amounts of tissue 
used in cDNA synthesis (− 7.1%, 95% CI [− 12.9, − 1.0]; − 6.3%, [− 11.8, − 0.4]; Fig. 3a). 
Despite the utilization of less muscle tissue during library preparations in the trained 
state, effective library sizes increased compared to baseline levels (low volume, 25%, 
and 38% at Week 2 and 12, respectively; moderate volume, 16%, and 26%; Fig. 3b). Ini-
tially, this increase was numerically less pronounced in the moderate volume condition 
(− 11%, [− 22, 1.7]; − 12%, [− 24, 2.2]; Fig. 3b), but after normalization to tissue weight, 
the two training modalities resulted in similar increases in effective library size (low vol-
ume, 43%, and 53% at Week 2 and 12, respectively; moderate volume, 43%, and 49%; 
Fig. 3c). Overall, this suggests marked increases in global mRNA expression in response 
to both low- and moderate-volume resistance training.
Identification of genes responding to moderate, compared to low exercise 
volume
During subsequent identification of differentially expressed (DE) genes in response 
to low- and moderate-volume resistance training, three normalization models were 
used and compared. The first model contained effective library sizes as a covariate, as 
(See figure on next page.)
Fig. 3 Global mRNA expression and transcriptome profiles in response to low and moderate volume 
resistance training. The amounts of muscle tissue used during cDNA synthesis varied over the course of the 
study and between volume conditions (a low-volume, LOW; moderate-volume, MOD). Library sizes increased 
during the course of the intervention, with a tendency towards a greater increase in the low-volume 
condition (b). Difference in library sizes between volume conditions when expressed per-unit tissue weight 
were diminished, though increases from baseline were maintained (c). The tissue offset-normalized model 
identified 21 genes with higher expression in the moderate volume condition (d, e), ten of which was shared 
with the effective library-size normalized model at week 2 (e), and none of which was shared with the naïve 
model. No volume-dependent differences were found at Week 12 using the tissue-offset model. At this time 
point, library-size and naïve models both showed a marked skew towards augmented expression in the 
low-volume condition. At Week 2, functional annotation identified gene sets relating to extracellular matrix 
in response to higher training volume (tissue-offset model, orange and purple circles, f), all of which were 
more highly expressed in MOD, indicated by the positive enrichment score. Orange circles denote gene sets 
that were identified from rank-based enrichment tests based on the full data set. Purple circles denote gene 
categories that were also identified using over-representation analysis (ORA). Normalization strategies had 
global effects on enrichment analyses using rank tests, assessed using fold-changes and minimum significant 
differences scores (not shown), illustrated with the tissue-offset model leading to marked increases in 
genes associated with the “Collagen containing extracellular matrix” gene set (g) as well as a shift in the full 
distribution of Log2 fold-changes between volume conditions towards MOD (shown as density curves). Black 
bars represent genes that belong to the gene set identified as enriched (g). Genes symbols indicate genes 
identified as differentially expressed in each normalization scenario
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previously suggested [36], while also containing tissue weight as an offset to account 
for amounts of tissue used during RNA-seq library preparation (tissue-offset model). 
The second model contained effective library sizes as a covariate only (library-size nor-
malization), thus representing an effort to compare expression levels across training 
modalities while accounting for technical variation during library preparation [25, 36]. 
The third model was a non-normalized model (naïve model, included for comparison) 
(Table 1).
At Week 2, 21 genes were identified as DE between low and moderate volume using 
the tissue-offset model, with all genes showing higher expression in the moderate vol-
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Similarly, 10 and seven genes were identified as DE between volume conditions using the 
library-size model and the naïve model, respectively (Fig. 3d and e). For the library-size 
model, seven of these DE genes showed higher expression in the moderate-volume con-
dition, overlapping completely with genes found using the tissue-offset model (Fig. 3e). 
For the naïve model, the seven DE genes all showed decreased expression in the moder-
ate volume condition, with 3 genes still overlapping with the library-size model, thus 
resulting in a contra-intuitive decrease in expression. Using tissue-offset model-derived 
estimates for functional analyses (Rank-based enrichment tests of minimum significant 
differences, MSD), revealed enrichment of genes associated with extracellular matrix 
(ECM) gene ontology (GO) sets (Fig. 3f, Table 2). The top-ranked GO terms were also 
identified by over-representation tests (ORA) using DE genes (Fig. 3f, Table 2, detailed 
table in Additional files 1 and 2). Using library-size model estimates similar top-ranked 
GO sets were identified as with the tissue-offset model albeit with lower levels of sig-
nificance and lower degrees of agreement between methods (Table 2). The naïve model 
generally identified GO sets with negative enrichment scores indicating gene sets with 
lower expression in moderate volume compared to low volume, with a weak agreement 
between enrichment methods (Table 2). The analytical consequences of using the differ-
ent normalization strategies were particularly apparent in comparisons of rank metrics, 
such as fold-changes. Importantly, this analytical approach uses the entire gene set to 
identify enriched gene sets, rather than being confined to DE genes. After controlling 
for amounts of tissue used during preparation of RNA-seq libraries, the distribution of 
Log2 differences between volume conditions shifted markedly in favor of higher train-
ing volume (Fig. 3g), and robust gene sets appeared with higher expression in the mod-
erate volume condition, such as genes belonging to the Collagen-containing ECM GO 
set (Fig. 3g). Accordingly, the number of DE genes identified to this GO set was highest 
using the tissue-offset model (n = 11), followed by the library-size model (n = 6), with no 
genes identified using the naïve model (Fig. 3g).
At Week 12, no genes were identified as differentially expressed between resistance 
training with low and moderate volume using the tissue-offset model (Fig. 3h; rested-
state biopsies sampled after finalization of the intervention). In contrast, a small num-
ber of genes were identified as DE between volume conditions using library-size and 
naïve models (n = 4 and n = 3, respectively; Fig. 3h and i), with all genes showing lower 
Table 1 Participant characteristics
Values from pre‑intervention assessments. Relative lean and fat mass from whole‑body data
Mean SD
Female n = 11 Age (years) 22.6 0.9
Body mass (kg) 166.2 6.2
Stature (cm) 61.5 7.4
Lean mass (%) 63.7 5.6
Fat mass (%) 32.2 5.7
Male n = 14 Age (years) 23.9 4.2
Body mass (kg) 183.7 5.6
Stature (cm) 77.4 10.4
Lean mass (%) 75.4 5.5
Fat mass (%) 20.1 5.7
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GO:0006401 RNA catabolic 
process
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GO:0006397 mRNA process-
ing
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GO:0000209 Protein poly-
ubiquitination
0.046 0.579 1.05 NA
Molecular 
function
GO:0003729 mRNA binding 0.003 0.844 0.99 NA
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GO:0019080 Viral gene 
expression
1.14e−30 1.75e−07  − 1.86 NA
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expression in the moderate volume condition (Fig. 3h and i). Of these genes, two were 
shared between models (Fig. 3i). Using tissue-offset model-derived estimates for func-
tional annotation analyses, revealed no consensus GO sets, using either of the two 
enrichment approaches (Table 2). In contrast, functional annotation based on estimates 
from the library-size and naïve model revealed GO terms related to cellular respiration 
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a Rank‑based enrichment test based on minimum significant difference identifies gene‑sets that are over‑represented 
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b Gene‑set enrichment analysis (GSEA) tests for over‑representation in among top and bottom genes based on  Log2 fold‑
changes in comparing moderate‑ (MOD) versus low‑volume (LOW) conditions. Positive normalized enrichment scores (NES) 
indicates genes with higher expression in MOD compared to LOW, negative NES indicates genes with higher expression in 
LOW compared to MOD
c Over‑representation tests based on differentially expressed genes. P‑values are adjusted for FDR
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genes in the low-volume condition (Table 2). No DE genes contributed to ORA-iden-
tified GO terms among the top-ranked GO terms from the library-size model. In the 
naïve model, genes related to cellular respiration were identified as DE with subsequent 
contribution in ORA-identified GO terms (Table 2).
Identification of genes with altered expression over time (0, 2 and 12 weeks)
At Week 2 and 12 (rested-state biopsies), we also investigated the overall effects of resist-
ance training on transcriptome profiles: i.e. the time effect, assessed by combining data 
from the two training modalities. At Week 2, resistance training led to increased expres-
sion for 3923, 1609, and 3875 genes and decreased expression of 77, 289, and 100 genes 
using the tissue-offset, the library-size, and the naïve model, respectively (Fig. 4a). The 
majority of these DE genes were found in the intersection between all models (Fig. 4a 
lower panel). At Week 12, resistance training led to increased expression of 1733, 584, 
and 5108 genes and decreased expression of 2, 19, and 2 genes using the tissue-offset, 
the library-size, and the naïve model, respectively (Fig.  4b). Here, the majority num-
ber of DE genes were found in the intersection between the tissue-offset model and the 
naïve model (Fig. 4b lower panel). At both Week 2 and 12 (and using any normalization 
model), functional analyses of DE genes revealed enrichment of GO terms associated 
with ECM structure, organization, and synthesis, as well as stress responses (Table 3).
Effects of acute exercise on transcriptome profiles (pre‑ to post‑exercise 
in Week 2)
At Week 2, we also investigated the effects of acute bouts of resistance exercise with 
low and moderate volume on transcriptome profiles. As we did not expect changes in 
the total RNA-to-muscle mass ratio in this short time span [37] and rather fluid shifts 
[38] may have affected tissue weight and hence downstream analyses in an undesirable 
manner, transcriptome analyses were performed using the library-size model. First, we 
performed an analysis of the effects of resistance training per se on transcriptome pro-
files (combining data from the two training modalities). These analyses identified 1736 
DE genes after acute resistance exercise, 707 of which showed increased expression 
and 1029 of which showed decreased expression (Fig. 5a). Genes that showed increased 
expression were generally associated with stress-related GO terms, including immune 
response (Table 4). Genes that showed decreased expression were associated with ECM-
related GO terms (Table  4), contrasting observations made in rested-state biopsies at 
Week 2 and 12 (Table 3; detailed table in Additional files 1 and 2). We then compared 
the effects of low and moderate-volume conditions. These analyses identified one sin-
gle DE gene (RFT1, Fig. 5b), which decreased to a greater extent in the moderate-vol-
ume condition. Despite this, rank-based enrichment tests with MSD identified five GO 
terms with significant enrichment. Among these five categories, three had genes with 
MSD > 0 (RNA splicing, RNA localization, and Covalent chromatin modification), indi-
cating that the lower bound of 95% CI did not overlap no-change. However, as differ-
ences between volume conditions were both negative and positive, as indicated by the 
rug-plot in Fig. 5c, these categories were not identified in gene-set enrichment analysis 
based on fold-changes. Overall, these analyses do not provide evidence for pronounced 
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volume-dependent regulation of mRNA expression in the acute recovery phase after 
resistance exercise (1-h).
Discussion
In the present study, we used a within-participant model to study the effects of low 
and moderate resistance training volumes on transcriptome responses. For these 
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Fig. 4 Comparing the effects of resistance training per se on transcriptome profiles using different 
normalization models. Volcano plot identifies differentially expressed genes at Week 2 (a) and Week 12 (b) 
(adjusted P-values < 0.05 and Log2 fold-changes >|0.5|, filled circles). Bar-plots shows the total number of DE 
genes (horizontal bars) and sets exclusively found in each model or shared among models (vertical bars). 
The majority of differentially expressed genes were identified by all three normalization models, though the 
effective library-size model identified a larger number of genes with decreased expression (a)
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study [3]. Training volume led to robust increases in muscle strength and limb lean 
mass, resembling observations made in the full study cohort [3], and previous studies 
[39]. Despite these benefits, few differences were detected in transcriptome profiles 
between volume conditions, with the most prominent exception being a selection of 
genes involved in extracellular matrix organization and biology in the early stages of 
resistance training. We have shown that disclosure of these differences was made pos-
sible by our systematic selection of bioinformatic tools.
Identification of a model‑specific bioinformatics pipeline
The continued development of bioinformatic tools for RNA-seq analyses require con-
tinuous optimization of analytic pipelines to any specific study conditions [24, 40]. 
To this end, we first sought to select a suitable read-trimming method. This is neces-
sary to provide high-quality downstream alignment and k-mer search in reads [30]. 
Two commonly used algorithms were compared [30, 31]. Trimmomatic provided data 
with higher quality than Trimgalore (Fig. 1G), which did not improve quality scores 
compared to non-filtered data. Second, we compared five mapping tools for perform-
ing transcript quantification of trimmed reads: two genome-based mapping tools 
(STAR [41] and HISAT2 [42]) and three transcript based mapping tools (RSEM [43], 
kallisto [44] and Salmon [45]). Transcript-based mapping tools resulted in stronger 
correlations between mRNA and protein profiles, measured as relationships between 
myosin heavy chain mRNA profiles and protein abundances in rested state biopsies 
[3] (Fig. 2a), which is known to correlate in resting human skeletal muscle [33–35]. 
This comparison was performed using gene-/protein-family normalization [34, 46], 
allowing the deduction of mRNA-to-protein relationships without the need for other 
normalization assumptions. Notably, a marked skew was observed in the relationship 
between MYH1 proportions and its corresponding Type IIX fiber following the ini-
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a Rank‑based enrichment test based on minimum significant difference identifies gene−sets that are over‑represented 
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b Gene−set enrichment analysis (GSEA) tests for over‑representation in among top and bottom genes based on  Log2 fold‑
changes in comparing time−points (Week 2 vs. Week 0 and Week 12 vs. Week 0). Positive normalized enrichment scores 
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expression in Week 0 compared to Week 2/12
c Over‑representation tests based on differentially expressed genes. P‑values are adjusted for FDR
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expression, as is typically seen in response to mechanical loading in such short time 
frames [47]. Furthermore, the transcript-based mapping tools (RSEM, kallisto, and 
Salmon) resulted in transcriptome profiles with an expected bimodal distribution 
of counts and a larger subset of detected genes compared to genome-based tools 
(Fig. 1h). They were also associated with the less technical variation, evident as lower 
Log2-fold differences in expression for a selection of highly expressed genes between 
the two legs at baseline [23], assuming minimal biological variation between such 
paired samples. In these analyses, RSEM displayed slightly lower average variation 
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Fig. 5 Comparing the effects of an acute bout of resistance training with low and moderate volume on 
transcriptome profiles in muscle biopsies. Overall, an acute bout of resistance training led to large-scale 
alterations in gene expression (volume-conditions combined) (a). Comparing differentially expressed 
events between volume conditions (low-volume, LOW; moderate-volume, MOD) identified one gene with 
volume-dependent changes in expression (RFT1, b). Three gene ontology categories were identified as 
significantly enriched using a rank-based test (minimum significant difference, MSD as the rank metric) as 
well as containing genes with unadjusted P-values < 0.05 (MSD > 0). Traces from the rank test are displayed in 
c 
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Comparison of normalization strategies
Transcriptome analyses often rely on the assumption that gene expression is counted 
and compared between conditions on a per-cell level [28]. This is implicitly assumed to 
be equivalent to measuring transcriptome data as ratios between mRNA and total RNA, 
as the input in sequencing or hybridization experiments usually is total RNA [13, 15, 48].
In the current study population, we previously showed that total RNA increases per-
unit-muscle tissue in a volume-dependent manner following initiation of resistance 
training [3]. Consequently, the preparation of cDNA libraries for RNA-seq experiments 
was unavoidably based on different amounts of tissue, as fixed amounts of total RNA 
(1000 ng) were used for this purpose. If unaccounted for, this would lead to a compari-
son of transcriptome data originating from different amounts of muscle tissue for the 
two volume conditions. We show that this leads to a contra-intuitive larger increase in 
global transcript counts in the low-volume condition compared to the moderate-volume 
condition (though without reaching statistical significance). In contrast, after adjusting 
for the difference in amounts of muscle tissue fed into RNA-seq experiments (i.e., tissue-
offset normalization), this apparent difference in average library size disappeared. Over-
all, we thus observed an increase in global mRNA expression per-unit-muscle weight 
(43–53%) in response to resistance training that did not depend on training volume, 
contrasting the observed volume-dependency of total RNA expression [3]. This global 
change in mRNA expression was associated with substantial alterations in the expres-
sion of a multitude of genes, with as many as 26 and 12% of the total read-count pool 
showing increased expression using the tissue-offset model at Week 2 and Week 12, 
respectively. These genes were associated with biological processes such as ECM synthe-
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c Over‑representation tests based on differentially expressed genes. P‑values are adjusted for FDR
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As the volume-dependent changes in muscle growth and total RNA levels in m. vastus 
lateralis arguably will affect downstream bioinformatics analyses and identification of 
DE genes, we aimed to compare three different normalization strategies during the sub-
sequent analyses: tissue-offset, library-size, and naïve. At Weeks 2 and 12, the different 
normalization strategies resulted in marked shifts in global mRNA responses between 
the two volume conditions, having pronounced effects on identification of GO terms 
during enrichment analyses (Fig. 3g). In general, tissue-offset normalization (providing 
mRNA expression per-mg-muscle weight) resulted in a global shift in mRNA responses 
towards moderate volume. At Week 2, this was evident as more robust increases in 
mRNA expression in response to higher training volume for most genes, contrasting 
findings in library-size and naïve analyses. At Week 12, this was evident as a counter-
balancing of mRNA expression profiles, with tissue-offset providing rather normally dis-
tributed responses to the two volume conditions, contrasting the skew towards larger 
mRNA expression in response to low training volume in library-size and naïve analyses. 
The utilization of generalized linear mixed models (GLMM) allowed convenient com-
parisons of normalization models, which could then be fitted using in the same statisti-
cal framework, as previously suggested [36]. GLMM also allowed the incorporation of 
random effects into the model to account for the repeated measures design. Although 
there are approaches to account for correlated observations in commonly used RNA-seq 
modeling frameworks [49], GLMMs provides a more robust and potentially more pow-
erful framework for dealing with correlated data [36].
Training volume‑dependent changes in transcriptome profiles.
Using the tissue-offset model, we were able to identify genes relating to ECM func-
tions as volume-sensitive during the early stages of resistance training. This may indi-
cate a role for ECM remodeling in the beneficial effects of higher training volumes on 
muscular adaptations and strength. As such, previous research has shown that ECM 
remodeling is induced by exercise training, both acutely [50–53], and after prolonged 
endurance and resistance training [13, 18, 54, 55], at both mRNA and protein levels 
[13, 18, 54, 55]. However, none of these previous studies have found ECM remod-
eling to be differentially affected by different exercise modalities. Rather, different 
resistance training modalities such as low- and high-load training have been associ-
ated with similar responses, measured as collagen synthesis [52]. Importantly, there 
seems to be a close association between training-induced changes in abundances of 
ECM-related mRNAs and their respective proteins, including collagen-organization 
proteins [54]. This suggests that ECM remodeling is primarily controlled at the tran-
scriptional level, which arguably increases the biological relevance of the herein pre-
sented transcriptome analyses. However, this relationship seems to involve a complex 
time course dependency. For example, transcriptional regulation of COL1A2 shows 
a considerable lag from stimuli to transcription, as shown in fibroblasts [56]. In line 
with this, our data on the effects of acute resistance exercise on transcriptome pro-
files, suggests a counterintuitive reduction in the expression of e.g., collagen mRNA 
immediately after exercise, as has also been found by others [18]. Indeed, enrichment 
analyses confirmed these negative changes in ECM-related transcripts in response to 
acute exercise, contrasting the effects of chronic resistance training [13, 18].
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The physical properties of ECM are distorted by disuse and aging, resulting in 
increased stiffness and potentially decreased force transmission and muscle efficiency 
[57, 58]. Training-induced ECM remodeling may thus constitute an effective meas-
ure to reverse these adversities [50–53], and has been suggested to exert a protective 
role against injury [51]. However, available studies are ambiguous in their conclusions 
[52, 53], and the link between observed changes in ECM-related gene expression and 
muscle biology and functionality remain uncertain. Adding to this, ECM remode-
ling-responses to training seems to be age-dependent [50, 59], and also shows a clear 
dependency of time. Indeed, in the present study, the volume-associated differences 
in ECM-related transcriptome profiles disappeared entirely after twelve weeks of 
resistance training, whereby no genes were identified as showing volume-dependent 
responses. From a general perspective, this indicates that after prolonged training, 
the biological state of the muscle may have reached a new equilibrium, with low- 
and moderate-volume training having led to similar muscle phenotypic traits. This 
would imply that the benefits of higher training volume are restricted to augmented 
increases in muscle mass, perhaps facilitated by increases in ribosomal biogenesis [3]. 
Notably, this is likely to be an oversimplification. Indeed, at the protein level, in the 
current study, higher training volume led to a more robust phenotypic switch from 
type IIX → type IIA fiber also after twelve weeks of training [3]. Taken together, our 
data provide valuable directions for future research. It suggests that ECM remodeling 
is volume-dependent, at least during the initial part of a training program. This needs 
to be confirmed by studies in other populations, and its biological and functional sig-
nificance needs clarification. Such studies should take advantage of the increased bio-
logical resolution of within-subject contralateral models.
Analyses of transcriptome responses to acute bouts of low and moderate resistance 
training volume revealed one single gene with volume-dependent changes in expres-
sion (RFT1). RFT1 is associated with the GO terms lipid transport, carbohydrate 
transport, and endoplasmic reticulum membrane. RFT1 expression has previously 
been shown to decrease in muscle immediately after training [22]. Although this 
warrants more research, one single gene arguably provides limited information. As 
such, rank-based enrichment tests identified three GO terms with volume-depend-
ent changes in gene expression in the acute data set (RNA splicing, RNA localization, 
and covalent chromatin modification). Upon closer examination, these gene sets con-
sisted of genes with both increased and decreased expression in the moderate- com-
pared to the low-volume condition. Only a small fraction of these transcripts showed 
actual positive MSDs, indicating changes with unadjusted P-values < 0.05. While this 
enrichment analysis supports acute volume-dependent regulation of gene sets after 
resistance training at the selected time point of biopsy sampling (1 h after sessions), 
it remains plausible that such regulation would have been more pronounced at later 
time points.
Conclusions
Transcriptomic analyses of skeletal muscle subjected to altered growth conditions 
should account for global changes in mRNA to total RNA and cell density to accu-
rately reflect biologically meaningful events. When accounting for such aspects, ECM 
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remodeling showed volume-dependent responses to resistance training. These recom-
mendations could be applicable to studies of other cell types and model systems under-
going increased or arrested growth. Also, the optimized selection of bioinformatic tools 




The full study design has been previously described in detail [3]. Thirty-four participants 
completed a 12-week training-intervention with legs allocated to either low- (one set per 
exercise) or moderate-volume (three sets per exercise) training (Fig. 1a). Muscle biopsies 
were obtained from each leg prior (Week 0) to and after the intervention (Week 12), 
as well as prior to (Week 2 Pre-ex) and 60-min after (Week 2 Post-ex) the last training 
session of week 2, as previously described [3]. Participants with a complete set of high-
quality RNA samples (RQI ≥ 7, n = 25) were selected for RNA-seq analyses (Fig.  1b). 
Training-induced changes in muscle size and strength were estimated for each leg using 
several methods (for a complete overview, see [3]). Herein, we present dual-energy X-ray 
absorptiometry (DXA) measurement of lean mass for the 25 participants eligible for 
RNA-seq, as well as a weighted combined measure of strength (combining data from dif-
ferent strength tests) (Table 1).
Training protocol
The training protocol consisted of unilateral lower body exercises (leg-press, leg-curl, 
and knee-extension). Each participant’s leg was randomly assigned to perform either 
one or three sets per exercise (low- vs. moderate-volume), ensuring within-participant 
comparisons. Rest periods between sets were 90–180  s.  The single-set leg was always 
trained in the rest period between the second and third sets of the multiple-set proto-
col. Training protocols were performed in a progressive manner, whereby resistance was 
continuously adjusted to ensure that the targeted number of repetitions was reached at 
volatile fatigue. This was equivalent to 10 repetitions maximum (RM) in weeks one and 
two, followed by 8RM in weeks three to five and 6RM in weeks six to twelve. Each week 
consisted of either 2 or 3 training sessions. From week four, weeks with three sessions 
contained one session at a sub-maximal load (90% of previous session load). All sessions 
commenced with a standardized warm-up. After each session, participants were given a 
standardized milk-based drink [3].
Muscle strength and lean mass assessments
Muscle strength was assessed twice before and once after the intervention. A detailed 
description of strength outcomes resulting from the study has been previously reported 
[3]. For the purpose of the present analyses, we present a weighted average of strength 
gains for the 25 participants eligible for RNA-seq, based on data from unilateral isomet-
ric and isokinetic (60°, 120° and 240° ×  s−1) knee extension, and one-repetition maximum 
(1RM) in unilateral knee extension and leg press, as previously reported [3]. Isometric 
and isokinetic strength was assessed using an individually adjusted dynamometer (Cybex 
6000, Cybex International, Medway USA). 1RM was defined as the maximum load lifted 
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through the full range of motion. From pre-intervention tests, the highest values were 
used for change score calculations. Limb lean-mass was assessed from full-body dual-
energy X-ray absorptiometry (DXA; Lunar prodigy, GE Healthcare, Oslo, Norway) scans 
performed prior to and after the intervention. Limb lean-mass was derived from a seg-
ment covering the full leg from collum femoris to the distal end of the foot defined in the 
analysis software (enCore, GE Healthcare, Oslo, Norway).
Muscle tissue sampling, immunohistochemistry and RNA extraction
Muscle tissue was obtained bilaterally from m. vastus lateralis using a 12-gauge needle 
(Universal-plus, Medax, San Possidonio, Italy) under local anesthesia (Xylocaine, 10 
mg×ml−1 with adrenaline 5 μg ×  ml−1, AstraZeneca AS, Oslo, Norge). Samples were 
obtained from the two legs within 10 min of each other at all time-points. All rested state 
samples were obtained in the morning after a standardized breakfast. Resting samples 
obtained in Week 2 were sampled approximately 48 h after the fourth session. After the 
training period (Week 12), samples were obtained six days after the last training session 
and three days after the last strength assessment. Participants were instructed to ingest 
standardized meals during the 24 h leading up to the sampling event, and to refrain from 
strenuous physical activity during the last 48 h. Samples for immunohistochemistry (~ 
15 mg) were transferred to a 4% formalin solution for fixation 24 − 72 h, before further 
preparation. Samples for RNA analyses (~ 25 mg) were dissected in ice-cold sterile saline 
solution (0.9% NaCl), blotted dry and snap-frozen using −80 °C isopentane, before stor-
age at −80 °C until further processing.
Immunohistochemistry was utilized to quantify myosin heavy chain abundance in 
formalin-fixed muscle biopsy cross-sections, performed as previously described and 
reported [3]. Briefly, 4 µm transverse sections were incubated with (1) a primary anti-
body that detects all three adult myosin heavy chain isoforms but type IIX (BF-35, 5 μg 
×  ml−1, Developmental Studies Hybridoma Bank, deposited by Schiaffino, S.) and (2) 
type I myosin (MyHCSlow, 1:4000, catalog M8421L, Sigma-Aldrich Norway AS, Oslo, 
Norway). Primary antibodies were visualized using BMU UltraView DAB and Ultra-
View Red (Ventana Medical Systems, Inc. Tucson, USA). Muscle fibers were identified 
as either Type I (red), Type IIA (brown), Type IIX (unstained), or hybrid fibers Type IIA/
IIX (light brown) (for representative images, see Fig. 3 in [3]). Hybrid fibers were ana-
lyzed as 0.5 × Type IIA and 0.5 × Type IIX.
For RNA extraction, the frozen muscle was homogenized in 1 ml of TRIzol reagent 
(Invitrogen, Life technologies AS, Oslo, Norway) using a bead homogenizer (Bullet 
Blender, Next Advanced, Averill Park, NY, USA). After phase separation, 400 μl of the 
aqueous phase was used in isopropanol precipitation of RNA, and after three washing 
steps (70% ethanol) the pellet was eluted in TE buffer. All samples showed a 260/280 nm 
ratio > 1.95 assessed by a spectrophotometer (NanoDrop 2000, ThermoFisher Scientific, 
Oslo, Norway). RNA integrity scores (RQI) were determined by capillary electrophore-
sis (Experion Automated Electrophoresis Station using RNA StdSens Assay, Bio-Rad). 
For each participant, all samples were extracted in the same extraction session in a ran-
domized order. Participants with complete sets of high-quality RNA samples had an 
average RQI score of 9.0 (0.4), [full data set, 8.1 (2.1), range 1–9.7] (Fig.  1c). Notably, 
to achieve accurate normalization of qPCR data (and potentially also RNA-seq data), a 
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commercially available exogenous RNA control (λ polyA External Standard Kit, Takara 
Bio Inc., Shiga, Japan) was added at a fixed amount per extraction prior to homogeniza-
tion (0.04 ng ml−1 of Trizol reagent), as previously described [3, 60]. Unfortunately, at 
present, we do not have access to the sequence of this spike-in, prohibiting its identifica-
tion in RNA-seq data and rendering its subsequent utilization for normalization pur-
poses difficult.
Illumina library preparation and sequencing
For each muscle sample, mRNA sequencing libraries were prepared from the same 
amount of RNA (1000 ng, depending on the minimum amount available) using TruSeq 
Stranded Total RNA Library Prep (Illumina, San Diego, CA USA). Paired-end sequenc-




Trim Galore (version 0.6.5, https ://githu b.com/Felix Krueg er/TrimG alore ) and Trimmo-
matic (version 0.39) [31] were used to discard low-quality reads and trim poor-quality 
bases before alignment, using default settings. The quality of filtered files was calculated 
by FastQC (version 0.11.4) and summarized using MultiQC (version 1.8) [61].
Read alignment
Filtered reads were aligned to the Human genome (GRCh38 release-97 downloaded 
from ftp.ensemble.org) using the alignment-based methods HISAT2 (version 2.1.0) [42], 
STAR (version 2.7.2) [41], and RSEM (version 1.3.1) [43], used together with Bowtie 2 
(version 2.3.4.3) [62], and non-alignment methods including kallisto (version 0.44.0) [44] 
and Salmon (version 0.13.1) [45]. For HISAT2 and STAR, HTSeq was used for quantifi-
cation as previously described [63]. RSEM, kallisto, and Salmon have in-built quantifica-
tion functions.
Modeling of gene counts
Gene counts were modeled using negative binomial generalized linear mixed models 
(GLMM), as suggested in [36], with modifications. Three model formulations were used to 
represent three different normalization scenarios. First, to account for fluctuations in RNA-
to-tissue ratios, the amount of tissue used in cDNA synthesis was included as an offset 
term together with the effective library size and study conditions (time and volume condi-
tion), added as a fixed effects in the model (tissue offset model). A simplified model con-
tained only the effective library size together with study conditions, included as fixed effects 
(Effective library-size model). And finally, a naïve model formulation, without any form of 
normalization term, was used for comparisons. For acute exercise effects (pre- to post-exer-
cise in the last session of week 2), only the library size normalized model was used as we 
expected that fluid shifts [38] could influence the muscle weight measurement, and changes 
in total RNA were unlikely to occur in this short time span [37]. The effective library size 
was calculated by multiplying the total library size with the RNA composition normaliza-
tion factor, calculated using the trimmed mean method [25], followed by dividing the value 
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by the median effective library size, as suggested by Cui et al. [36]. The effect of resistance 
training on gene counts was assessed as (1) the effect of exercise volume and (2) the effect 
of time. For analyses of the effect of exercise volume, differential expression was evaluated 
using GLMMs containing the interaction between time and exercise volume. For analyses 
of the effect of time, differential expression was evaluated using GLMMs containing only 
the time factor, combining all data irrespective of volume condition. In all models, a single 
random effect was used, giving each participant an individual intercept. Models were itera-
tively fitted using glmmTMB [64]. Utilization of the negative binomial distribution was sup-
ported by comparing the full model with a Poisson model (not containing the dispersion 
term), providing likelihood-ratio tests P-values that were distributed primarily below 0.05 
(0.37% of models showed P > 0.05). Heteroscedasticity was assessed using the uniformity 
test in the DHARMa package [65], which generally showed good agreement with model 
assumptions, providing P-values concentrated near 1 (98.51% of models showed P > 0.05). 
Genes were identified as differentially expressed when the absolute Log2 fold-change was 
greater than 0.5, and the adjusted P-value was below 5%. P-values were adjusted per-model 
coefficient to control the false discovery rate [66].
Functional annotation
Enrichment analyses of gene ontology (GO) gene sets were performed using three 
approaches. First, a non-parametric rank test (described in [67] and implemented in the 
tmod package [68], version 0.40) was performed based on gene-specific minimum sig-
nificant differences (MSD). MSD was defined as the lower limit of the 95% confidence 
interval (CI, based on estimated standard errors) around the Log fold-change (FC) when 
Log(FC) > 0 and the negative inverse of the upper 95% CI when Log(FC) < 0. This metric 
has been shown to have lower false-positive rates compared to other metrics applied dur-
ing enrichment analyses [69]. As the MSD metric is positive when the CI does not over-
lap 0 and negative when overlap occurs, the rank test does not discern between up and 
down-regulated gene sets. A second approach, gene set enrichment analysis (GSEA) [70], 
was used to quantify the directional regulation of the gene set. GSEA was performed using 
the fgsea package [71] with Log(FC) as the gene level metric. Thirdly, over-representation 
analysis (ORA) was performed to assess if genes identified as differentially expressed (|Log2 
fold-change|> 0.5 and adjusted P-values < 0.05; DE-genes) belonged to specific gene sets. 
ORA was performed using the enrichGO function in the clusterProfiler package [72], (ver-
sion 3.16.0). GO gene sets (biological process, cellular component, and molecular function) 
were retrieved from the molecular signature database (version 7.1) [73].
Statistical analysis
Descriptive data are presented as mean and standard deviation (SD). Changes in mus-
cle strength and mass were estimated using linear mixed models on change scores with 
baseline values as covariates. The performance of alignment tools was assessed by com-
paring log-differences between biological replicates, as suggested by Teng et al. [74], with 
modifications. Briefly, a subset of genes previously shown to be stably expressed between 
tissues was selected [32], whereupon log-differences between paired biopsy samples 
were calculated (i.e., using biopsies collected from each of the two legs prior to the train-
ing intervention). In addition, alignment tools were assessed by comparing relationships 
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(Pearson’s correlation coefficient) between gene family profiling of myosin heavy chains 
(MYH1, MYH2, and MYH7; muscle-specific) and the corresponding myosin heavy chain 
protein expression (measured using immunohistochemistry as fiber types IIX, IIA, and 
I). These mRNA and protein profiles were expressed as a fraction of total counts, thus 
removing the need for normalization of the RNA-seq data, as previously described for 
qPCR data [34]. Notably, these data also provided insight into the overall biological 
validity of the RNA-seq data, linking gene counts to protein phenotypes.
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Abstract 17 
The biological relevance and accuracy of gene expression data depend on the adequacy 18 
of data normalization. This is due both to its role in resolving and accounting for technical 19 
variation and errors, and to its defining role in shaping the biological viewpoint of data 20 
interpretations. Yet, normalization is often treated in serendipitous manners. This is 21 
especially true for its impact on the viewpoint of biological interpretations, and may have 22 
exacerbated consequences for conclusions in studies involving pronounced cellular 23 
plasticity. 24 
In this case report, we highlight the consequences of using three fundamentally different 25 
normalization approaches for interpreting RNA-seq data from human skeletal muscle 26 
undergoing exercise-training induced growth. Briefly, 25 participants conducted 12 27 
weeks of high-load resistance training. Muscle biopsy specimens were sampled from m. 28 
vastus lateralis before, after two weeks of training (week 2) and after the intervention 29 
(week 12), and were subsequently analyzed using RNA-seq. Transcript counts were 30 
modeled as i) per-library-size, ii) per-total-RNA, and iii) per-sample-size (per-mg-tissue-31 
mass). Initially, this led to identification of three sets of stable genes, which were 32 
subsequently used for calculation of normalization factors and modelling of training-33 
associated changes in whole-transcriptome transcript expression. 34 
The three modes of transcript counts led to identification of different sets of stable genes. 35 
In general, genes that showed stable expression in the per-library-size dataset, showed 36 
increased expression in per-total-RNA and per-sample-size datasets. This led to three 37 
deviating sets of normalization factors, eventually leading to differential estimates of 38 
training-associated changes in transcript expression. Briefly, while 33% and 26% of 39 
transcripts showed no differences between normalization modes at weeks 2 and 12, 40 
respectively, 28 and 24% of transcripts showed changes in per-total-RNA and per-41 
sample-size scenarios only. At week 2, this was manifested as opposite conclusions for 42 
5% of the transcripts between per-library-size and per-sample-size data (↑ and ↓, 43 
respectively). Most down-regulated transcripts (7% and 4%) were found exclusively 44 
using per-library-size normalization. 45 
Scientists should be explicit with their choice of normalization strategies and should 46 
interpret results of gene expression analyses with caution. This is particularly important 47 
for data sets involving a limited number of genes and involving growing or differentiating 48 
cellular models, where the risk of biased conclusions are likely elevated.  49 
3 
Keywords: RNA-seq, skeletal muscle, normalization, resistance training 50 
Introduction 51 
In gene expression analyses, data normalization can be performed using many different 52 
approaches, acting as a major determinant of the validity and reliability of interpretations [1–53 
4]. For any data set, the available normalization strategies are partially predetermined by the 54 
technique used for data acquisition. Still, normalization always involves a myriad of explicit 55 
choices that may profoundly affect the analytical outcome. For example, for studies utilizing 56 
quantitative PCR (qPCR), the selection of internal reference genes will largely define 57 
downstream analyses and conclusions, and the utilization of non-validated reference genes will 58 
lead to substantial bias [2]. Analogous to this, for studies involving RNA sequencing, 59 
appropriate library size scaling will determine samples’ comparability in downstream statistical 60 
analysis [3, 4]. Overall, data normalization essentially targets sources of technique-specific 61 
artifacts and non-biological variation. In addition, it also defines the biological perspective from 62 
which data are interpreted [1, 5]. This means that the choice of normalization mode will define 63 
the biological output of the experiment. Indeed, the expression of mRNA transcripts can be 64 
quantified using three distinctly different approaches, relative to the overall mRNA pool (i, 65 
i.e. using geometric averaging), the total amount of RNA (ii), or the amount of tissue or number 66 
of cells used in the experiment (iii) [1, 5]. 67 
While each of these perspectives holds biological merit, providing gene expression data that 68 
can be interpreted and compared between samples (e.g., changes from before to after a specific 69 
treatment), they do so in different manners. First, the per-library-size approach provides data 70 
that inform on the relative abundances of transcripts relative to all other transcripts, arguably 71 
enabling assessment of transcript expression that compares their ability to compete for slots on 72 
ribosomes. Second, the per-total-RNA approach provides data that inform on the absolute level 73 
of transcripts relative to the entire pool of RNA, enabling assessment of transcript expression 74 
that compares their ability to recognize and bind to ribosomes. Third, the per-sample-size 75 
approach provides data that inform on the overall abundances of transcripts in the biological 76 
sample at hand, and thus their content per-cell or per-tissue weight. Therefore, the three 77 
different normalization scenarios provide different biological perspectives, setting the stage for 78 
data interpretations. These differences will be exacerbated in experimental models and designs 79 
involving large cellular perturbations, accompanying changes in the overall mRNA and total 80 
RNA expression [5–7]. Despite this, the consequence of a specific normalization strategy for 81 
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data interpretation is rarely explicitly addressed in the biomedical literature, even though it 82 
represents an old and ever-present issue in mRNA-based analyses [1, 5]. 83 
The present study aimed to investigate the consequences of using each of the three modes of 84 
normalization (per-library-size, per-total-RNA, and per-sample-size) for transcriptome 85 
profiling of RNA-seq data in a highly plastic model of human biology. Briefly, twenty-five 86 
human participants conducted twelve weeks of high-load resistance training using a within-87 
participant study design. Each participant performed exercise training with either low or 88 
moderate volume, allocated to either leg [8]. Overall, both study protocols led to substantial 89 
changes in muscle strength, mass, and biology, with the latter being evaluated from bilateral 90 
muscle biopsies (m. vastus lateralis) sampled at baseline and after two and twelve weeks of 91 
training. Biopsy samples showed marked increases in overall total RNA and mRNA 92 
abundances, arguably making it an adequate experimental system for the proposed comparisons 93 
[8, 9]. In the current analyses, the first objective was to identify a subset of gene transcripts that 94 
show relative stability within participants across all time points, measured as transcript 95 
abundances per-library-size, per-total-RNA, and per-sample-size, respectively. Secondly, we 96 
used the resulting reference gene sets to normalize the entire RNA-seq dataset, ultimately 97 
providing estimates of transcript abundances corresponding to each of the three perspectives of 98 
normalization. 99 
Methods 100 
Study overview 101 
Thirty-four participants completed a 12-week progressive resistance training intervention with 102 
legs randomly allocated to either low (one set per exercise) or moderate-volume (three sets per 103 
exercise) training, as previously described [8]. The training intervention consisted of leg-press, 104 
leg- curl, and knee-extension. Bilateral muscle biopsies were obtained before the intervention 105 
and after two and twelve weeks of training. Total RNA was extracted from the biopsy material 106 
(TRIzol, ThermoFisher Scientific, Oslo, Norway)[8], and samples were selected for analysis 107 
based on RNA integrity scores. Twenty-five participants had a complete set of samples with 108 
integrity scores ≥ 7 (Average RQI 9, SD: 0.4; Experion Automated Electrophoresis Station 109 
using RNA StdSens Assay, Bio-Rad, Norway) and were selected for the RNA-sequencing 110 
experiment [9]. A fixed amount of total RNA (1000 ng) was used for RNA-seq library 111 
preparations and subjected to Paired-end sequencing (Illumina HiSeq 3000, Illumina, San 112 
Diego, CA USA), as detailed elsewhere [9]. 113 
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Filtering and read alignment 114 
Trimmomatic (version 0.39) [10] was used before alignment to filter out low-quality reads, as 115 
well as to remove poor-quality bases and adaptor sequence using default settings. The quality 116 
of filtered files was calculated using FastQC (version 0.11.4). After quality filtering, reads were 117 
aligned to the human genome and quantified on the level of transcripts using RSEM (version 118 
1.3.1) [11] and GRCh38 release-97 (downloaded from ftp.ensemble.org). 119 
Identification of stable reference genes and modeling of transcript counts 120 
We assumed that expressing transcripts to crude estimates of each biological denominator 121 
(mRNA, total RNA, or sample size) would introduce bias in downstream analyses due to 122 
incomparable scaling and measurement errors between normalization modes. Therefore, we 123 
selected internal reference genes to create comparable normalization factors between 124 
normalization modes for subsequent analyses. Reference genes were selected from a subset of 125 
transcripts with robust expression across all samples, filtered with the minimum count per 126 
sample set to 30. After filtering, 5687 genes remained in the data set for assessment of within-127 
participant stability. Identification of stable transcripts in each of the normalization scenarios 128 
(per library size, per total RNA, and per sample size) was made using transcript counts 129 
transformed to counts per million (CPM). CPM values were calculated after expressing counts 130 
per scaled library size (total counts scaled by trimmed mean of M-values [4]), amount of tissue 131 
(mg of tissue × 10 ), or total RNA (1 × 10 , assuming equal total RNA in each reaction) used 132 
in library preparation. CPM values were log-transformed before being fitted to linear mixed-133 
effects models on a target-by-target basis. Models were subsequently used to (1) assess the 134 
effects of the intervention on transcript abundances over time and between volume conditions 135 
and to (2) determine the intra class correlation coefficient (ICC) defined as the amount of 136 
variance attributed to between-participant variation relative to the total variance. For each 137 
normalization mode, maximal t-values calculated from model coefficients representing study 138 
conditions (time and exercise volume) were used to remove transcripts that showed indices of 139 
systematic effects of the intervention. Transcripts with absolute t-values 1.5 were subjected to 140 
subsequent ranking based on ICC values. The top ten transcripts from each normalization mode 141 
were defined as stable reference genes, suitable for the calculation of normalization 142 
denominators. Selected transcripts were scaled (𝑥 /𝑚𝑎𝑥(𝑥)) and averaged per sample to form 143 
the sample reference. To compare sample references from each normalization mode, ratios were 144 
evaluated over time from estimates obtained from linear mixed-effects models. 145 
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The full set of transcripts (excluding reference genes, filtered with minimum count = 1, n = 146 
12066) was modeled on a target-by-target basis using negative binomial generalized linear 147 
mixed models (GLMM)[9, 12] with normalization mode-specific reference genes used as 148 
offsets in each model fit to express gene counts per-library-size, per-total-RNA and per-sample-149 
size. Model fits were used to assess the effects of study conditions on relative gene counts. For 150 
the sake of this analysis, samples from each leg were considered biological replicates to 151 
determine the impact of exercise training per se (time-effects). Differentially expressed genes 152 
were defined if significantly different from baseline on a target-by-target basis (unadjusted p < 153 
0.05). 154 
After filtering of low abundance transcripts (minimum count per sample = 30), 5687 remained 155 
in the data set for further assessment of within participant stability. Gene counts were 156 
transformed to express gene counts per the total scaled library size, per input total RNA, and 157 
per tissue mass. As a fixed amount of total RNA was used for library preparation, the raw counts 158 
were used to express counts per total RNA. The amount of tissue used in library preparations 159 
was used as the denominator in transforming transcript counts to counts per tissue mass. 160 
Transformed transcript counts were subsequently fitted to linear mixed-effects models on a 161 
target-by-target basis to (1) assess the effects of the intervention over time and between volume 162 
conditions, and (2) to determine the intraclass correlation coefficient (ICC) defined as the 163 
amount of variation attributed to between-participant variation. Maximal t-values from each 164 
model coefficients representing time and time/volume-condition interactions were used to filter 165 
transcripts with evidence of systematic effects. Transcripts with absolute t-values ≤ 1.5 were 166 
further considered for ICC. Transcripts were subsequently ranked based on their ICC and the 167 
top ten transcript from each normalization scenario were used as internal references. Selected 168 
transcripts were scaled (𝑥 /𝑚𝑎𝑥(𝑥)) and averaged per sample to form the sample reference. 169 
Sample references from each normalization scenario were used as an offset in negative binomial 170 
generalized linear mixed models (GLMM) to assess the effects of study conditions of gene 171 
counts of non-reference genes from the pool of high abundance transcripts (n = 5687). 172 
Results 173 
The training intervention led to robust increases in muscle mass and strength (on average 4% 174 
and 25%, respectively [8]). This was accompanied by an increase in total RNA from baseline 175 
to weeks two and twelve (on average 27% and 17%, respectively) and an increase in the 176 
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sequenced library size, despite a lower amount of tissue being used during library preparations 177 
[8, 9]. 178 
In the present RNA-seq data set, the three modes of normalization led to the identification of 179 
three different clusters of stable gene transcripts across untrained and resistance-trained muscle 180 
specimens. Each of the three gene clusters consisted of genes that showed unaltered expression 181 
across muscle biopsies sampled from each participant (and as such was not affected by the 182 
resistance training). The number of genes in the three clusters varied substantially (per-library-183 
size, n=1266; per-total-RNA, n=90; per-sample-size, n=18), with per-library-size normalization 184 
being associated with higher ICC estimates, suggesting higher degrees of consistency between 185 
samples. The top ten most stable transcripts from each normalization scenario were then 186 
identified based on ICC estimates (Table 1). There was no overlap between the per-library-size 187 
cluster and either of the two other clusters among these transcripts. At the same time, per-total-188 
RNA and per-samples-size data sets displayed two overlapping transcripts (Table 1). 189 
Sample references, computed as the scaled average of the ten most stable transcripts per 190 
normalization mode, were analyzed as ratios to explore dissimilarities over time. Stable 191 
transcripts identified in the per-library-size dataset, showed clearly increased expression 192 
estimates in per-total-RNA and per-sample-size datasets (Figure 1A, right panels). Similarly, 193 
stable genes identified in the per-sample-size dataset, showed decreased expression in the per-194 
total-RNA dataset (Figure 1A, upper left panel). These differences were more pronounced in 195 
samples obtained after two weeks of resistance training (Figure 1A). 196 
We further used sample references to identify differentially expressed transcripts from baseline 197 
to after training for each of the three normalization modes. Most differentially expressed 198 
transcripts were shared among all three normalization modes (33% and 26% from baseline to 199 
week two and twelve, respectively, Figure 1B). However, a substantial fraction of differentially 200 
expressed targets were exclusively identified in per-total-RNA and per-sample-size datasets 201 
(Figure 1B). A smaller fraction of differentially expressed transcripts were identified in the per-202 
sample-size mode only. Most transcripts identified as differentially expressed were identified 203 
with higher expression at weeks two and twelve. However, transcripts identified with lower 204 
expression were predominantly identified on a per-library-size basis. At week 2, 5% of all 205 
transcripts were identified as down-regulated using per-library-size normalization but up-206 
regulated when expressed per-sample-size (Figure 1B). 207 
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Table 1. Genes selected as stable reference genes from each normalization scenario. 208 
Normalization strategy Transcript ID Gene Symbol Gene biotype Intraclass correlation 
Per-library-size 
ENST00000643905   0.9157487 
ENST00000439211 DHFR protein coding 0.8773145 
ENST00000582787 SP2-DT lncRNA 0.8733079 
ENST00000342992 TTN protein coding 0.8661879 
ENST00000361681 MT-ND6 protein coding 0.8643855 
ENST00000371470 MAGOH protein coding 0.8469231 
ENST00000234256 SLC1A4 protein coding 0.8425609 
ENST00000341162 FCF1 protein coding 0.8411509 
ENST00000480046 METTL2B protein coding 0.8399730 
ENST00000295955 RPL9 protein coding 0.8289768 
Per-total-RNA) 
ENST00000445125  processed pseudogene 0.7159682 
ENST00000312184 TMEM70 protein coding 0.5795889 
ENST00000552002 CHURC1 protein coding 0.5598877 
ENST00000357033 DMD protein coding 0.5592342 
ENST00000275300 SLC22A3 protein coding 0.5557768 
ENST00000496823 BCL6 protein coding 0.5488948 
ENST00000546248 TRDN protein coding 0.5222352 
ENST00000309881 CD36 protein coding 0.5059408 
ENST00000005178 PDK4 protein coding 0.4966191 
ENST00000522603 ASPH protein coding 0.4927794 
Per-sample-size 
ENST00000496823 BCL6 protein coding 0.5369798 
ENST00000546248 TRDN protein coding 0.4976999 
ENST00000216019 DDX17 protein coding 0.4619666 
ENST00000005178 PDK4 protein coding 0.4589237 
ENST00000361915 AGL protein coding 0.4219960 
ENST00000418381   0.4167778 
ENST00000294724 AGL protein coding 0.4050706 
ENST00000366645 EXOC8 protein coding 0.3911603 
ENST00000261349 LRP6 protein coding 0.3841484 
ENST00000306270 IBTK protein coding 0.3287734 
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Discussion 209 
The present study shows that the choice of normalization modality will affect the outcome of 210 
gene expression analyses in models of load-induced skeletal muscle plasticity in humans. The 211 
three modes of normalization (per-library-size, per-total-RNA, and per-sample size) were 212 
associated with different patterns of differentially expressed transcripts in response to resistance 213 
training. In general, per-library-size-based normalization underestimated increases in mRNA 214 
abundances compared to the other two approaches. Such underestimation is an effect of the 215 
assumption that most transcripts/genes remain unchanged in response to treatment, an 216 
assumption corresponding to using the library size as the point of reference in gene expression 217 
studies [4, 13]. Indeed, in the extreme case of global scale transcription amplification in 218 
response to a treatment [6], the assumption of relative transcription stability between samples 219 
leads to underestimation of transcript expression, and thus potentially erroneous conclusions. 220 
This is the case in studies of resistance training-induced muscle hypertrophy, where ribosome 221 
biogenesis, and thus increased ribosomal RNA transcription and total RNA expression, are 222 
known to occur [8, 14, 15]. In such studies, neglecting to account for changes in total RNA 223 
expression during analyses of transcript data will lead to underestimation of transcript 224 
abundances per tissue mass [14]. 225 
While the results from the present study indicate the impact of using different normalization 226 
strategies, they do not inform us on the rights and wrongs of normalization choices. The correct 227 
use of a specific normalization strategy depends on the research questions and model systems 228 
under study. For example, in systems where relative transcript abundances are of primary 229 
interest or in models where whole-transcriptome expression remain stable, it seems prudent to 230 
assume that transcript abundances will both relative to other transcripts (per-library-size) and 231 
in absolute terms (per-sample-size) [5]. However, as exemplified in the present study, in 232 
systems where these assumptions are not true, and global changes occur in variables such as 233 
total RNA and global mRNA expression, absolute expression of transcript may be a more 234 
suitable outcome. In such studies, the selection of normalization strategy that violate these 235 
assumptions will lead to biased conclusions [5]. In general, studies involving gene expression 236 
seldom account for these perspectives during data analyses [5], and their consequences for data 237 
interpretations remain underappreciated, reducing the ecological validity of analyses and 238 
making comparisons between studies difficult. To alleviate this, researchers should explicitly 239 
state and ideally test their assumptions regarding choices of normalization strategies. 240 
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Conclusion 241 
In the present study, we show that the choice of normalization modality (per-library-size vs per-242 
total-RNA vs per-sample-size) has pronounced effects on interpretations of transcriptome 243 
responses in a human model of load-induced skeletal muscle plasticity. For any study of gene 244 
expression, data normalization should be conducted and evaluated with care and intent, 245 
ensuring the stability and representativity of normalization denominators, and importantly also 246 
the biological relevance of outcome measures. 247 
References 248 
1. Huggett J, Dheda K, Bustin S, Zumla A. Real-time RT-PCR normalisation; strategies and 249 
considerations. Genes Immun. 2005;6:279–84. doi:10.1038/sj.gene.6364190. 250 
2. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, et al. Accurate 251 
normalization of real-time quantitative RT-PCR data by geometric averaging of multiple 252 
internal control genes. Genome Biol. 2002;3:RESEARCH0034. 253 
http://www.ncbi.nlm.nih.gov/pubmed/12184808. 254 
3. Anders S, Huber W. Differential expression analysis for sequence count data. Genome 255 
Biology. 2010;11:R106. doi:10.1186/gb-2010-11-10-r106. 256 
4. Robinson MD, Oshlack A. A scaling normalization method for differential expression 257 
analysis of RNA-seq data. Genome Biology. 2010;11:R25. doi:10.1186/gb-2010-11-3-r25. 258 
5. Coate JE, Doyle JJ. Variation in transcriptome size: Are we getting the message? 259 
Chromosoma. 2015;124:27–43. doi:10.1007/s00412-014-0496-3. 260 
6. Lovén J, Orlando DA, Sigova AA, Lin CY, Rahl PB, Burge CB, et al. Revisiting global gene 261 
expression analysis. Cell. 2012;151:476–82. doi:10.1016/j.cell.2012.10.012. 262 
7. Hansen MC, Nielsen AK, Molin S, Hammer K, Kilstrup M. Changes in rRNA levels during 263 
stress invalidates results from mRNA blotting: Fluorescence in situ rRNA hybridization permits 264 
renormalization for estimation of cellular mRNA levels. J Bacteriol. 2001;183:4747–51. 265 
doi:10.1128/jb.183.16.4747-4751.2001. 266 
8. Hammarström D, Øfsteng S, Koll L, Hanestadhaugen M, Hollan I, Apró W, et al. Benefits 267 
of higher resistance-training volume are related to ribosome biogenesis. The Journal of 268 
physiology. 2020;598:543–65. doi:10.1113/JP278455. 269 
9. Khan Y, Hammarström D, Rønnestad BR, Ellefsen S, Ahmad R. Increased biological 270 
relevance of transcriptome analyses in human skeletal muscle using a model-specific pipeline. 271 
BMC Bioinformatics. 2020;21:548. doi:10.1186/s12859-020-03866-y. 272 
10. Bolger AM, Lohse M, Usadel B. Trimmomatic: A flexible trimmer for illumina sequence 273 
data. Bioinformatics (Oxford, England). 2014;30:2114–20. doi:10.1093/bioinformatics/btu170. 274 
11. Li B, Dewey CN. RSEM: Accurate transcript quantification from RNA-seq data with or 275 
without a reference genome. BMC Bioinformatics. 2011;12:323. doi:10.1186/1471-2105-12-276 
323. 277 
11 
12. Cui S, Ji T, Li J, Cheng J, Qiu J. What if we ignore the random effects when analyzing 278 
RNA-seq data in a multifactor experiment. Stat Appl Genet Mol Biol. 2016;15:87–105. 279 
doi:10.1515/sagmb-2015-0011. 280 
13. Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for 281 
RNA-seq data with DESeq2. Genome Biology. 2014;15:550. doi:10.1186/s13059-014-0550-8. 282 
14. Chaillou T, Malgoyre A, Banzet S, Chapot R, Koulmann N, Pugniere P, et al. Pitfalls in 283 
target mRNA quantification for real-time quantitative RT-PCR in overload-induced skeletal 284 
muscle hypertrophy. Physiol Genomics. 2011;43:228–35. 285 
doi:10.1152/physiolgenomics.00109.2010. 286 
15. Figueiredo VC, McCarthy JJ. Regulation of ribosome biogenesis in skeletal muscle 287 
hypertrophy. Physiology (Bethesda). 2019;34:30–42. 288 
Figure captions 289 
Figure 1. (A) Fold-changes of sample references (average of the top ten stable genes per 290 
normalization mode) ratios with numerators plotted over columns and denominators over rows. 291 
Error bars represent 95% CI. (B) Genes identified as differentially up and down regulated over 292 
time (differences from Week 0 to Week 2 and 12 respectively) from generalized linear models 293 
with each normalization factor used as an model offset. Up- and down-regulation determined 294 
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Chronic obstructive pulmonary disease does 
not impair responses to resistance training
Knut Sindre Mølmen1* , Daniel Hammarström1, Gunnar Slettaløkken Falch1, Morten Grundtvig2, Lise Koll3, 
Marita Hanestadhaugen3, Yusuf Khan1,4, Rafi Ahmad4,5, Bente Malerbakken6, Tore Jørgen Rødølen7, 
Roger Lien7, Bent R. Rønnestad1, Truls Raastad8 and Stian Ellefsen1,9 
Abstract 
Background: Subjects with chronic obstructive pulmonary disease (COPD) are prone to accelerated decay of muscle 
strength and mass with advancing age. This is believed to be driven by disease-inherent systemic pathophysiologies, 
which are also assumed to drive muscle cells into a state of anabolic resistance, leading to impaired abilities to adapt 
to resistance exercise training. Currently, this phenomenon remains largely unstudied. In this study, we aimed to 
investigate the assumed negative effects of COPD for health- and muscle-related responsiveness to resistance training 
using a healthy control-based translational approach.
Methods: Subjects with COPD (n = 20, GOLD II-III,  FEV1predicted 57 ± 11%, age 69 ± 5) and healthy controls (Healthy, 
n = 58,  FEV1predicted 112 ± 16%, age 67 ± 4) conducted identical whole-body resistance training interventions for 
13 weeks, consisting of two weekly supervised training sessions. Leg exercises were performed unilaterally, with one 
leg conducting high-load training (10RM) and the contralateral leg conducting low-load training (30RM). Measure-
ments included muscle strength  (nvariables = 7), endurance performance  (nvariables = 6), muscle mass  (nvariables = 3), mus-
cle quality, muscle biology (m. vastus lateralis; muscle fiber characteristics, RNA content including transcriptome) and 
health variables (body composition, blood). For core outcome domains, weighted combined factors were calculated 
from the range of singular assessments.
Results: COPD displayed well-known pathophysiologies at baseline, including elevated levels of systemic low-grade 
inflammation ([c-reactive  protein]serum), reduced muscle mass and functionality, and muscle biological aberrancies. 
Despite this, resistance training led to improved lower-limb muscle strength (15 ± 8%), muscle mass (7 ± 5%), muscle 
quality (8 ± 8%) and lower-limb/whole-body endurance performance (26 ± 12%/8 ± 9%) in COPD, resembling or 
exceeding responses in Healthy, measured in both relative and numeric change terms. Within the COPD cluster, lower 
 FEV1predicted was associated with larger numeric and relative increases in muscle mass and superior relative improve-
ments in maximal muscle strength. This was accompanied by similar changes in hallmarks of muscle biology such 
as rRNA-content↑, muscle fiber cross-sectional area↑, type IIX proportions↓, and changes in mRNA transcriptomics. 
Neither of the core outcome domains were differentially affected by resistance training load.
Conclusions: COPD showed hitherto largely unrecognized responsiveness to resistance training, rejecting the notion 
of disease-related impairments and rather advocating such training as a potent measure to relieve pathophysiologies.
© The Author(s) 2021. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, 
adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and 
the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material 
in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material 
is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the 
permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http:// creat iveco 
mmons. org/ licen ses/ by/4. 0/. The Creative Commons Public Domain Dedication waiver (http:// creat iveco mmons. org/ publi cdoma in/ 
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Introduction
Chronic obstructive pulmonary disease (COPD) is 
associated with impaired cardiorespiratory fitness and 
decreased skeletal muscle mass and strength [1], leading 
to reduced levels of daily activity and reduced quality of 
life [2, 3]. This deterioration is accompanied by systemic 
co-morbidities such as reduced levels of testosterone [4], 
vitamin D [5, 6] and oxygen saturation levels [7], and ele-
vated levels of low-grade inflammation [8], which argua-
bly leaves COPD subjects in a state of anabolic resistance 
[9], resulting in impaired abilities to adapt to exercise 
training [10–12]. In particular, these pathophysiologies 
are believed to impair adaptations to resistance training, 
which represent the most potent intervention for improv-
ing muscle functions [13–16] and preventing escalation 
into late-stage morbidities such as pulmonary cachexia 
[17]. Despite this general belief, the presence of anabolic 
resistance in COPD subjects and its consequences for 
responses to resistance training remain circumstantial. A 
mere single study has compared functional and biologi-
cal adaptations to resistance training between COPD and 
healthy controls (ISRCTN ID: 22764439) [18–20], and as 
such was limited by a relatively short training interven-
tion (8  weeks), a rather untraditional training protocol 
with little clinical and practical relevance, and a limited 
selection of outcome variables. Whereas the study failed 
to disclose COPD-related impairments in muscle 
strength and growth responses, it seems premature to 
dismiss the notion that COPD pathophysiologies may 
impair training responsiveness [21], and there is clearly 
need for further study.
The primary aim of the present study was to investigate 
the assumed negative effects of COPD pathophysiolo-
gies on physiological responses to 13 weeks of resistance 
training, with emphasis on a broad range of muscle func-
tional and biological outcome measures. The second-
ary aim was to investigate inherent differences between 
COPD and Healthy, and to investigate the interaction 
between two different resistance training modalities and 
training responsiveness (high-load vs. low-load resist-
ance training; 10 vs 30 repetitions maximum, RM).
Methods
For in-depth description of study protocols and methods, 
including description of a placebo-controlled vitamin 
 D3 supplementation protocol (randomized clinical trial), 
see Figs.  1, 2 and clinicaltrial.gov (ClinicalTrials.gov 
Identifier: NCT02598830). The study was designed and 
scaled to allow elucidation of the effects of vitamin  D3 
supplementation for adaptations to resistance training, 
as well as to compare training responsiveness between 
COPD and Healthy. The vitamin  D3 perspective is cov-
ered in detail elsewhere [22].
Study ethics and participants
The study was approved by the Regional Commit-
tee for Medical and Health Research Ethics (refer-
ence no. 2013/1094), preregistered at clinicaltrials.gov 
(NCT02598830), and conducted according to the Decla-
ration of Helsinki. All participants were informed about 
the potential risks and discomforts associated with the 
study and gave their informed consent prior to study 
enrolment.
Persons with either medical diagnosis of stable COPD 
(GOLD grade II-III [23], predicted forced expiratory 
volume in first second  (FEV1) between 80%-30%,  FEV1/
forced vital capacity (FVC) < 70% after reversibility test-
ing, n = 24, age 70 ± 5) or normal lung function (n = 70, 
age 67 ± 5) received the study intervention. For study 
flow chart, see Fig. 1. For baseline characteristics of the 
participants completing the study, see Table 1.
Study conduct
COPD and Healthy conducted identical 13-week resist-
ance training protocols, consisting of two weekly full-
body training sessions (Fig. 2) with primary focus on leg 
exercises. The leg exercises, i.e. leg press, knee extension 
and knee flexion, were performed unilaterally in that 
consecutive order, with one of the legs of each participant 
being randomly assigned to perform three sets of 10RM 
(high-load) and the contralateral leg to perform three 
sets of 30RM (low-load). For each exercise, all three sets 
for one leg were conducted before the other leg was exer-
cised. This unilateral training protocol served two pur-
poses: i) to circumvent issues relating to conduction of 
training with two-legged exercises in COPD [24] and ii) 
to investigate the relative efficacy of two different train-
ing modalities (10RM vs 30RM). Exercises and sets were 
separated by ~ 2 min of rest, with individual adjustments 
being made whenever participants needed a longer rest 
period. All sessions were supervised by qualified per-
sonnel and lasted for ~ 60  min. The effectiveness of the 
training intervention was assessed as a wide range of out-
come measures (Fig.  2), including multiple assessments 
Trial registration: ClinicalTrials.gov ID: NCT02598830. Registered November 6th 2015, https:// clini caltr ials. gov/ ct2/ 
show/ NCT02 598830
Keywords: Anabolic resistance, COPD, Pathophysiology, Skeletal muscle, Strength training, Training load
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Assessed for eligibility (n=130)
Excluded (n=35)




Excluded from analyses (n=0)
Lost to follow-up (n=12)
COPD (n=3)
Healthy (n=9)
Reasons not related to the study (n=6)
Extensive travelling (n=1)
Back pain (n=2)





Lost to follow-up (n=4)
COPD (n=1)
Healthy (n=3)








Fig. 1 CONSORT flow chart of the study. The study was conducted as a double-blind randomized clinical trial, with the primary aim of investigating 
the effects of vitamin  D3 supplementation on resistance training-associated adaptations in a mixed population of older subjects, including both 
COPD and healthy control subjects (COPD and Healthy, respectively) (ClinicalTrials.gov Identifier: NCT02598830). Vitamin  D3 supplementation did 
not affect any primary or secondary outcome, and no conditional effects were observed for COPD vs Healthy in that context [22]. In the present 
study, the main purpose was to compare the effects of resistance training between COPD and Healthy participants (number of participants 
completing the study protocol; n COPD = 20; n Healthy = 58)
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of endurance performance, muscle strength and mass, 
measures of work economy/efficiency, and collection of 
blood and vastus lateralis biopsies (both legs) (Fig. 2).
Blood and muscle measurements
Prior to collection of blood and muscle biopsies, par-
ticipants were instructed to attend an overnight fast and 
to avoid heavy physical activity for the last 48  h. Blood 
samples were analyzed for serum concentrations of hor-
mones, lipids, and markers of iron metabolism and tissue 
damage, as previously described [22]. Muscle biopsies 
were analyzed for muscle fiber type proportions, myonu-
clei content, muscle fiber cross-sectional area (CSA), and 
rRNA and mRNA content (total RNA, rRNA subspecies, 
myosin heavy chain isoforms I, IIA and IIX, and whole-
genome transcriptome), as previously described [22, 25, 
26]. Transcriptome analysis was restricted to a subset of 
participants (COPD, n = 19 (n prior to resistance train-
ing, 19; n after 3 ½ week of training, 17; n post resistance 
training, 19); Healthy, n = 34 for all time points), selected 
based on quality of total RNA samples (RNA Qual-
ity Indicator > 7.0, avg 9.0 ± 0.5), with participants with 
COPD and participants with complete sets of muscle 
biopsies being prioritized.
Data analyses and statistics
Analyses were conducted per-protocol, due to the trans-
lational approach of the study. For continuous variables, 
linear mixed-effects models were used to examine differ-
ences between COPD and Healthy, both at baseline and 
as responses to resistance training. For the latter, rela-
tive and numeric changes from baseline were defined as 
dependent variables, with COPD/Healthy being defined 
as the fixed effect. Effects of sex were implemented into 
the models. Analyses included evaluation of interaction 
effects with training load (repeated measures/observa-
tions from high- and low-load training legs were added 
to the model for unilateral outcome measures) and 
sex. Time effects were examined using mixed model-
ling, with the dependent variable and time points being 
defined as repeated measures/observations. To describe 
the relationship between COPD severity and training 
responses, simple linear regression analyses of core out-
come domains change scores and predicted  FEV1 were 
performed.
For non-continuous variables, generalized linear 
mixed-effects models (GLMMs) were used (binomial 
GLMMs, immunohistochemical fiber type proportion 
analyses; negative binomial GLMMs, rRNA/mRNA con-
tent in quantitative real-time polymerase chain reaction 
(qPCR) and transcriptome analyses). For transcriptome 
analyses, gene counts were modelled using the total 
library size as a fixed effect [27], together with sex and 
study conditions (time points and COPD/Healthy). 
Models were iteratively fitted using glmmTMB [28]. 
Genes were regarded as differentially expressed when 
the numeric  log2 fold-change/difference were greater 
than 0.5 and the adjusted p-value (false discovery rate 
adjusted per model coefficient) was below 5% [25]. More-
over, enrichment analyses were performed on Hallmark, 
Fig. 2 Schematic overview of the study protocol, including its time line (A; ‡indicates the defined baseline measurement for the specific outcome 
measure), training volumes during the resistance training (RT) intervention (B), perceived exertion (Borg RPE, 6–20) reported after training sessions 
(C), and relative training loads (% of 1RM) during the training period (D). Training volume is presented as average increases in per-session for 
lower-body appendices from the first week of training (kg . repetitions; high-load (10RM) and low-load (30RM) leg press and knee extension 
combined). Training loads in numeric values (kg) during the resistance training intervention are provided in Additional file 1: Fig. S1. COPD, 
participants diagnosed with chronic obstructive pulmonary disease; Healthy, healthy control participants; *statistical different from 1th training 
week; #statistical difference between COPD and Healthy. Data are presented as means with 95% confidence limits. Methodological notes on 
retrieval of outcome measures: i) Lung function. Spirometry testing was performed following the guidelines from the American Thoracic Society 
and the European Respiratory Society [72]. Participants with COPD were tested before and after inhalation of two bronchodilators (salbutamol/
ipratropiumbromid). ii) Muscle strength and performance (STR and Musc. perf ). Muscle strength was assessed as one-repetition maximum (1RM) 
in unilateral knee extension and leg press, bilateral chest press, and handgrip. Muscle performance was defined as the number of repetitions 
achieved at 50% of pre-study 1RM and was assessed using unilateral knee extension and bilateral chest press. Isokinetic unilateral knee-extension 
torque was tested at three angular speeds (60°, 120° and 240°.  sec−1; Humac Norm, CSMi, Stoughton, MA, USA). iii) One-legged cycling and 
bicycling performance (1-LC and  VO2max). Participants conducted one-legged cycling tests (Excalibur Sport, Lode BV, Groningen, the Netherlands) 
to assess  O2-costs and mechanical efficiency [73] during submaximal cycling, and maximal one-legged oxygen consumption (V̇O2max) and 
maximal workload. Maximal two-legged cycling V̇O2max and workload were tested on a separate day. Oxygen consumption was measured using 
the JAEGER Oxycon Pro™ system (Carefusion GmbH, Höchberg, Germany). iv) Functional performance (Func.). Functional tests were conducted 
as the maximal number of sit-to-stands during one minute (seat height: 45 cm) and as the number of steps onto a 20 cm step box during 6 min. 
v) Health-related quality of life (SF-36 and CAT). All participants completed the Short Form (36-item) Health Survey (SF-36). COPD participants 
also completed the COPD Assessment Test (CAT) questionnaire. vi) Muscle thickness and body mass composition (US/DXA). Muscle thickness 
of m. vastus lateralis and m. rectus femoris were measured using B-mode ultrasonography (SmartUs EXT-1 M, Telemed, Vilnius, Lithuania). Body 
mass composition was measured using dual-energy X-ray absorptiometry (DXA; Lunar Prodigy, GE Healthcare, Madison, WI, USA). At pre study, 
all participants completed a questionnaire regarding regular weekly activity habits. The results (time spent for different activities) were translated 
into energy expenditure  (kcals.week−1) during activities using number of metabolic equivalents provided in Jetté et al. [74]. During week 11, all 
participants conducted a dietary registration, in which they logged their dietary intake for three days, including one weekend day
(See figure on next page.)
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Fig. 2 (See legend on previous page.)
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Table 1 Characteristics of the participants completing the study
COPD Healthy Sex-adjusted estimated difference
COPD – Healthy (95% CI) P-value
General
 Participants, completing (no. ♂/♀) / dropouts† (no.) 20 (12/8) / 2 58 (21/37) / 2 – –
 Age (years) 69 ± 5 (range, 60–79) 67 ± 4 (range, 57–78) 2 (0, 5) 0.049*
 Height (cm) 171 (10) 170 (10) −3 (−6, 0) 0.056
 Body mass (kg) 73 (18) 76 (16) −7 (−14, 0) 0.061
 Body mass index  (kg.  m2) 25 (5) 26 (5) −2 (−4, 1) 0.237
 Pack-years (no.) 30 (16) 6 (10) 23 (17, 29)  < 0.001*
 GOLD grade (no. of grade II/III) 15/5 – – –
 COPD Assessment Test™ score (0–40) 16.6 (6.8) – – –
 Self-reported conception of health (0–10) 4.9 (1.2) 6.7 (1.6) − 1.7 (− 2.5, − 0.7) 0.001*
Physical activity level
 Household work  (kcals.week−1) 1754 (2062) 1866 (2201) − 164 (− 1322, 995) 0.779
 Recreational activities  (kcals.week−1) 2512 (2619) 2654 (1841) 188 (− 862, 1237) 0.723
 Total activity  (kcals.week−1) 4266 (4036) 4520 (2837) 24 (− 1657, 1704) 0.978
Pulmonary function
 FVC (L) 3.2 (0.9) 3.6 (0.9) − 0.7 (− 1.0, − 0.4)  < 0.001*
 FVC (% predicted) 97 (19) 112 (16) − 13 (− 22, − 4) 0.003*
  FEV1  (L
.  sec−1) 1.5 (0.4) 2.7 (0.7) − 1.4 (− 1.6, − 1.2)  < 0.001*
  FEV1 (% predicted) 57 (11) 104 (16) − 47 (− 55, − 39)  < 0.001*
  FEV1/FVC (%) 47 (8) 75 (6) − 28 (− 31, − 24)  < 0.001*
 PEF  (L.  sec−1) 5.0 (1.6) 7.7 (2.1) − 3.4 (− 4.1, − 2.7)  < 0.001*
Pulmonary medication
  B2-agonists (no.) 17/20 – – –
 Muscarinic agonists (no.) 15/20 – – –
 Medication containing both  b2-agonist and glucocorticoid 
(no.)
10/20 – – –
Body composition
 Total lean mass (kg) ♂, 53 (4); ♀, 36 (6) ♂, 60 (5); ♀, 41 (4) − 6 (− 9, − 4)  < 0.001*
 Whole-body bone mineral density  (g.  cm2) ♂, 1.2 (0.1); ♀, 1.0 (0.2) ♂, 1.3 (0.1); ♀, 1.1 (0.1) − 0.1 (− 0.2, − 0.0) 0.007*
 Total fat mass (kg) ♂, 26 (10); ♀, 27 (15) ♂, 26 (9); ♀, 25 (10) 1 (− 5, 7) 0.703
 Visceral fat (kg) ♂, 1.9 (1.3); ♀, 1.0 (0.7) ♂, 1.7 (1.0); ♀, 0.8 (0.7) 0.2 (− 0.3, 0.7) 0.412
Lower−-body muscle strength
 1RM leg press (kg) ♂, 121 (35); ♀, 82 (21) ♂, 152 (27); ♀, 124 (25) − 36 (− 47, − 26)  < 0.001*
 1RM knee extension (kg) ♂, 21 (4); ♀, 11 (4) ♂, 31 (5); ♀, 16 (3) − 7 (− 9, − 5)  < 0.001*
 Peak torque knee extension 60° .  sec−1 (Nm) ♂, 127 (34); ♀, 80 (25) ♂, 160 32); ♀, 101 (16) − 27 (− 36, − 17)  < 0.001*
 Peak torque knee extension 180° .  sec−1 (Nm) ♂, 83 (25); ♀, 47 (17) ♂, 102 (23); ♀, 62 (11) − 19 (− 28, − 9)  < 0.001*
 Peak torque knee extension 240° .  sec−1 (Nm) ♂, 68 (20); ♀, 38 (14) ♂, 84 (20); ♀, 50 (9) − 15 (− 20, − 9)  < 0.001*
 Lower-body muscle strength factor (AU) ♂, 0.5 (0.1); ♀, 0.3 (0.1) ♂, 0.6 (0.1); ♀, 0.4 (0.1) − 0.1 (− 0.2, − 0.1)  < 0.001*
Lower-body muscle mass measures
 Leg lean mass (kg) ♂, 18 (2); ♀, 12 (3) ♂, 20 (2); ♀, 14 (2) − 3 (− 4, − 2)  < 0.001*
 M. vastus lateralis thickness (mm) ♂, 20 (3); ♀, 18 (5) ♂, 22 (3); ♀, 20 (3) − 2 (− 3, − 1) 0.002*
 M. rectus femoris thickness (mm) ♂, 13 (4); ♀, 10 (3) ♂, 16 (4); ♀, 15 (4) − 4 (− 5, − 2)  < 0.001*
 Lower-body muscle mass factor (AU) ♂, 0.6 (0.1); ♀, 0.5 (0.1) ♂, 0.7 (0.1); ♀, 0.6 (0.1) − 0.1 (− 0.2, − 0.1)  < 0.001*
Endurance measures
 Maximal power output one-legged cycling (W) ♂, 73 (13); ♀, 48 (17) ♂, 148 (28); ♀, 108 (21) − 67 (− 77, − 58)  < 0.001*
 Maximal power output two-legged cycling (W) ♂, 118 (38); ♀, 75 (32) ♂, 252 (48); ♀, 167 (32) − 113 (− 134, − 92)  < 0.001*
 Maximal oxygen consumption (mL  O2
.  kg−1.  min−1) ♂, 20 (5); ♀, 16 (5) ♂, 35 (7); ♀, 28 (6) − 14 (− 18, − 10)  < 0.001*
 6 min step test (maximal number of steps) ♂, 123 (35); ♀, 115 (44) ♂, 208 (41); ♀, 196 (38) − 83 (− 105, − 61)  < 0.001*
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Kyoto encyclopedia of Genes and Genomes (KEGG) and 
Gene Ontology gene sets, using two approaches. First, 
a non-parametric rank test was performed based on 
gene-specific minimum significant differences. Second, 
a gene set enrichment analysis (GSEA) was performed 
to quantify directional regulation of the gene set. GSEA 
was performed using the fgsea package [29]. Consen-
sus results (i.e. when both the non-directional rank test 
and the directional GSEA turned out significant) were 
interpreted as having greater biological meaning, while 
Hallmark was interpreted as contributing with the most 
meaningful stand-alone interpretation, as it reduces the 
analytical noise by taking into account genes that over-
lap between gene sets [30]. All gene sets were retrieved 
using the molecular signature database (version 7.1.) [31]. 
Overview of gene enrichment analyses with exact p-val-
ues are presented in Additional file 1: Table S3. A reposi-
tory containing all transcriptome data and scripts used 
for transcriptome and enrichment analyses are available 
at https:// github. com/ dhamm arstr om/ rnaseq- copd.
For all immunohistochemical variables, statistical 
models were weighted for numbers of counted fibers per 
biopsy. This was done to account for the reduced reliabil-
ity accompanying fewer observations/fibers [22].
To achieve reliable assessment of core outcome 
domains, and thus to lower the risk of statistical errors, 
combined factors were calculated for outcome meas-
ures relating to lower-body muscle strength (composed 
of values from the variables 1RM knee extension and leg 
press (I), and peak torque for knee extension at 60, 180 
and 240°/sec (II)), lower-body muscle mass (leg lean mass 
(I) and vastus lateralis and rectus femoris thickness (II)), 
one-legged endurance performance (maximal workload 
achieved during one-legged cycling (I) and number of 
repetitions at 50% of 1RM knee extension at pre-study 
(II)) and whole-body endurance performance (maximal 
workload achieved during bicycling (I), maximal number 
of steps achieved in a 6-min test (II), and maximal num-
ber of sit-to-stands in a 1-min test (III)), as previously 
described [22]. During factor calculation, each of the 
underlying variables were normalized to the participant 
with the highest value recorded during the RCT, resulting 
in individual scores ≤ 1. Thereafter, outcome domain fac-
tors were calculated as the mean of the normalized val-
ues for each variable for each participant. For details, see 
Additional file 1: Table S1.
In all mixed-effects models, a single random effect was 
used, giving each participant an individual intercept. Sta-
tistical significance was set to p < 0.05. In both text and 
figures, data are presented as adjusted, marginal means, 
with or without 95% confidence intervals, unless other-
wise stated. Statistical analyses were performed using 
SPSS Statistics package version 24 (IBM, Chicago, IL, 
USA) (statistical models with continuous variables, as 
well as immunohistochemical fiber type proportions) and 
R software [32] (statistical analyses of rRNA/mRNA con-
tent). Figures were made using Prism Software (Graph-
Pad 8, San Diego, CA, USA) and R software [32].
Results and discussion
Baseline characteristics: COPD vs Healthy
Exercise capacity, body composition and muscle and blood 
biology
At baseline (prior to onset of training), COPD displayed 
impaired exercise capacity compared to Healthy, as 
expected from previous studies [3, 18, 20, 33]. This was 
evident as impaired whole-body performance (range: 
−  41 −  54%, Table  1), and lower-body unilateral mus-
cle strength and endurance performance (−  17 −  30%, 
Table 1), presumably reflecting the cardiorespiratory and 
muscular limitations inherent to the condition [21], and 
likely being decoupled from levels of habitual physical 
Table 1 (continued)
COPD Healthy Sex-adjusted estimated difference
COPD – Healthy (95% CI) P-value
 1 min sit-to-stand test (maximal number) ♂, 21 (5); ♀, 21 (6) ♂, 30 (5); ♀, 29 (5) − 9 (− 12, − 6)  < 0.001*
  nrepetitions at 50% of 1RM knee  extensionpre study ♂, 19 (5); ♀, 17 (5) ♂, 23 (6); ♀, 20 (7) − 4 (− 6, − 1) 0.005*
 One-legged endurance performance factor (AU) ♂, 0.2 (0.0); ♀, 0.2 (0.0) ♂, 0.4 (0.1); ♀, 0.3 (0.1) − 0.2 (− 0.2, − 0.1)  < 0.001*
 Whole-body endurance performance factor (AU) ♂, 0.4 (0.1); ♀, 0.3 (0.1) ♂, 0.7 (0.1); ♀, 0.6 (0.1) − 0.3 (− 0.3, − 0.2)  < 0.001*
COPD, participants diagnosed with chronic obstructive pulmonary disease; Healthy, healthy control participants; ♂, males; ♀, females; †, dropouts during the training 
period; *study clusters are significantly different from each other (p < 0.05); GOLD, Global Initiative for Chronic Obstructive Lung Disease; pack-years, (number of 
cigarettes smoked per day/20) × number of years smoked; FVC, forced vital capacity;  FEV1, forced expiratory volume in one second; PEF, peak expiratory flow; 1RM, 
one repetition maximum; Nm, newton-meter; AU, arbitrary units. Data mainly presented as mean (SD), and sex-adjusted estimated mean differences between 
study clusters (95% CI). For core outcome domains, i.e. lower-body muscle strength, lower-body muscle mass, one-legged endurance performance and whole-body 
endurance performance, factors were calculated. Briefly, each factor was calculated using multiple singular outcome measures, where each of these variables were 
normalized to the participant with the highest value recorded during the study, resulting in individual scores ≤ 1. Thereafter, outcome domain factors were calculated 
as the mean of the normalized values for each variable for each subject (see Additional file 1: Table S1 for complete overview over calculations and composition of 
each factor)
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activity, as no difference was observed between study 
clusters prior to onset of the study (Table  1). Alongside 
the reduced exercise capacity, COPD had less lean body 
mass than Healthy (− 13%, Table 1), with 45% of COPD 
showing signs of sarcopenia, as defined by Baumgartner 
et al. [34]. In the legs, this was manifested as -16% reduc-
tions in leg-specific lean mass and −  9/−  24% smaller 
vastus lateralis/rectus femoris thicknesses (Table  1), 
offering potential explanations for the impaired maximal 
leg muscle strength. Of note, for markers of muscle mass 
the difference between study clusters was likely related 
to traits inherent to the COPD condition rather than 
to the small age difference between COPD and Healthy 
(−  2  years; Table  1), as the magnitude of the difference 
would have implied an annual loss of ~ 2.6 kg lean mass 
per year in the COPD cluster, deviating substantially 
from the expected loss in this age group (~ 0.5  kg per 
year) [35].
For muscle biological variables, the COPD cluster 
showed lowered proportions of type I fibers and greater 
proportions of type IIA and IIX muscle fibers in vas-
tus lateralis compared to Healthy (32/23% vs 13/9%, 
respectively), corroborating with previous studies 
[36, 37]. For type I fibers, COPD showed larger CSA 
(12%, Table  2) and larger myonuclear domain (CSA 
per myonuclei; 20%, Table 2), with no such differences 
being observed for type II fibers. This contrasts previ-
ous studies, who have reported smaller or similar CSA 
in type I fibers in COPD compared to Healthy [33, 38, 
39], and may point to a compensatory mechanism for 
the likely loss of motor units in COPD subjects [40], 
whereby reduced quantities of muscle fibers are com-
pensated for by increased sizes of remaining fibers, as 
previously reported in rodents [41]. These observed 
differences in muscle fiber characteristics were accom-
panied by differences in RNA expression. Although 
COPD and Healthy showed similar levels of total RNA 
and rRNA expression per amount of muscle tissue at 
baseline (Table  2), COPD displayed distinct whole-
genome transcriptome profiles, with 227 genes being 
differentially expressed compared to Healthy (151↑ and 
76↓; Fig. 3A and Additional file 1: Table S2). Hallmark 
enrichment analysis revealed lower expression of genes 
involved in oxidative phosphorylation (consensus, i.e. 
agreement between GSEA and rank-based analyses), 
corroborating with the lower type I proportion, as well 
as greater expression of genes involved in regulation 
of myogenesis (Rank) (Fig.  3A, B, Table  3; confirmed 
by gene ontology analysis, Additional file  1: Table  S3), 
which may be related to the pathophysiological eleva-
tion of protein turnover in COPD [42, 43].
For blood variables, the COPD cluster showed ele-
vated levels of low-grade inflammation compared to 
Healthy, measured as levels of c-reactive protein prior 
to the study (5.0 vs 1.6   mg.L−1, p = 0.001, data not 
shown; baseline (i.e. prior to resistance training), 5.0 vs 
1.6  mg.L−1, p = 0.053, Table 4), as expected from previ-
ous studies [8]. For other characteristics, including hor-
monal status in blood (e.g. testosterone), no differences 
were observed between COPD and Healthy (Table 4).
Table 2 Baseline characteristics of m. vastus lateralis for COPD and Healthy
COPD, participants diagnosed with chronic obstructive pulmonary disease; Healthy, healthy control participants. Data presented as mean (SD), and sex-adjusted 
estimated mean differences between study clusters (95% CI). Alpha level at p < 0.05
COPD Healthy Sex-adjusted estimated difference
COPD – Healthy (95% CI) P-value
Cross-sectional area (µm2)
 Type I 4614 (1088) 3720 (951) 449 (70, 827) 0.020*
 Type II 3639 (1235) 3059 (1121) 182 (− 118, 482) 0.232
Myonuclei per fiber
 Type I 2.2 (0.9) 2.1 (0.9) − 0.1 (− 0.4, 0.2) 0.357
 Type II 2.1 (0.7) 1.9 (0.7) − 0.1 (− 0.3, 0.2) 0.504
Myonuclear domain (cross sectional area/nuclei per fiber)
 Type I 2292 (585) 1928 (1030) 360 (107, 613) 0.006*
 Type II 1775 (529) 1740 (1049) − 62 (− 316, 191) 0.628
Fiber type proportion (%)
 Type I 52 (15) 65 (14) − 16 (− 24, − 9)  < 0.001*
 Type IIA 32 (12) 23 (11) 10 (4, 16) 0.001*
 Type IIX 13 (7) 9 (6) 5 (1, 9) 0.007*
 Type IIA/IIX 3 (2) 2 (2) 0.7 (− 0.4, 1.9) 0.159
Total RNA (ng / ml) 477 (103) 504 (106) − 20 (-59, 18) 0.302
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The efficacy of the resistance training intervention: COPD 
vs Healthy
For both COPD and Healthy, the training interven-
tion was associated with low drop-out rates (n = 4, ~ 5%; 
COPD, n = 2), high adherence to the protocol (COPD, 
97%; Healthy, 98%; measured as the average number of 
training sessions completed), progressive increases in 
training volume (Fig. 2), and robust increases in muscle 
strength per training session (e.g. 1RM knee extension, 
0.9%  .  session−1/0.8%  .  session−1, COPD/Healthy; 1RM 
leg press, 1.4% .  session−1/1.3% .  session−1). The habitual 
dietary intake was similar between COPD and Healthy, 
with protein intake being 1.2 (0.3) and 1.3 (0.4) g  .  kg−1 . 
 day−1, respectively, complying with current guidelines 
[44]. The vitamin  D3 supplementation RCT of the project 
did not enhance or affect training-associated changes for 
any of the primary or secondary outcome measures [22].
Muscle strength, muscle mass, muscle quality and one‑legged 
endurance performance
Overall, COPD showed larger training-associated 
increases in lower-body muscle strength and mass 
compared to Healthy (the two legs/training modalities 
combined), measured as relative changes in combined 
factors from baseline (Fig. 4A), with no difference being 
observed for numeric changes (Fig.  4A). COPD and 
Healthy showed similarly scaled improvements in muscle 
quality and one-legged endurance performance (Fig. 4A). 
Within the COPD cluster, worsening of lung function (i.e. 
decreasing predicted  FEV1 values) was associated with 
larger numeric and relative increases in muscle mass, as 
well as larger relative improvements in maximal muscle 
strength, with no such relationship being observed for 
muscle quality or one-legged endurance performance 
(Table  5). Neither of the four core outcome domains 
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Fig. 3 Whole-genome transcriptome analyses of m. vastus lateralis in COPD and Healthy (COPD, n = 19; Healthy, n = 34). At baseline, numerous 
genes were differentially expressed between COPD and Healthy. In A, differences in gene expression between COPD and Healthy are presented 
with leading edge genes (i.e. genes that contributes to the enrichment score) from two gene sets identified as differentially expressed between 
COPD and Healthy from gene enrichment analyses (oxidative phosphorylation and myogenesis; see Table 3). In B, average fold differences 
(COPD-Healthy) of genes contributing to baseline differences in oxidative phosphorylation and myogenesis gene sets are shown as individual 
data points, and violin plots shows the distribution of all leading edge genes from each gene set. C displays the average development of each 
gene set over time, where the dotted line indicates the mean fold change of all genes contributing to the differential change over time between 
COPD and Healthy. COPD displayed larger increases in expression of genes relating to oxidative phosphorylation after 3½ weeks of training, and 
more pronounced decreases in genes associated with myogenesis to after the training intervention (Post-RT; see Table 3). FDR, false discovery 
rate-adjusted p-value
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performance) were differentially affected by resistance 
training load (neither in COPD nor in Healthy), suggest-
ing that 30RM training is an effective alternative to 10RM 
training in older individuals (Fig.  4B, C). Of note, the 
comparisons between 10 and 30RM training responses 
may have been confounded by the so-called cross-educa-
tion effect, whereby training of one limb affects functional 
and biological characteristics of the contralateral limb. 
However, the true existence of such cross-education 
effects remains disputed, and if it does exist, its impact is 
likely restricted to neuromuscular functionality [45, 46], 
with no apparent effects on muscle biological measures 
such as mRNA abundance [45], mitochondrial content 
[47, 48], capillarization [49], muscle protein synthesis 
[50] or muscle hypertrophy [51, 52]. In accordance with 
this, the cross-education effect may have affected meas-
ures of muscle strength and one-legged endurance per-
formance in the present study. Importantly, however, 
several measures were implemented into the study pro-
tocol to minimize its impact, including extensive famil-
iarization to training and physical testing (e.g. baseline 
muscle strength was measured after 3 ½ weeks of intro-
duction to training and was preceded by 3–5 familiariza-
tion sessions to muscle strength testing) [22].
Overall, COPD showed marked and hitherto unrec-
ognized responsiveness to resistance training in respect 
of improvements in muscle strength, muscle mass, mus-
cle quality and one-legged endurance performance, 
contradicting previous suggestions of a negative impact 
of co-morbidities such as low cardiorespiratory fitness 
and chronic low-grade systemic inflammation [8, 24]. 
Indeed, a more severe COPD diagnosis was associated 
with larger increases in muscle mass and muscle strength 
improvements. This observation cannot be readily 
explained by baseline differences between the COPD par-
ticipants (e.g. baseline muscle mass vs predicted  FEV1, 
p = 0.998; baseline muscle strength vs predicted  FEV1, 
p = 0.646). The marked training responsiveness in COPD 
was presumably also decoupled from initial differences in 
physical activity habits between study clusters, as COPD 
and Healthy showed similar characteristics regarding 
these measures (Table  1), though some caution is war-
ranted for interpretation of such self-reported recall 
questionnaire results [53].
Cycling and functional performance
COPD and Healthy showed pronounced and similarly 
scaled training-associated improvements in whole-
body endurance performance, measured as changes 
from baseline, including 6-min step test performance, 
1-min sit-to-stand performance and maximal workload 
achieved during two-legged cycling (Fig.  5). Surpris-
ingly, COPD and Healthy also showed similar changes 
in performance for these outcome measures in numeric 
terms, with exception of 6-min step test performance, 
for which Healthy showed larger improvements 
Table 3 Comparison of Hallmark gene sets identified in whole-genome transcriptome data between COPD (n = 19) and Healthy 
(n = 34), assessed at baseline and as resistance training-associated changes
*Consensus significance indicates agreement between directional (GSEA) and non-directional (Rank) hypothesis test of overrepresentation (see methods for details). 
†Indicates number of identified genes in the gene set and total number of genes in the gene set in parentheses. ‡Rank-based enrichment test, based on minimum 
significant difference (MSD), identifies gene sets that are overrepresented among top-ranked genes without a directional hypothesis. § Fraction of genes in gene set 
with unadjusted 95% CI not spanning zero, i.e. MSD > 0. || Gene-set enrichment analysis (GSEA) tests for overrepresentation among top and bottom genes based on 
 Log2 fold differences or changes × -log10(P-values) in comparing differences at baseline or changes from baseline between COPD and Healthy. A positive normalized 
enrichment score (NES) indicate gene set with higher expression in COPD than Healthy; negative NES indicate gene set with lower expression at respective time-
points. ** Number of genes in leading edge (LE, genes that contributes to the enrichment score) with the fraction of leading edge genes with unadjusted 95% CI not 
spanning zero. ∆ change score
Comparison Gene set Significance 
category*
Set  size† Rank 
P-value‡
% MSD >  0§ GSEA 
P-value||
NES LE** Log2 fold 






Consensus 190 (200) 0.007 36.8%  < 0.001 − 2.10 70 (94.3%) − 0.24 (− 0.45, 
− 0.13)
Myogenesis Rank 163 (200)  < 0.001 33.7% 0.417 1.21 45 (75.6%) 0.46 (0.19, 1.5)






GSEA 115 (200) 0.956 7.8% 0.014 1.71 20 (35%) 0.39 (0.13, 0.76)
Oxidative phos-
phorylation
GSEA 190 (200) 0.999 1.1% 0.009 1.69 83 (2.4%) 0.11 (0.05, 0.39)
Pancreas beta 
cells






Myogenesis Consensus 163 (200)  < 0.001 42.3%  < 0.001 − 1.52 68 (85.3%) − 0.5 (− 1.13, 
− 0.26)
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(COPD, 6 steps; Healthy, 17 steps; ∆11 steps, p = 0.009; 
Fig. 5), arguably related to the considerable cardiorespi-
ratory demand of this test, leaving COPD with morbid-
ity-specific restraints. Corroborating with this, within 
the COPD cluster, there was no association between 
the severity of the COPD diagnosis and resistance 
training-induced changes in whole-body endurance 
performance (Table  5). For other performance indices 
such as cycling economy and gross efficiency, which 
were measured using a one-legged cycling protocol, 
COPD showed larger relative improvements compared 
to Healthy (∆4% (COPD – Healthy) for both cycling 
economy and gross efficiency, Fig. 5). For these indices 
of cycling performance, COPD, but not Healthy, dis-
played benefits of 10RM compared to 30RM training 
(Fig. 5), corresponding to previously observed effects of 
heavy resistance training in healthy, young individuals 
[54].
Together, these observations reiterate on the sub-
stantial benefits of resistance training for subjects with 
COPD, even for performance measures that pose large 
whole-body metabolic demands, which has previously 
Table 4 Effects of the training intervention on body composition and blood variables in COPD and Healthy, assessed as changes from 
baseline to after completion of the study (per study cluster) and as differential changes between study clusters
Body composition analyses, n COPD = 19, n Healthy = 48; blood analyses, n COPD = 20, n Healthy = 58. *significant difference between COPD and Healthy at baseline; 
†only men were included in testosterone analysis; ↓significant decrease from baseline to post RT (after 13 weeks of resistance training); ↑significant increase from 
baseline to post RT. Alpha level at p < 0.05. Data are presented as means (SD)
COPD Healthy ∆ COPD vs∆ 
Healthy (P 
value)Baseline Post RT Time effect 
(P < 0.05)
Baseline Post RT Time effect 
(P < 0.05)
Dual-energy x-ray absorptiometry
 Whole-body bone mineral density (g .  cm2) 1.13 (0.21) 1.13 (0.21) No 1.15 (0.16) 1.14 (0.15) No 0.119
 Total lean mass (kg) 46.7 (9.9) 47.6 (10.2) Yes ↑ 48.1 (10.0) 48.6 (10.0) Yes ↑ 0.395
 Appendicular lean mass (kg) 20.3 (5.3) 20.9 (5.5) Yes ↑ 21.6 (5.0) 21.9 (5.0) Yes ↑ 0.166
 Total fat mass (kg) 26.4 (11.7) 26.3 (11.5) No 25.3 (9.3) 24.4 (9.2) Yes ↓ 0.068
 Visceral fat (kg) 1.59 (1.18) 1.56 (1.21) No 1.12 (0.98) 1.01 (0.81) Yes ↓ 0.138
Inflammation
 C-reactive protein (mg .  L−1) 3.4 (5.0) 3.6 (4.0) No 1.7 (2.5) 1.8 (3.5) No 0.934
Hormones
 Cortisol (nmol .  L−1) 307 (130)* 310 (109) No 369 (88) 372 (99) No 0.861
 Growth hormone (µg .  L−1) 1.4 (2.8) 1.4 (3.1) No 1.1 (1.7) 1.3 (1.6) No 0.837
 IGF-1 (nmol . L −1) 15.7 (4.2) 15.0 (4.5) No 14.4 (3.2) 13.6 (3.1) Yes ↓ 0.977
 Testosterone (nmol .  L−1)† 11.2 (4.4) 11.4 (4.2) No 11.9 (3.3) 12.4 (4.2) No 0.938
 Sex-hormone binding globulin (nmol .  L−1) 60 (33) 60 (34) No 60 (22) 60 (21) No 0.488
 Androstenedione (nmol .  L−1) 3.3 (2.4) 3.3 (2.4) No 3.8 (2.7) 3.8 (2.4) No 0.984
 Parathyroid hormone (pmol .  L−1) 5.7 (2.6) 6.0 (3.3) No 5.0 (2.2) 5.2 (1.9) No 0.870
Lipid profile variables
 Triglycerides (mmol .  L−1) 1.2 (0.5) 1.1 (0.5) No 1.2 (0.5) 1.1 (0.6) Yes ↓ 0.661
 HDL (mmol .  L−1) 1.6 (0.6) 1.7 (0.5) No 1.7 (0.5) 1.7 (0.5) No 0.523
 LDL (mmol .  L−1) 2.8 (1.0)* 2.8 (1.0) No 3.4 (1.0) 3.3 (0.8) No 0.775
Iron biology variables
  Fe2+ (µmol .l  L−1) 18 (7) 18 (6) No 18 (6) 18 (5) No 0.410
 Transferrin (g .  L−1) 2.66 (0.44)* 2.67 (0.45) No 2.41 (0.27) 2.38 (0.29) No 0.563
 Ferritin (µg .  L−1) 113 (92) 90 (81) Yes ↓ 139 (79) 133 (68) No 0.089
Calcium status
 Calcium (mmol .  L−1) 2.4 (0.1) 2.4 (0.1) No 2.4 (0.1) 2.4 (0.1) No 0.865
 Albumin-corrected calcium (mmol .  L−1) 2.3 (0.1) 2.3 (0.1) No 2.3 (0.1) 2.3 (0.1) No 0.802
Tissue damage variables
 Aspartate transaminase (units .  L−1) 27 (9) 24 (6) No 26 (21) 26 (7) No 0.807
 Creatine kinase (units .  L−1) 112 (69) 123 (71) No 95 (47) 125 (72) Yes ↑ 0.523
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been suggested to be irresponsive to such training [55]. 
As such, it seems plausible that the observed improve-
ments in 6-min step test performance, 1-min sit-to-stand 
performance and two-legged cycling were associated 
with improvements in work economy/gross efficiency 
and muscle strength, as neither COPD nor Healthy 
showed training-associated changes in maximal oxygen 
consumption (Fig.  5), with improvements in anaerobic 
capacity being a potential contributor (not measured).
Fig. 4 Effects of the resistance training intervention on lower-body muscle strength (COPD, n = 18; Healthy, n = 50), lower-body muscle mass 
(COPD, n = 19; Healthy, n = 47), one-legged endurance performance (COPD, n = 15; Healthy, n = 49) and lower-body muscle quality (COPD, 
n = 18; Healthy, n = 38) in COPD and Healthy. Each outcome domain is represented by a combined factor, computed from various performance 
assessments, as defined in the upper panel of the figure and previously described [22]. A presents comparison of overall training effects between 
COPD and Healthy, measured as relative changes from baseline to after the resistance training intervention (per study cluster; left panel) and as 
relative and numeric differences in change scores between study clusters (right panels). In these analyses, high- and low-load resistance training 
(10RM and 30RM, respectively) were combined, warranted by the lack of differences between training load conditions in (B, C). COPD showed 
greater relative changes in muscle strength and muscle mass than Healthy. B, C presents comparison of effects of 10RM and 30RM resistance 
training in COPD (B) and Healthy (C) (i.e. per study cluster), measured as relative changes from baseline to after the intervention (left panels) and 
as relative and numeric differences in change scores between load conditions (right panels). #statistically different effects of resistance training 
between COPD and Healthy. Data are presented as means with 95% confidence limits
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Muscle fiber characteristics
Whereas COPD and Healthy displayed similar increases 
in type II fiber CSA in m. vastus lateralis in response to 
resistance training (COPD, 18%; Healthy, 24%; ∆-6%, 
p = 0.438; Fig.  6, upper panel), only Healthy showed 
increases in type I fiber CSA (16%), with no statisti-
cal difference being observed between study clusters. 
For Healthy, the increase in CSA was accompanied 
by increased myonuclei  .  fiber−1 in both fiber types 
(36%/25% for type I/II; Fig. 7), leading to decreased myo-
nuclear domain size estimates in type I fibers (-10%, 
Fig. 7). For COPD, no such effects were observed (Fig. 7). 
Despite the lack of difference between the two study clus-
ters for these variables, the data hints at blunted plasticity 
of type I muscle fibers in COPD only, potentially relating 
to their altered biological characteristics at baseline or to 
blunted myonuclear accretion. Interestingly, in sub-anal-
yses, the blunted type I responses in COPD seemed to be 
specific to 10RM training, with a tendency towards supe-
rior responses to 30RM training (10RM, -3%; 30RM, 19%; 
∆22%, p = 0.060; Fig.  6, middle panel). Such a phenom-
enon is supported by previous observations in responses 
to blood-flow-restricted low-load training [56], which 
arguably is mimicked by COPD subjects during low-load 
training, as they display inherent lowering of oxygen sat-
uration in blood.
Both COPD and Healthy displayed training-associ-
ated reductions in type IIX muscle fiber proportions 
(Fig.  7). While this reduction was more pronounced in 
COPD when measured at the protein level (immunohis-
tochemistry), it was more pronounced in Healthy when 
measured at the mRNA level, suggesting differential 
orchestration of muscle fiber shifts between study clus-
ters, possibly relating to their inherently different muscle 
fiber proportions at baseline.
Muscle RNA content
In general, COPD and Healthy showed similar increases 
in ribosomal RNA abundance per unit muscle tissue 
weight, measured as both total RNA and rRNA expres-
sion, and measured after both 3½ week (1.19/1.29 and 
1.16/1.16 fold increases, total RNA/rRNA abundances) 
and after finalization of the training intervention 
(1.12/1.05 and 1.19/1.17 fold increases) (Fig.  8). While 
these changes in ribosomal RNA content were generally 
similar between COPD and Healthy, a few noteworthy 
differences were evident, including a more robust early 
increase in 45s pre-rRNA abundance in COPD (Fig.  8) 
and a trend towards reduced changes in response to 
13  weeks training in COPD, which led to the absence 
of time effects for all rRNA species. The early increases 
in ribosomal content seen in both COPD and Healthy 
resemble those typically seen after similar interventions 
in untrained young individuals [26], and may be impor-
tant for muscle growth capabilities over the entirety of 
the study period [26, 57], accommodating increases in 
protein synthesis capacity, thus potentially contribut-
ing to the pronounced muscular responses to resistance 
training seen in both study clusters.
In both COPD and Healthy, resistance training led 
to marked changes in mRNA transcriptome profiles, 
with 499 and 312 differentially expressed genes being 
observed after 3½ and 13 weeks of resistance training, 
Table 5 Simple linear regression analyses on the relationship between training response and lung function in COPD participants
FEV1predicted, predicted forced expiratory volume in first second; r, Pearson’s r; P, P-value
Analysis n Slope (95% CI) Intercept (95% CI) r P
Change in muscle strength vs  FEV1predicted
 % change 18 − 0.3 (− 0.6, 0.0) 34.8 (16.8, 52.9) − 0.504 0.033
 Numeric change 18 − 0.001 (− 0.003, 0.001) 0.121 (0.017, 0.225) − 0.303 0.222
Change in muscle mass vs  FEV1predicted
 % change 19 − 0.3 (− 0.4, − 0.1) 21.4 (12.1, 30.7) − 0.624 0.004
 Numeric change 19 − 0.002 (− 0.003, 0.000) 0.127 (0.068, 0.186) − 0.603 0.006
Change in muscle quality vs  FEV1predicted
 % change 18 − 0.1 (− 0.4, 0.2) 12.6 (− 4.2, 29.4) − 0.141 0.577
 Numeric change 18 0.000 (− 0.002, 0.002) 0.063 (− 0.060, 0.186) − 0.038 0.881
Change in one-legged endurance performance vs  FEV1predicted
 % change 15 0.3 (− 0.4, 1.0) 8.5 (− 32.8, 49.7) 0.249 0.371
 Numeric change 15 0.001 (− 0.001, 0.002) 0.006 (− 0.066, 0.079) 0.282 0.308
Change in whole-body endurance performance vs  FEV1predicted
 % change 17 − 0.2 (− 0.6, 0.3) 17.7 (− 7.8, 43.1) − 0.211 0.416
 Numeric change 17 0.000 (− 0.001, 0.001) 0.023 (− 0.042, 0.089) 0.012 0.963
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Fig. 5 Comparison of the effects of the resistance training intervention on whole-body endurance performance in COPD and Healthy, presented 
as relative changes from baseline (per study cluster; A) and as relative and numeric differences in change scores between study clusters (B and 
C, respectively). Endurance measures included maximal oxygen consumption (V̇O2max,  cl
.  min−1; COPD, n = 15; Healthy, n = 54) and maximal 
workload (watts; COPD, n = 18; Healthy, n = 55) achieved during two-legged cycling, cycling economy  (cl.  min−1; COPD, n = 15; Healthy, n = 54) and 
gross efficiency measured during submaximal one-legged cycling, the number of steps achieved during 6-min step test (COPD, n = 18; Healthy, 
n = 57) and the number of sit-to-stands achieved during a 1-min sit-to-stand test (COPD, n = 19; Healthy, n = 56). COPD showed greater relative 
improvements in cycling economy and gross efficiency. For these outcome measures, COPD, but not Healthy, displayed benefits of high-load 
training (10RM) compared to low-load training (30RM) (D and E). Healthy showed greater numeric improvement in the number of steps achieved 
during the 6-min step test. COPD and Healthy showed similar relative and numeric training-associated changes in the whole-body endurance 
performance factor. #statistically different response to resistance training between study clusters. ‡statistically different response to 10RM and 30RM 
resistance training in study cluster. Data are presented as means with 95% confidence limits
Fig. 6 Effects of the resistance training intervention on cross-sectional area of muscle fiber types I and II in m. vastus lateralis in COPD (n = 18) and 
Healthy (n = 55). A presents comparison of overall training effects on fiber CSA between COPD and Healthy, measured as relative changes from 
baseline to after the training intervention (per study cluster; left panel) and as relative differences in change scores between study clusters (right 
panel). In these analyses, high- and low-load resistance training (10RM and 30RM, respectively) were combined, warranted by the lack of significant 
differences between training load conditions in (B, C), though COPD tended to show higher efficacy of 30RM resistance training for changes in 
fiber type I CSA. B, C presents comparisons of effects of 10RM and 30RM resistance training on fiber CSA in COPD (B) and Healthy (C) (i.e. per study 
cluster), measured as relative changes from baseline to after the training intervention (left panels) and as relative and numeric differences in change 
scores between load conditions (right panels). Data are presented as means with 95% confidence limits
(See figure on next page.)
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respectively (for general information about transcrip-
tomic responses, see Mølmen et  al. [22]). Overall, at 
the single-gene level, no transcripts showed differential 
responses to training between the two study clusters, 
neither at 3½ weeks nor at 13 weeks, despite clear dif-
ferences in transcriptome profiles at baseline (Fig.  3A 
and Additional file  1: Table  S2). In contrast, enrich-
ment analyses revealed traces of differential changes 
(Fig. 3C, Table 3 and Additional file 1: TableS 3), with 
COPD showing more pronounces increases in expres-
sion of genes relating to oxidative phosphorylation after 
3½ weeks (GSEA), and, in particular, more pronounced 
decreases in genes associated with myogenesis after 
13  weeks (consensus) (Fig.  3C, Table  3). Interestingly, 
as these two gene sets represented the most prominent 
differences between COPD and Healthy at baseline 
(Fig.  3A, B), and as resistance training led to direc-
tional changes that mitigated these differences, train-
ing arguably shifted the COPD phenotype in a healthy 
direction.
Blood and health‑related outcomes
Overall, COPD and Healthy showed similar training-
associated increases in whole-body and appendicular 
lean mass (Table 4). This was accompanied by increased 
appendicular skeletal muscle mass index relative to the 
sex-specific mean of young, healthy adults (COPD, from 
84 to 86%; Healthy, from 95 to 97%), suggesting that 
the intervention was effective for reversing age-related 
decline in muscle mass. For blood variables such as mark-
ers of systemic inflammation and hormone, lipid and 
iron biology, no noteworthy effects were observed of the 
intervention, nor were any differential changes observed 
between COPD and Healthy (Table 4).
Lung function
For COPD, the training intervention did not affect any of 
the lung function variables (Table 6), implying no effects 
on this core epidemiological trait. This seems reasonable 
given the irreversible nature of the respiratory impair-
ments of COPD, contradicting the beneficial effects 
observed in Hoff et al. [14] In contrast, for Healthy, the 
intervention was associated with reduced FVC and  FEV1 
(−  2.7% and −  1.5%, respectively). Rather than being a 
consequence of the intervention protocol per se, this may 
be due to a general age-related decline, as the magnitude 
of the changes resemble those seen in corresponding age 
cohorts over a similar time frame [58].
Health‑related quality of life
For COPD, the intervention was associated with marked 
improvements in several aspects of health-related qual-
ity of life (Table 7). These included reduced experience of 
limitations of physical functioning and improved social 
function and mental health, with only marginal effects 
being seen in Healthy. While these changes of course may 
be directly related to the resistance training intervention, 
they may also be related to other aspects of the study 
protocol, such as performing training sessions in a social 
setting and the close follow-up each participant received 
from study personnel. As the intervention was conducted 
without a control group (not receiving the intervention 
protocol), caution is warranted for interpretation of these 
data.
Concluding remarks
COPD-related pathophysiologies, such as reduced tes-
tosterone [4], vitamin D [5] and oxygen saturation levels 
[7, 59] in blood, and elevated levels of low-grade inflam-
mation [8], are generally believed to drive metabolism 
into a chronic catabolic state [4, 7, 9]. This has been sug-
gested to lead to impaired responses to lifestyle inter-
ventions such as resistance training [7, 60], which are 
essential measures for preventing and treating disease-
related reductions in skeletal muscle mass and strength, 
counteracting escalation into serious conditions such as 
pulmonary cachexia [17]. Despite this general belief, the 
(See figure on next page.)
Fig. 7 Comparisons of the effects of the resistance training intervention on changes in myonuclei per fiber and myonuclei domain in muscle 
fiber types I and II (A, B; COPD, n = 11; Healthy, n = 34), and on changes in muscle fiber type proportions in COPD and Healthy, measured using 
immunohistochemistry (C–E; COPD, n = 17; Healthy, n = 51)) and qPCR (gene family profiling-normalized myosin heavy chain mRNA expression, 
F–H; COPD, n = 19; Healthy, n = 55), as previously described [26, 75]. Myonuclei domain was calculated as mean fiber cross-sectional area divided 
by myonuclei per fiber. For myonuclei per fiber and myonuclei domain in muscle fiber types I and II, comparisons are presented as relative changes 
from baseline to after the training intervention (per study cluster; A) and as relative differences in change scores between study clusters (B). For 
muscle fiber type proportions, data are presented as adjusted values at baseline and after the training intervention (Post RT), and results are 
presented as the effect of the training intervention for the study clusters combined and its interaction with study clusters (C–H). For myonuclei 
variables, no training-associated differences were observed between study clusters. Both COPD and Healthy displayed training-associated 
reductions in proportions of type IIX muscle fibers, measured using both immunohistochemistry and qPCR. Intriguingly, while this reduction was 
greater in COPD when measured at the protein level (immunohistochemistry), it was greater in Healthy when measured at the mRNA level (qPCR), 
indicating differentially regulated muscle fiber shifting in COPD and Healthy. Data are presented as means with 95% confidence limits
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presence of impaired training responsiveness in COPD 
is not backed by experimental data, and there is limited 
de facto evidence for such impairments. To date, a mere 
single study has compared responses between COPD and 
healthy control subjects [18–20], and as such failing to 
lend support to the prevailing view, though being limited 
by a relatively short time span (8 weeks) and a restricted 
selection of outcome variables. In the present study, we 
largely disavow the myth of impaired responsiveness to 
training in COPD, measured as responses to a 13-week 
Fig. 7 (See legend on previous page.)
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whole-body resistance training intervention, conducted 
using an exhaustive follow-up and testing protocol, which 
included extensive test–retest validations (for details, see 
Mølmen et  al. [22]). Whereas COPD participants dis-
played clear and well-known disease-related aberrancies 
compared to Healthy at baseline, including altered skel-
etal muscle characteristics and elevated levels of systemic 
inflammation, they showed similar or superior improve-
ments for virtually every measure of health, performance 
and biology. Specifically, COPD showed greater relative 
improvements in core outcome domains such as lower-
body muscle strength and mass, and similar relative 
improvements in muscle quality, one-legged endurance 
performance and whole-body endurance performance. 
These similarities were also evident in numeric change 
terms, suggesting that the improvements seen in COPD 
was decoupled from the compromised levels at base-
line. Indeed, within the COPD cluster, worsening of 
lung function was associated with larger numeric and 
relative increases in muscle mass, as well as larger rela-
tive improvements in maximal muscle strength. These 
observations were accompanied by similar alterations 
in muscle biology, including changes in hallmark traits 
such as muscle fiber characteristics, rRNA content and 
transcriptome profiles. Together, these data suggest that 
COPD-related etiologies and pathophysiologies do not 
impair responsiveness to resistance training, at least not 
for skeletal muscle characteristics, and at least not in the 
Fig. 8 Effects of the resistance training intervention on total RNA content (A) and rRNA expression (B–F) in m. vastus lateralis of COPD (n = 19) 
and Healthy (n = 55). Data are presented as fold changes from baseline to Week 3½ (Post-intro RT; seven training sessions) and to after the training 
intervention (Post RT; 26 training sessions). Total RNA (A), 18s rRNA (B), 28s rRNA (C), 5.8s rRNA (D) 5s rRNA (E) and 45s pre-rRNA (F) abundances. 
Total RNA- and qPCR-analyses were assessed as per-amounts of tissue weight, as previously described [22, 26]. #statistical difference in fold change 
between COPD and Healthy (alpha level, p < 0.05). Data are presented as means with 95% confidence limits
Table 6 Effects of the training intervention on lung function in COPD (n = 20) and Healthy (n = 58), assessed as changes from baseline 
to after completion of the study (per study cluster) and as differential changes between study clusters
FVC forced vital capacity, FEV1 forced expiratory volume in one second, PEF peak expiratory flow, ∆ change score, ↓significant decrease from baseline to post RT (after 
13 weeks of resistance training). Alpha level at p < 0.05. Values are means with standard deviation
COPD Healthy
Baseline Post RT Time effect 
p < 0.05)
Baseline Post RT Time effect 
(p < 0.05)
∆ COPD vs 
∆ healthy 
(p-value)
FVC (L) 3.3 ± 0.9 3.2 ± 0.9 No 3.6 ± 0.9 3.5 ± 0.8 Yes↓ 0.189
FEV1 (L 
.  sec−1) 1.5 ± 0.4 1.5 ± 0.4 No 2.7 ± 0.7 2.7 ± 0.6 Yes↓ 0.243
FEV1 (% predicted) 56 ± 11 58 ± 13 No 103 ± 16 103 ± 16 No 0.138
FEV1/FVC (%) 47 ± 8 48 ± 10 No 75 ± 6 76 ± 6 No 0.714
PEF (L .  sec−1) 5.0 ± 1.6 5.1 ± 1.6 No 7.8 ± 2.1 7.6 ± 2.2 No 0.238
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enrolled cluster of COPD participants (GOLD grade II-
III) and within the time frame of the current study.
During planning of the study protocol, two strategies 
were implemented to resolve the hypothesized, albeit 
rejected, negative impact of COPD-specific pathophysi-
ologies for the efficacy of resistance training. First, as 
vitamin D insufficiency is common among COPD sub-
jects [5], and has been suggested to contribute to devel-
opment of anabolic resistance [61], dietary habits were 
manipulated to investigate the effects of vitamin  D3 sup-
plementation. Contrary to our hypothesis, vitamin  D3 did 
not enhance responses to resistance training for any of 
the outcome variables [22]. Second, the resistance train-
ing protocol was conducted using two different training 
modalities, 10RM and 30RM resistance training, per-
formed in a contralateral manner. The efficacies of these 
training modalities were initially hypothesized to be dis-
similarly affected by COPD-related pathophysiologies, 
as they convey muscular adaptations through different 
signaling cues in the cellular environment (i.e. mechani-
cal tension vs metabolic perturbation) [62], and may thus 
well be differentially affected by extracellular signaling 
such as inflammation and oxygen availability. While this 
hypothesis was rejected for all core outcome domains, 
with no differences being observed between training 
modalities and no evidence being found for the pres-
ence of impaired training responsiveness, a noteworthy 
observation was made for muscle fiber-specific traits. 
Specifically, in COPD, 10RM training was associated 
with blunted growth of type I muscle fiber CSA, a phe-
nomenon that was not observed for responses to 30RM 
training, suggesting that 30RM offers benefits for mus-
cle fiber type I hypertrophy. In addition to this, 10RM 
was associated with greater improvements in cycling 
economy and gross efficiency in COPD. These observa-
tions warrant further study. Of note, the unilateral resist-
ance-training design was arguably supportive for the 
pronounced resistance-training effects in COPD partici-
pants. By reducing cardiorespiratory demand, and thus 
facilitating higher degrees of muscle activation and mus-
cle mass-specific intensities during exercise compared 
to conventional two-legged resistance exercise [24] this 
seems to translate into larger functional improvements 
for this population [16].
Study limitations. Functional and physiological 
responses to resistance training is not uniform in the 
human population, and covary with individual character-
istics such as genetics, epigenetics and composites of the 
inner physiological milieu [63–65]. For any research pro-
ject that aim to understand the aetiology of such training, 
the interpretation of outcome data is thus a complicated 
task, which is further complicated by our present crude 
understanding of the interplay between the characteris-
tics in question and their associated response patterns. 
While these limitations need to be acknowledged also 
in the current analyses, their presence underlines the 
importance of making study-design decisions that con-
tribute to increase the ecological validity of the research 
project. As an example, in the present study, the advent 
of contralateral training protocols arguably increased the 
resolution of 10RM vs 30RM comparisons by removing 
genetic variability as a source of variation, albeit even 
Table 7 Effects of the training intervention on health-related quality of life in COPD and Healthy, measured using COPD Assessment 
Test (CAT; COPD-only, n = 20) and the 36-item Short Form Health Survey (SF-36; all participants; n COPD = 20, n Healthy = 57), and 
assessed as changes from baseline to after completion of the study (per study cluster; CAT and SF-36) and as differential changes 
between study clusters (SF-36)
*difference between COPD and Healthy at baseline; ↑significant increase from baseline to after the training intervention (Post RT). Alpha level at p < 0.05. Values are 
means with standard deviation
COPD Healthy ∆ COPD vs 
∆ Healthy (P 
value)Baseline Post RT Time effect 
P < 0.05)
Baseline Post RT Time effect 
(P < 0.05)
COPD assessment Test™ 
score (0–40)
16.6 ± 6.8 16.4 ± 6.8 No – – – –
Short Form (36) Health Survey (0–100)
 Physical function* 63 ± 19 67 ± 18 No 90 ± 14 92 ± 12 No 0.321
 Role physical* 43 ± 34 59 ± 37 Yes↑ 87 ± 25 94 ± 18 No 0.226
 Bodily pain 71 ± 27 82 ± 19 Yes↑ 79 ± 21 80 ± 19 No 0.070
 General health* 48 ± 20 56 ± 19 No 75 ± 18 80 ± 12 No 0.208
 Vitality* 52 ± 16 57 ± 13 No 72 ± 18 78 ± 11 Yes↑ 0.509
 Social function* 74 ± 23 84 ± 16 Yes↑ 90 ± 18 94 ± 13 No 0.280
 Role emotional* 65 ± 39 84 ± 26 Yes↑ 93 ± 19 96 ± 15 No 0.059
 Mental health* 77 ± 13 84 ± 13 Yes↑ 86 ± 11 89 ± 8 Yes↑ 0.196
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this perspective may have been affected by additional 
complications, such as the previously discussed cross-
education effect. Furthermore, in any study, it is prudent 
to monitor, and ideally also account for, exogenous fac-
tors that may have impacted the physiological milieu, and 
therefore also training responses. In the present study, 
these included surveillance of lifestyle characteristics 
such as habitual dietary intake, activities of daily living 
and intake of pulmonary medication. For habitual pat-
terns of dietary intake and activities of daily living, we 
observed no difference between study clusters (COPD 
vs Healthy), though it should be acknowledged that the 
collection of these data were performed only once dur-
ing the study, and as such were performed using diary/
questionnaire, making them prone to validity issues and 
warranting caution upon their interpretation [53, 66]. For 
pulmonary medication, the COPD and Healthy clusters 
deviated from each other for disease-related reasons, 
with 19 out of 20 COPD participants reporting intake of 
either  beta2-agonists, muscarinic agonists, or drugs con-
taining a mixture of  beta2-agonists and glucocorticoids, 
as detailed in Table  1. These drugs are known to affect 
muscle biology and functionality in humans [67–70], and 
as such may have influenced the outcome of the study. 
However, the reported medication status of the COPD 
participants corresponds to what is normal for COPD 
subjects in general [71], and as such reflects the popula-
tion intended to be studied.
In conclusion, 13-week resistance training program 
was well-tolerated by subjects with COPD and led to pro-
nounced improvements for a range of health and muscle 
functional and biological variables, resembling or exceed-
ing those seen in Healthy, with some outcome measures 
even showing indices of more beneficial adaptations in 
COPD participants with a more severe diagnosis. COPD 
was thus not associated with impaired responsiveness to 
resistance exercise training, which rather posed a potent 
measure to relieve disease-related pathophysiologies.
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Abstract
Background Lifestyle therapy with resistance training is a potent measure to counteract age-related loss in muscle strength
and mass. Unfortunately, many individuals fail to respond in the expected manner. This phenomenon is particularly common
among older adults and those with chronic diseases (e.g. chronic obstructive pulmonary disease, COPD) and may involve en-
docrine variables such as vitamin D. At present, the effects of vitamin D supplementation on responses to resistance training
remain largely unexplored.
Methods Ninety-five male and female participants (healthy, n = 71; COPD, n = 24; age 68 ± 5 years) were randomly assigned
to receive either vitamin D3 or placebo supplementation for 28 weeks in a double-blinded manner (latitude 61°N, September–
May). Seventy-eight participants completed the RCT, which was initiated by 12 weeks of supplementation-only (two weeks
with 10 000 IU/day, followed by 2000 IU/day), followed by 13 weeks of combined supplementation (2000 IU/day) and super-
vised whole-body resistance training (twice weekly), interspersed with testing and measurements. Outcome measures in-
cluded multiple assessments of muscle strength (nvariables = 7), endurance performance (n = 6), and muscle mass (n = 3,
legs, primary), as well as muscle quality (legs), muscle biology (m. vastus lateralis; muscle fibre characteristics, transcriptome),
and health-related variables (e.g. visceral fat mass and blood lipid profile). For main outcome domains such as muscle strength
and muscle mass, weighted combined factors were calculated from the range of singular assessments.
Results Overall, 13 weeks of resistance training increased muscle strength (13% ± 8%), muscle mass (9% ± 8%), and endur-
ance performance (one-legged, 23% ± 15%; whole-body, 8% ± 7%), assessed as weighted combined factors, and were associ-
ated with changes in health variables (e.g. visceral fat, 6% ± 21%; [LDL]serum, 4% ± 14%) and muscle tissue characteristics
such as fibre type proportions (e.g. IIX, 3% points), myonuclei per fibre (30% ± 65%), total RNA/rRNA abundances (15%/
6–19%), and transcriptome profiles (e.g. 312 differentially expressed genes). Vitamin D3 supplementation did not affect
training-associated changes for any of the main outcome domains, despite robust increases in [25(OH)D]serum (Δ49% vs.
placebo). No conditional effects were observed for COPD vs. healthy or pre-RCT [25(OH)D]serum. In secondary analyses, vitamin
D3 affected expression of gene sets involved in vascular functions in muscle tissue and strength gains in participants with high
fat mass, which advocates further study.
Conclusions Vitamin D3 supplementation did not affect muscular responses to resistance training in older adults with or
without COPD.
Keywords Strength training; Cholecalciferol; Muscle plasticity
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Introduction
Aging is associated with progressive loss of muscle strength
and mass, accompanied by declines in physical performance.
In 2016, this had escalated into ~11 million Europeans
(>65 years of age) suffering from sarcopenia,1 a formally
recognized disease characterized by severe loss of muscle
quantity and quality.1 Sarcopenia increases the likelihood of
adverse events such as falling, fractures, physical disability,
morbidity and mortality,2,3 further fuelling muscle deteriora-
tion, resulting in a spiralling decrease in overall health and
health-related quality of life.4–6 In Europe, the prevalence of
sarcopenia is expected to increase to at least ~19 million
by 2045,1 coinciding with increasing proportions of older
adults, potentiated by suboptimal nutrition and increasing in-
cidences of causal morbidities such as systemic inflammatory
diseases.7,8 For elderly to stay healthy, active and indepen-
dent, efficient interventions are warranted for its prevention,
treatment and reversal.7,8 To this end, lifestyle therapy with
resistance training is an attractive, low-cost and potent
intervention.9,10 Unfortunately, the benefits of such interven-
tions are not always consistent, especially in the older popu-
lation, with selected individuals and populations showing
impaired abilities to increase muscle strength and mass.11,12
At present, this training-response-spectrum has an unknown
causality, although it interdepends on factors such as
genetics,13,14 epigenetics,14 and composites of the inner
physiological milieu, including nutrition,15,16 endocrine vari-
ables (e.g. vitamin D),17,18 and hallmarks of health such as
low-grade chronic inflammation.19 There is thus a need for
development of combinatorial lifestyle protocols that target
and correct these factors alongside resistance training,
thereby allowing adequate muscle adaptations to occur.
Over the last two decades, vitamin D has emerged as a
potential determinant of muscle functionality and biology.20
There seems to be a robust relationship between heteroge-
neity in vitamin D status and traits such as physical
performance21–23 and susceptibility to falling,24 suggesting a
causal association between vitamin D and increased risk of
sarcopenia.25 As such, vitamin D status varies substantially
in the human population, both in an annual cycle, and
between individuals and groups of individuals.26,27 Vitamin
D insufficiency is particularly prevalent in older adults, mea-
sured as 25-hydroxyvitamin D (25(OH)D) levels <50 nmol/L,
and especially in older adults living in the Northern
Hemisphere,27,28 where cutaneous vitamin D synthesis is
miniscule or absent during winter months.29 In accordance
with this, exogenous vitamin D supplementation is gaining
momentum as a potential ergogenic aid for preventing and
treating sarcopenia.25 Unfortunately, the presumed benefits
of vitamin D supplementation deduced from crossover stud-
ies are not necessary supported by data from interventional
studies. While some studies and meta-analyses report
favourable effects of vitamin D supplementation per se on
muscle strength30–32 and falling,33,34 with benefits being
more pronounced in subjects with low baseline values
(<30 nmol/L)35 and in older subjects,35 others do not.36–39
These discrepancies may not be surprising, as resistance
training is arguably necessary to provoke changes in muscle
functions.40 However, a similar ambiguity is present in the
few studies that have assessed the effects of vitamin D
supplementation on outcomes of resistance training.41–44
While none of these studies report clear benefits of vitamin
D supplementation for alterations in muscle strength,41–44
muscle mass,42–44 or incidences of falling,41,43 a recent
meta-analysis still concluded that it provides benefits for
training-associated changes in lower body muscle strength.40
Consequently, we have limited and conflicting knowledge
about the combined effects of vitamin D supplementation
and resistance training for muscle functions and biology
in humans. The present confusion may partly be attributed
to methodological uncertainties in available studies, poten-
tially lowering their ecological validity and explaining
their lack of coherence with the resulting meta-analysis
data. This includes heterogeneous study populations
(varying from young adults42,44 to older adults44 to
elderly41,43) with large differences in baseline 25(OH)D levels
(average 31 nmol/L43–71 nmol/L44), large variation in vitamin
D dosage (from 400 IU/day43–4000 IU/day42), lack of
familiarization to strength tests,41,43 suboptimal training
protocols41,43 (failing to comply to current guidelines, advo-
cating resistance training with controlled maximal effort45,46),
low compliance to training,41,43 and a lack of dietary assess-
ment during the intervention.41,43,44 Also, neither of the stud-
ies included a period of vitamin D supplementation prior to
resistance training, which may be necessary to prime muscle
cells for adaptations, potentially acting by changing epige-
netic traits, which has been observed in other cell types, such
as T-cells47 and oral squamous cell carcinoma cells.48 Further-
more, the effects of vitamin D supplementation on muscle
fibre characteristics and biology remain poorly understood
and unclear.49 In theory, vitamin D may potentiate muscle
fibre responsiveness in two ways. Either directly by acting
through vitamin D receptors in muscle fibres or progenitor
cells, perhaps inducing intramuscular signalling pathways
such as the p38 mitogen-activated protein kinase
pathway,50,51 or indirectly by interacting with systemic signal-
ling event, perhaps inducing testosterone signalling52 and
thereby facilitating muscle plasticity. Our lack of insight is
underlined by the longstanding uncertainty of the presence
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of vitamin D receptors in muscle tissue,53 although several
indications advocate its expression. First, there seems to be
associations between mutations in the vitamin D receptor
and muscle weakness in both humans and mice.54,55 Second,
muscle-specific knock-out of the vitamin D receptor in mice
deteriorates muscle strength and mass in a manner that re-
semble sarcopenia.56,57 The prevailing uncertainty is fuelled
by a seeming lack of effects of vitamin D supplementation
per se on the muscle transcriptome in vitamin D-insufficient
frail elderly, although also in that study the vitamin D dosage
was relatively low (400 IU/day).58 To date, a mere single
study has assessed the effects of vitamin D supplementations
on resistance training-induced muscle biological adaptations
in humans, and as such assessing only a limited selection of
traits and failing to disclose conclusive findings.44
The aim of the present study was to investigate the
effects of 12 weeks of vitamin D3 supplementation only
(the initial two weeks with 10 000 international units
(IU)/day, succeeded by 10 weeks with 2000 IU/day), followed
by 13 weeks of combined vitamin D3 supplementation
(2000 IU/day) and resistance training, on training-associated
adaptations in a mixed population of older subjects. The
RCT thus allowed assessment of responses to both vitamin
D3 supplementation-only and combined vitamin D3 supple-
mentation and resistance training. The study population
included individuals that were either at risk of developing
sarcopenia (age or disease, i.e. COPD patients)59,60 or showed
diagnostic indications of sarcopenia (16.4% of the partici-
pants had appendicular lean mass (kg)/m2 greater than two
standard deviations below the sex-specific means of young
adults).61 Outcome measures included a large range of
muscle strength and endurance performance tests, multiple
assessments of muscle mass, muscle quality, in-depth analy-
ses of muscle biology including muscle fibre characteristics
and analyses of the muscle transcriptome, and a range of
health-related measures including body composition, blood
variables and self-reported health variables.
Methods
Study ethics and participants
The study was approved by the Regional Committee for
Medical and Health Research Ethics - South-East Norway
(reference no: 2013/1094) and was preregistered at
ClinicalTrials.gov (ClinicalTrials.gov Identifier: NCT02598830).
All participants were informed about the potential risks and
discomforts associated with the study and gave their
informed consent prior to study enrolment. The study was
conducted according to the Declaration of Helsinki.
Ninety-five male and female participants (age 68 ± 5 years,
range 56–77) were enrolled into the study (Figure 1).
Eligibility criteria were consumption of less than 400 interna-
tional units (IU) of vitamin D3 per day for the two months
leading up to the study, and either normal lung function or
medical diagnosis of COPD (GOLD62 grade II or III, FEV1
predicted between 80% - 30%, FEV1/FVC < 70% after
reversibility testing with inhalation of salbutamol and
ipratropiumbromid). Exclusion criteria were unstable cardio-
vascular disease, chronic granulomatous disease, known
active malignancy within the last five years, serious psychiat-
ric comorbidity, steroid use the previous two months and
musculoskeletal disorders preventing the participant from
participating in the resistance training programme. Initially,
all participants were screened using spirometry and a medical
questionnaire. For healthy participants, this formed the basis
for inclusion. For COPD participants and participants with un-
clear disease status, the initial screening was followed by con-
sultation with a medical doctor to ensure that they met
diagnostic criteria corresponding to GOLD grade II or III,
followed by inclusion. All participants were recreationally ac-
tive, but none had partaken in systematic resistance training
for the 12 months leading up to the study. During study
conduct, all participants were instructed to restrict vitamin
D intake from food sources to <400 IU/day and to abstain
from solarium and travels to southern and/or sunny areas.
Participants were randomly assigned into one of the two
study arms (vitamin D3 vs. placebo) using concealed
allocation, stratified by sex and health status (COPD vs.
non-COPD) (Figure 1 and Table 1). An off-site third party
performed the randomization. During the initial two weeks
of the study, the vitamin D3 arm consumed 10 000 IU vita-
min D3/day, followed by 2000 IU/day for the remainder of
the study period. Placebo capsules contained cold-pressed
olive oil and were identical in appearance to vitamin D3
capsules. Pharma Nord ApS (Vejle, Denmark) produced
the two supplements, complying with Good Manufacturing
Practice requirements. All participants consumed 500 mg
calcium/day (Nycoplus, Takeda AS, Asker, Norway). Vitamin
D status was primarily assessed as 25(OH)D levels in blood
(Figure 2), corroborating with previous studies,63 and
secondarily as 1,25 dihydroxycholecalciferol (1,25(OH)2D;
the biologically active form). 25(OH)D is accepted to be
the most reliable measure of vitamin D status,64 as it is
unaffected by parathyroid hormone (PTH) activity, and is
more stable and represents more accurate measurements
compared with 1,25(OH)2D.
64
Of the 95 participants included in the study, one with-
drew from the study prior to onset on supplementation,
12 withdrew prior to onset of resistance training (vitamin
D3 arm, n = 9; placebo arm, n = 3), and 4 participants
withdrew during the resistance training period (vitamin D3
arm, n = 3; placebo arm, n = 1) (Figure 1). In summary,
78 participants completed the study; 58 healthy partici-
pants and 20 COPD participants. For participant characteris-
tics, see Table 1.
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Study conduct
The study was conducted as a double-blind randomized
clinical trial (RCT), consisting of an initial 12 weeks of
supplementation-only (in average, 3333 IU vitamin D3/day
or placebo; 14 days of 10 000 IU vitamin D3/day, 10 weeks
of 2000 IU/day), followed by 13 weeks of combined supple-
mentation (2000 IU vitamin D3/day or placebo) and resis-
tance training (Figure 2). During study conduct, supplement
allocation was blinded for both participants and investigators.
Unblinding was performed after completion of primary out-
come measure clean-up and analyses. The intervention was
conducted at Lillehammer, Norway (latitude 61°N) from
September to May, ensuring low or no natural vitamin D
synthesis by the skin from sunlight UVB radiation.29 Prior to
onset of the supplementation protocol (i.e. pre-RCT), partici-
pants undertook two weeks of baseline testing and tissue/
blood sampling (Figure 2, Weeks 2 and 1), including test-
ing of unilateral strength and muscle performance (tested
twice, separated by at least 48 h; the first test was performed
at ~95% of maximal effort), lung function, and collection of
fasting blood and rested-state muscle biopsy, sampled from
m. vastus lateralis of the dominant leg using the microbiopsy
technique (Bard Magnum, Bard, Covington, GA, USA). There-
after, participants were randomized to the two supplementa-
tion arms. After two weeks of supplementation, a second
blood sample was collected (Figure 2, Week 2) to validate
the efficacy of vitamin D3 supplementation for blood 25
(OH)D and 1,25(OH)2D levels. Prior to introduction to
resistance training, the participants conducted repeated
Figure 1 CONSORT flow chart of the study.
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performance tests at several occasions (Figure 2, Week
2–Week 13), including unilateral maximal strength and mus-
cular performance, isokinetic unilateral knee-extension
torque, measures of functional capacity (i.e. 6-min step and
1-min sit-to-stand test), submaximal and maximal one-legged
cycling, and maximal bicycling. During the last week before in-
troduction to resistance training (Figure 2,Week 13), bilateral
rested-state biopsies and a fasted blood sample were col-
lected, muscle thickness of m. vastus lateralis and m. rectus
femoris were measured using ultrasound (SmartUs EXT-1 M;
Telemed, Vilnius, Lithuania), and body composition was
measured using dual-energy X-ray absorptiometry scan
(DXA; Lunar Prodigy, GE Healthcare, Chicago, IL, USA).
The training intervention consisted of 13 weeks of two
weekly whole-body resistance training sessions (Figure 2,
Week 14–27). Leg exercises were performed unilaterally to
allow within-participant differentiation of resistance training
load. Accordingly, for each participant, the two legs were ran-
domly assigned to perform either three sets with 10 repeti-
tions to exhaustion (high-load resistance exercise) or three
sets with 30 repetitions to exhaustion (low-load resistance
exercise); that is, each participant performed both protocols
Table 1 Participant characteristics
Vitamin D3 arm Placebo arm
Participants (n) 46 48
Females (n) 24 27
COPD subjects (n) 12 12
Age (years ± SD) 69 ± 5 67 ± 4
Weight (kg ± SD) 75 ± 17 75 ± 16
Lean mass (kg ± SD) 48 ± 11 48 ± 9
Fat percentage (% ± SD) 35 ± 6 34 ± 9
Body mass index (kg/m2 ± SD) 26 ± 5 26 ± 5
1RM knee extension (kg ± SD) 18 ± 8 18 ± 7
1RM chest press (kg ± SD) 47 ± 17 45 ± 16
Withdrawn prior to intro. RT (n) 9 3
Withdrawn after intro. RT (n) 3 1
Renal function
Creatinine (μmol/L) 78 ± 18 80 ± 22
Est. GFR (mL/min/1.73 m2) 80 ± 15 79 ± 15
CKD stage 3, i.e. est. GFR of 30–59 (n) 2 3
Lung function
FVC (L ± SD) 3.4 ± 0.8 3.6 ± 0.9
FEV1/FVC (% ± SD) 67 ± 15 69 ± 14
FEV1 (% predicted ± SD) 87 ± 24 94 ± 26
PEF (L/s ± SD) 6.9 ± 2.4 7.1 ± 2.1
Habitual dietary data
Kilocalories/day ± SD 1777 ± 529 1985 ± 611
Protein (g/kg/day ± SD) 1.26 ± 0.40 1.27 ± 0.36
Fat (g/kg/day ± SD) 0.99 ± 0.47 1.05 ± 0.38
Carbohydrates (g/kg/day ± SD) 2.46 ± 1.05 2.88 ± 1.03
Alcohol (units/day ± SD) 0.76 ± 0.92 0.67 ± 1.04
Vitamin D (IU/day ± SD) 281 ± 235 331 ± 260
Other vitamin D exposures
Number of hours outdoors per week 8.8 ± 6.0 8.9 ± 6.4
Fish for dinner per week 1.9 ± 0.8 1.8 ± 0.7
Fish for other meals per week 2.0 ± 1.7 1.6 ± 1.1
Cod liver oil (teaspoons per week) 1.2 ± 3.8 1.6 ± 3.4
Cod liver oil (capsules per week) 1.5 ± 3.8 2.0 ± 3.8
Number of eggs eaten per week 3.2 ± 1.8 2.9 ± 2.2
Adherence
Adherence to supplementation plan (%) 99 (91–100) 99 (93–100)
Adherence to the training protocol (%) 98 (81–100) 98 (81–100)
Training volume (kg x repetitions) Leg press
Knee
extension RPE Leg press
Knee
extension RPE
Training week 1 (Introduction period, week 1) 4074 (1741) 298 (143) 15.4 (1.4) 4307 (1737) 360 (206) 15.4 (1.5)
Training week 4 (Training period, week 1) 5117 (2199) 364 (187) 15.9 (1.4) 5393 (2247) 407 (201) 16.0 (1.3)
Training week 8 (Training period, week 5) 6071 (2710) 446 (233) 16.5 (1.5) 6200 (2638) 495 (255) 16.6 (1.3)
Training week 13 (Training period, week 10) 6698 (3183) 489 (255) 17.0 (1.3) 6706 (2598) 550 (293) 17.1 (1.2)
1RM, one repetition maximum; CKD, chronic kidney disease; FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity; GFR, glomer-
ular filtration rate (calculated using the Modification of Diet in Renal Disease study equation; IU, international units; PEF, peak expiratory
flow; RT, resistance training; RPE, rating of perceived exertion (6–20).
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Figure 2 Schematic overview of the study protocol. Pre-defined main time frames (baseline and end time points) for specific outcome measures (the
color lines represents the measurement marked with the same color at the top of the figure; (A), vitamin D-status (25-hydroxyvitamin D levels, (B) and
1,25 dihydroxyvitamin D levels (C) during the RCT, training volume during the resistance training intervention (D), and perceived exertion (Borg RPE,
6–20) reported after training sessions (E). The training volume was calculated as average increase in volume (kg · repetitions) in leg press and knee ex-
tension from the first week of training. STR, maximal strength test; Musc.perf., test of muscular performance; 1-LC, one-legged cycling test; Func., test of
functional capacity (6-min step test and 1-min sit-to-stand test); US, ultrasound measures of muscle thickness; DXA, Dual-energy X-ray Absorptiometry;
V̇O2max, maximal oxygen consumption; IU, international units; RT, resistance training; 25(OH)D, 25-hydroxyvitamin D. In (B), statistical differences be-
tween time points and supplementation arms are denoted by letters: different letter indicates P < 0.05, that is, all time point measures denoted with
the same letter are statistically similar (P > 0.05). Data for 25(OH)D and training volume are presented as means with 95% confidence intervals.
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in each session. For the upper-body, resistance exercises
were performed bilaterally, consisting of two sets of 10 repe-
titions to exhaustion. After seven training sessions (i.e. after
3.5 weeks of training; post-introduction to resistance train-
ing), participants performed a selected battery of tests and
measurements (Figure 2, i.e. Week 17–18), including rested-
state bilateral muscle biopsies, a fasted blood sample, and
measures of muscle strength, performance and torque. These
tests were conducted for two reasons i) to assess the initial
response to resistance training and ii) to reduce the impact
of neural adaptations for training-associated increases in per-
formance (i.e. Week 17–18 was defined as baseline for these
performance measurements). After the training intervention
(post-RCT), the complete battery of tests and measurements
were repeated (Figure 2, i.e. Week 28–30). During week 24,
participants conducted a dietary registration, in which they
logged their dietary intake for 3 days, including one weekend
day (Table 1). Throughout the entirety of the study, partici-
pants completed a weekly health survey every Sunday eve-
ning, which included information about supplementation
compliance, self-reported health and potential discomforts
caused by the nutritional supplement, such as digestive is-
sues, sleep issues, issues with the urinary system, issues with
the vestibular system, and dermal irritations. Moderate ver-
bal motivation was given to all participants during all perfor-
mance tests.
Resistance-exercise training protocol
All participants performed the same whole-body resistance-
exercise training programme, consisting of the following ex-
ercises (listed in order of conductance): unilateral leg press,
unilateral knee extension, unilateral knee flexion, chest press,
and lat pulldown. Leg exercises were performed as three
series of 10 repetitions (high-load) and 30 repetitions (low-
load) to exhaustion (10RM and 30RM, respectively), and
upper-body exercises were performed as two series of 10
repetitions (high-load) to exhaustion, as previously described.
Exercises and sets were separated by 2 min of rest. For leg ex-
ercises, all three sets for one leg were conducted before the
other leg was exercised. The order in which the two legs were
exercised was switched between each session. For all exer-
cises, training loads were adjusted from session to session,
i.e. when participants managed to perform more than 12 or
35 repetitions per set for high- and low-load training, respec-
tively. All sessions were supervised by qualified personnel to
ensure correct technical execution and to ensure maximal ef-
forts through verbal encouragement. To aid recovery and to
ensure adequate protein intake after training, participants
ingested half a protein bar immediately after each training
session (~15 g protein; Big 100, Proteinfabrikken, Sandefjord,
Norway).
Spirometry
Spirometry testing was performed using either the Oxycon
Pro™ with the TripleV digital volume sensor (Carefusion
GmbH, Höchberg, Germany) or the Spirare SPS320 ultrasonic
spirometer (Diagnostica AS, Oslo, Norway) following guide-
lines from the American Thoracic Society and the European
Respiratory Society.65 Importantly, for each particular partici-
pant, all spirometry tests were performed using the same
system. Participants with COPD were tested before and after
inhalation of two bronchodilators (salbutamol, 0.2 mg and
ipratropiumbromid, 20 μg).
Muscle strength and performance
Maximal muscle strength was assessed as one repetition
maximum (1RM) in unilateral knee extension and leg press
(Technogym, Cesena, Italy) and bilateral chest press (Panatta,
Apiro, Italy). Each test started with specific warm-up,
consisting of 10, 6, and 3 repetitions at 40%, 70%, and 85%
of the anticipated maximum. Thereafter, 1RM was found by
increasing the resistance progressively until the weight
could not be lifted through the full range of motion. Loads
were increased in intervals of 1.25, 2.5, and 1.25 kg for
knee extension, leg press, and chest press, respectively. Two
minutes of rest was provided between attempts. Maximal
handgrip strength was measured for the dominant hand
using a hand-held dynamometer (Baseline®, Fabrication
Enterprises, Inc., Elmsford, NY, USA). Each test session
consisted of three attempts, and the average score was
used in further analyses.
Muscle performance was defined as the maximal number
of repetitions achieved at 50% of pre-RCT 1RM and was
assessed in unilateral knee extension and bilateral chest
press. Participants were instructed to lift at a composed
and controlled pace, with <1 s breaks in the lower and upper
position. Whenever this requirement was not met, or partic-
ipants failed to lift the weight through the full range of mo-
tion, the test was aborted.
Isokinetic unilateral knee-extension torque was assessed
using a dynamometer (Humac Norm, CSMi, Stoughton, MA,
USA). Participants were seated and secured with the knee
joint aligned with the rotation axis of the dynamometer. Max-
imal isokinetic torque was tested at three angular speeds
(60°, 120°, and 240° per second) with 2 min of rest provided
between each of them. Prior to each test session, participants
were familiarized with the test protocol by performing three
submaximal efforts at each angular speed. Participants were
given three attempts performed in immediate succession.
The highest value was used in further analyses.
For all tests of unilateral strength and performance, the
dominant leg was tested first. Seat position and general
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settings for each test were noted for each participant and
reproduced at each time-point.
One-legged cycling and bicycling performance
Participants conducted one-legged cycling tests (Excalibur
Sport, Lode BV, Groningen, the Netherlands) to assess O2-costs
of submaximal cycling, and maximal one-legged oxygen con-
sumption (V̇O2max) and power output (Wmax). Each test was
initiated by 2 × 5 min submaximal workloads at 30 and 40
watts (healthy), respectively, or 20 and 30 watts (COPD) with
a cadence of 60 revolutions per minute. Loads were individu-
ally adjusted if the predefined workload was higher than
50% of the Wmax achieved during the familiarization session.
Thereafter, a maximal step-wise incremental protocol was
conducted (10 and 5 watts/min for healthy and COPD partici-
pants, respectively). Starting loads were individually adjusted
to elicit exhaustion after 6–10 min of cycling, based on results
from the familiarization session. The cadence was freely
chosen (>50 rpm). The test was terminated when cadence fell
below 50 rpm. For all participants, submaximal and maximal
performance on the dominant leg was tested first. After test-
ing of the first leg, participants were allowed 20 min rest
and/or low-intensity cycling, before testing of the other leg.
During one-legged cycling tests, a 10 kg counterweight was
attached to the contralateral ergometer crank to facilitate
smooth cycling. The foot of the non-exercising leg was rested
on a chair placed in front of the subject. Breath-to-breathmea-
surements of pulmonary oxygen consumption and ventilation
(JAEGER Oxycon PRO™; Carefusion GmbH, Höchberg,
Germany) and heart rate (Polar Electro Oy, Kempele, Finland)
was monitored continuously during all tests. The average oxy-
gen consumption during the last 2 min of each submaximal
workload was defined as the O2-cost, while V̇O2max was
defined as the highest average oxygen consumption measured
over a period of 30-s. Measurement of capillary lactate
concentration (Biosen C-line, EKF Diagnostics, Barleben,
Germany) was performed after finalization of tests.
Testing of maximal bilateral cycling V̇O2max and Wmax was
performed on a separate day. A step-wise incremental proto-
col (20 and 15 watts/min for healthy men and women,
respectively; 10 watts/min for participants with COPD) was
conducted. Oxygen consumption was measured continuously
using a computerized metabolic system with mixing chamber
(JAEGER Oxycon PRO™; Carefusion GmbH, Höchberg,
Germany). Prior to each cycling test, the gas analyser was
calibrated using certified calibration gases with known con-
centrations, and the flow turbine (TripleV; JAEGER,
Carefusion GmbH, Höchberg, Germany) was calibrated using
the metabolic system’s automatic volume calibration, or a
3 L, 5530 series calibration syringe (Hans Rudolph Inc., Kansas
City, MO, USA), for one-legged and bicycling tests,
respectively.
Functional performance
One-minute sit-to-stand and 6-min step tests were conducted
in consecutive order on the same test day. Each test session
was initiated with 10 min warm-up of low-intensity bicycling.
Briefly, during the 1-min sit-to-stand tests, participants were
instructed to fold their arms and sit/stand up for as many
times possible during a 1-min period. The seat was 45 cm
from the floor. Sit-to-stand repetitions were approved if both
knees and hip joints were fully extended after each seating.
Three minutes after the 1-min sit-to-stand test, the 6-min
step test was conducted. Briefly, participants were instructed
to perform as many steps as possible onto a 20 cm high step
box with a non-slip rubber surface within 6 min (Reebok Step;
Boston, MA, USA). During each step, participants were
instructed to place both legs on the box, with the hip fully
extended.
Muscle thickness by ultrasound and dual-energy
X-ray absorptiometry-derived body mass measures
Prior to measurements of muscle thickness and DXA mea-
surements, the participants were instructed to attend an
overnight fast and avoid heavy physical activity for the last
24 h leading up to the event.
Muscle thickness of m. vastus lateralis and m. rectus
femoris were measured using B-mode ultrasonography
(SmartUs EXT-1 M, Telemed, Vilnius, Lithuania) with a
39 mm 12 MHz, linear array probe. Transverse images were
obtained ~60% distally from the trochanter major towards
the femoral lateral epicondyle. Three images were captured
for each muscle, where the probe was relocated to the
same position between each image. The position of the
probe was marked on the skin and subsequently marked
on a soft transparent plastic sheet superimposed on the
thigh. Landmarks such as moles and scars were also
marked on the plastic sheet for relocation of the scanned
areas during post-training measurements. During analysis,
pre and post images from the same participant were
analysed consecutively using the Fiji software66 and by
two independent researchers. The average muscle thickness
of the three images captured per muscle was used for fur-
ther analyses.
Body composition was determined using DXA (Lunar
Prodigy, GE Healthcare, Madison, WI, USA) and was analysed
using the manufacturer’s software, in accordance with the
manufacturer’s protocol. Leg lean mass was defined as the
region distally of collum femoris. Care was taken to match
the region of interest on pre and post images. Analyses of
both muscle thickness and body composition were per-
formed in a blinded manner regarding participant identity
and time point of the measurement.
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Blood sampling and measurements, and muscle
biopsy sampling
Prior to collection of blood and muscle biopsies, participants
were instructed to attend an overnight fast and to avoid
heavy physical activity for the last 48 h leading up to the
event. All blood samples and muscle biopsies were collected
between 08:00 and 11:00 a.m. Blood samples were collected
from an antecubital vein into serum-separating tubes and
kept at room temperature for 30 min before centrifugation
(2600 g, 15 min). Serum was aliquoted and stored at 80°C
until further processing. Serum concentrations of total
testosterone, cortisol, growth hormone, insulin-like growth-
factor 1 (IGF-1), sex-hormone binding globulin (SHBG) and
androstenedione were measured using an Immulite 2000
analyser with kits from the Immulite Immunoassay System
menu (Siemens Medical Solutions Diagnostics, Malvern, PA,
USA). Serum 25(OH)D, parathyroid hormone, calcium, albu-
min, creatinine, creatine kinase, aspartate aminotransferase,
C-reactive protein, triglycerides, low-density lipoprotein,
high-density lipoprotein, thyroid hormones and iron metabo-
lism variables were measured using a Roche Cobas 6000
analyser and kits from Roche (Roche Diagnostics, Rotkreuz,
Switzerland). In a subset of participants, 1,25(OH)2D levels
in serum were measured at Week 1, Week 2, Week 13
and Week 28 (vitamin D3 arm, n = 19; placebo arm, n = 21)
using enzyme immunoassays with kits from Immunodiagnos-
tic Systems (IDS, Boldon, Tyne & Wear, UK).
Muscle biopsies were sampled from m. vastus lateralis un-
der local anaesthesia (Lidocaine, 10 mg/mL, AstraZenaca AS,
Oslo, Norway) using a 12-gauge needle (Universal Plus,
Medax, San Possidonio, Italy) operated with a spring-loaded
biopsy instrument (Bard Magnum, Bard, Covington, GA,
USA), as previously described.67 Biopsies were sampled at
1/3 of the distance from the patella to the anterior superior
iliac spine. The tissue was quickly dissected free of blood
and visible connective tissue in ice-cold sterile saline solution
(0.9% NaCl). Samples for immunohistochemistry were trans-
ferred to a 4% formalin solution for fixation for 24–72 h,
before further preparation. Samples for RNA analyses were
blotted dry, snap-frozen in isopentane (80°C) and stored
at 80°C until further processing.
Immunohistochemistry
Formalin-fixed muscle biopsies were processed rapidly using
a Shandon Excelsior ES (Thermo Fisher Scientific, Waltham,
MA, USA), whereupon biopsies were paraffin-embedded
and sectioned into transverse sections (4 μm). Antigen
retrieval was performed at 97°C for 20 min in a target
retrieval solution (cat. no. DM828, Agilent Dako, Santa Clara,
CA, USA) using a PT link (PT 200, Agilent Dako, Santa Clara,
CA, USA). Staining was performed using a DAKO Autostainer
Link 48 (Agilent Dako, Santa Clara, CA, USA). For determina-
tion of muscle fibre types, cross-sections were first treated
with protease 2 (cat. no. 760–2019, Roche Diagnostics,
Rotkreuz, Switzerland), before they were triple-stained using
2.5 μg/mL BA-F8, BF-35 and 6H1 (all from Developmental
Studies Hybridoma Bank, University of Iowa, Iowa City, IA,
USA; BA-F8 and BF-35 deposited by Schiaffino, S., Uni. of Pa-
dova, Italy; 6H1 deposited by Lucas, C., Uni. of Sydney,
Australia). Visualization of the primary antibodies was
achieved by incubation of appropriate secondary antibodies,
diluted 1:400: goat anti-mouse Alexa Fluor (Thermo Fisher
Scientific, Waltham, MA, USA) 350 (IgGγ2b, cat. no.
A21140), 488 (IgGγ1, cat. no. A21121) and 594 (IgM H + L,
cat. no. A21044) for BA-F8, BF-35 and 6H1, respectively.
For determination of muscle fibre cross-sectional area
(CSA) and numbers of myonuclei per muscle fibre type, a dif-
ferent tissue cross-section was double-stained using primary
antibodies against muscle fibre membrane (dystrophin, di-
luted 1:100, cat. no. PA1–21011; Thermo Fisher Scientific,
Waltham, MA, USA) and myosin heavy chain I (diluted
1:2000, cat. no. M8421, Sigma-Aldrich, Saint-Louis, MO,
USA). Visualization was achieved using the secondary anti-
bodies Alexa Fluor 594 (IgG H + L, diluted 1:400, cat. no.
A11037) and 488 (IgG1γ1, diluted 1:400, cat. no. A21121), re-
spectively (Thermo Fisher Scientific, Waltham, MA, USA).
Muscle sections were then covered with a coverslip and
glued with EverBrite™ Hardset Mounting Medium with DAPI
(cat. no. 23004, Biotium Inc., Fremont, CA, USA), to visualize
cell nuclei.
Images of stained cross-sections were captured using a
high-resolution camera (Axiocam, Zeiss, Oberkochen,
Germany) mounted on a light microscope (Axioskop-2, Zeiss,
Oberkochen, Germany), with a fluorescent light source
(X-Cite 120, EXFO Photonic Solutions Inc., Mississauga,
Canada). Multiple images were taken using 20× objectives
to capture the entirety of each cross-section. For representa-
tive images, see Figure 3. All analyses of muscle fibre charac-
teristics were performed using automated procedures,
ensuring unbiased quantification.
Analyses of muscle fibre type proportions were performed
using the Cell Counter function in the Fiji software,66
whereby muscle fibres were categorized as either type I, type
IIA, type IIX or hybrid fibres type IIA/IIX. Sections and/or
images with insufficient staining to distinguish between fibre
types were excluded. Muscle fibre type-specific CSA (type I or
type II) were calculated using the TEMA software
(CheckVision, Hadsund, Denmark). Myonuclei were counted
using the CellProfiler software.68
Total RNA extraction and qPCR
Approximately 10–20 mg of wet muscle tissue (average
13 ± 4 mg, range 3–26 mg) was homogenized in a total
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volume of 1 mL TRIzol reagent (Invitrogen, Carlsbad, CA, USA)
using 0.5 mm RNase-free zirconium oxide beads and a bead
homogenizer (Bullet Blender, Next Advance, Averill Park, NY,
USA), as previously described.67 To enable analysis of target
gene expression per unit tissue weight, an exogenous RNA
control (λ polyA External Standard Kit, Takara Bio Inc., Shiga,
Japan) was added at a fixed amount (0.04 ng/mL of Trizol re-
agent) per extraction prior to homogenization, as previously
described.69,70 Following phase separation, 450 μL of the
upper phase was transferred to a new tube and RNA was pre-
cipitated using isopropanol. The resulting RNA pellet was
washed three times with 75% ethanol, eluted in 30 μL TE
buffer, and diluted to 100 ng RNA/μL, following quantification
of total RNA concentration using μDrop plate and the
Multiskan GO microplate spectrophotometer (Thermo
Fisher Scientific, Waltham, MA, USA). RNA integrity was
assessed using capillary electrophoresis (Experion Automated
Electrophoresis Station using RNA StdSens Assay, Bio-Rad,
Hercules, CA, USA) with average integrity score (RNA quality
indicator; RQI): 8.9 ± 0.8.
Five hundred nanograms of RNA were reverse transcribed
using anchored oligo-dT (Thermo Fisher Scientific, Waltham,
MA, USA), random hexamer primers (Thermo Fisher
Scientific, Waltham, MA, USA) and Super-Script IV Reverse
Transcriptase (Invitrogen, Carlsbad, CA, USA), according to
manufacturers’ instructions. All samples were reverse tran-
scribed in duplicates and diluted 1:50 prior to quantitative
real-time polymerase chain reaction (qPCR). qPCR reactions
were conducted using a fast-cycling real-time detection sys-
tem (Applied Biosystems 7500 fast Real-Time PCR Systems,
Life Technologies AS), with total volumes of 10 μL, containing
2 μL cDNA (1:25 dilutions), target gene-specific primers (final
concentration 0.5 μM) and a commercial master mix (2× SYBR
Select Master Mix, Applied Biosystems, Life Technologies
Corp., Carlsbad, CA, USA). qPCR reactions consisted of 40 cy-
cles (3 s 95°C denaturing and 30 s 60°C annealing).
Melt-curve analyses were performed for all reactions to ver-
ify single-product amplification. Gene-specific primers were
designed using Primer3Plus71 and synthesized by Thermo
Scientific, except for the external RNA control, for which
primers were supplied with the kit (λ polyA External Standard
Kit, Takara Bio Inc., Shiga, Japan). Raw fluorescence data were
exported from the platform-specific software and amplifica-
tion curves were modelled using a best-fit sigmoidal
model using the qpcR-package72 written for R.73 Threshold
cycles (Ct) were estimated from the models by the
second-derivate maximum method with technical duplicates
modelled independently. Amplification efficiencies were esti-
mated for every reaction.74 For every primer pair, mean am-
plification efficiencies (E) were utilized to transform data to
the linear scale using E–Ct. Primer sequences and primer
characteristics (i.e. average primer efficiencies and Ct values)
are presented in Supporting Information, Table S1. Gene
expression data were log-transformed prior to statistical
analysis. As Ct values, but not primer efficiencies depend on
RNA integrity,75 RQI scores were used as a random variable
on a per-target basis to control for potential degradation dur-
ing statistical analyses (see below).
RNA sequencing
RNA sequencing was performed on pairwise muscle samples
collected before the RCT (vitamin D3, n = 11; placebo, n = 13),
after 12 weeks of supplementation-only (vitamin D3, n = 24;
placebo, n = 29), after 3.5 weeks of introduction to resistance
training (vitamin D3, n = 23; placebo, n = 28), and after
13 weeks of resistance training (vitamin D3 arm, n = 24; pla-
cebo arm, n = 29). Samples was selected based on quality
of total RNA samples (RQI > 7.0, avg 9.0 ± 0.5). Participants
with complete sets of muscle biopsies were prioritized. For
each muscle sample, mRNA sequencing libraries were pre-
pared from 1000 ng of total RNA using TruSeq Stranded Total
RNA Library Prep (Illumina, San Diego, CA, USA). Paired-end
sequencing (150 bp) was performed using an Illumina HiSeq
Figure 3 Representative immunohistochemistry images of (A) myosin heavy chain I (green) and cell membrane (red), (B) myonuclei (blue) and cell
membrane (dystrophin, red), and (C) myosin heavy chain I (blue), IIA (green), IIX (red), and IIA/IIX hybrids (orange). Images in (A) and (B) are from
the same tissue cross-section: triple-staining myosin heavy chain I, dystrophin and cell nuclei.
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3000 (Illumina, San Diego, CA, USA) at the Norwegian
Sequencing Centre, Oslo, Norway.
Data analyses and statistics
As defined in the pre-registration of the study protocol
(ClinicalTrials.gov Identifier: NCT02598830), the effects of vi-
tamin D3 supplementation for different outcome measures
were evaluated using different baseline time points (outlined
in Figure 2). For transparency, statistical comparisons of all
outcome measures and all relevant time points are presented
in Supporting Information, Tables S2 and S3. These tables also
specify the statistical models used for each specific variable
and analysis. In general, for continuous variables, the effects
of vitamin D3 supplementation (compared with placebo)
were investigated using linear mixed-effects models with
the relative change from baseline being defined as the
dependent variable and the supplementation arms being de-
fined as the fixed effect. The two different training loads
(high- and low-load) were added to the model as repeated
measures/observations (for unilateral outcome measures),
and baseline values were used as co-variates. For all partici-
pants, random intercepts were specified. For all unilateral
leg variables, interaction effects were explored between the
fixed effect and health status (COPD vs. non-COPD) and train-
ing loads. For other variables, interactions were investigated
between the fixed effect (vitamin D3 vs. placebo) and health
status, with the exception for blood variables, for which the
interaction with sex was also examined. For all statistical
analyses of immunohistochemical variables (muscle fibre
CSA, fibre type proportion, and myonuclei per fibre), the
models were weighted for the number of counted fibres
per biopsy. This was carried out to account for the
reduced reliability accompanying fewer observations/fibres
(see Supporting Information, Figure S2). For non-continuous
variables, a different statistical approach was used to investi-
gate the effects of the vitamin D3 supplementation. For fibre
type proportions (immunohistochemistry) and variables from
the weekly health survey, a generalized linear mixed model
(GLMM) with binomial error distribution and link function
was used to examine differences in changes between supple-
mentation arms (time*supplementation arm interactions).
For gene family-based analyses of myosin heavy-chain mRNA
data,76 a GLMM with negative binomial distribution/link
function (log-link) was used following transformation to tran-
script counts.77 Target gene mRNA abundance, expressed as
per unit muscle weight using the external reference gene,
were analysed using mixed linear models with within-model
normalization through the addition of random effects of
technical replicates. To allow for gene-specific variances, var-
iance functions were specified per strata (per gene). RQI
scores were included in the model on a per target basis to
control for RNA degradation. The number of observations
per statistical analysis is presented in Supporting Information,
Table S2. For most outcome measures, the main effect of
time was examined using mixed modelling, using absolute
values for the dependent variable and time points as re-
peated measures/observations with random intercepts for
each subject (Supporting Information, Table S2 for complete
overview).
During transcriptome analyses, gene counts were modelled
using negative binomial GLMM with the total library size
modelled as a fixed effect78 together with sex and study con-
ditions (time point and supplementation arms). The effect of
resistance training on gene counts was assessed as i) the ef-
fect of time and ii) its interaction with supplementation arm
(vitamin D3 and placebo supplementation). For analyses of
the effect of time, differential expression was evaluated using
GLMMs containing only the time factor, combining all data ir-
respective of supplementation arm. For analyses of the effect
of supplementation over time, differential expression was
evaluated using GLMMs containing the interaction between
time and supplementation arm. The supplementation-only
period was modelled independently of the training period.
In all models, a single random effect was used, giving each
participant an individual intercept. Models were iteratively
fitted using glmmTMB.79 Model adequacy was tested for each
model fit by assessing uniformity of simulated residuals.80 A
total of 15 093 genes were included in the RNA-seq data set
after initial filtering, and 0.4–3.7% of these were subsequently
removed due to violation of the uniformity assumption
(P < 0.05). Genes were identified as differentially expressed
when the absolute log2 fold-change was greater than 0.5
and the adjusted P-value (false discovery rate adjusted per
model coefficient) was below 5%. Enrichment analyses of
gene ontology (GO) gene sets were performed using two
approaches. First, a non-parametric rank test81,82 was
performed based on gene-specific minimum significant differ-
ences (MSD). MSD was defined as the lower limit of the 95%
confidence interval (CI, based on estimated standard errors)
around the log fold-change (FC) when log (FC) > 0 and the
negative inverse of the upper 95% CI when log (FC)< 0. Genes
with MSD < 0 were further ranked based on P-values. The
rank test assessed non-directional changes in gene sets. Sec-
ond, gene set enrichment analysis (GSEA)83 was performed
to quantify directional regulation of the gene set. GSEA was
performed using the fgsea package,84 with log10(P-values)
*log2(fold-change) acting as the gene level metric.
85 Consen-
sus results between the two analyses were given higher
importance. GO gene sets (biological process, cellular compo-
nent and molecular function), as well as Hallmark and KEGG
gene sets were retrieved from the molecular signature data-
base (version 7.1).86 Overview of enrichment analyses with
exact P-values are presented in Supporting Information,
Tables S5, S6, and S8–S10.
To achieve reliable assessment of the main outcome do-
mains muscle strength, muscle mass, one-legged endurance
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performance and whole-body endurance performance, and
thus to lower the risk of statistical errors, combined factors
were calculated for outcome measures. For complete over-
view over the composition of each factor, see Supporting
Information, Table S4. During factor calculation, each of the
underlying variables were normalized to the participant with
the highest value recorded during the RCT, resulting in
individual scores ≤1. Thereafter, outcome domain factors
were calculated as the mean of the normalized values for
each variable for each subject (e.g. the muscle mass factor
of the legs included muscle thickness, leg lean mass, and
muscle fibre CSA). To evaluate the biological coherence of
these factors, a factor analysis was performed to ensure
correlation between the combined factors and their underly-
ing outcome variables (Supporting Information, Table S4).87
To assess the effect of vitamin D3 supplementation for
changes in these combined factors, linear mixed-effects
models were used, as previously described. In addition, these
factors were used to investigate the influence of pre-RCT
levels of 25(OH)D, body fat proportions and body mass index
on the effects of vitamin D3 supplementation. To perform
these analyses, each of the two supplementation arms were
divided into quartiles, defined by baseline 25(OH)D, body
fat percentage and body mass index levels, respectively
(quartile 1, lowest, … quartile 4, highest). For each of the
calculated factors, the effect of quartile and the interaction
between quartile and supplementation arm was examined
using mixed modelling.
Statistical significance was set to P < 0.05. In the text, data
are presented as means ± standard deviation. In figures, data
are shown as adjusted, estimated marginal means of relative
changes and differences in relative changes between supple-
mentation arms, with 95% confidence intervals, unless other-
wise stated. Statistical analyses were performed using SPSS
Statistics package version 24 (IBM, Chicago, IL, USA) and R
software.73 Figures were made using Prism Software
(GraphPad 8, San Diego, CA, USA) and R software.73
Results and discussion
Effects of vitamin D3 supplementation on 25(OH)D
and 1,25(OH)2D in blood
At pre-RCT, participants in vitamin D3 and placebo interven-
tion arms had similar [25(OH)D] levels in serum (80 nmol/L
vs. 78 nmol/L, range: 24–144 nmol/L, Figure 2). [25(OH)D]
levels did not differ between participants with different
health status (i.e. with or without COPD diagnosis). In
the vitamin D3 arm, the study was initiated by 14 days
of high-dosage vitamin D3 intake (10 000 IU per day), which
led to 42 nmol/L increases in [25(OH)D] (to 122 ± 24 nmol/L;
range = 82–175 nmol/L; P < 0.001), with no change in the
placebo arm (79 ± 31 nmol/L; range = 36–167 nmol/L) (Figure
2). During the remainder of the study (weeks 3–30), vitamin
D3 was ingested at 2000 IU per day, which led to stabilization
of [25(OH)D] at elevated levels compared with the placebo
arm (Week 13, Δ45 nmol/L; Week 17, Δ49 nmol/L; Week 29,
Δ46 nmol/L; Figure 2), resembling the efficacy of previous
studies with comparable study protocols (~2500 IU per
day).88,89 Conversely, in the placebo arm, [25(OH)D] either de-
clined or was similar to pre-RCT levels (Week 13, 8 nmol/L;
Week 17,11 nmol/L; Week 29,6 nmol/L; Figure 2), corrob-
orating with changes typically seen in Northern populations
during winter months,27 with the notable observation that
values were slightly higher than expected.28
After the initial 14 days of supplementation-only, the
marked increases in 25(OH)D in the vitamin D3 arm were ac-
companied by robust increases in [1,25(OH)2D] compared
with the placebo arm (vitamin D3, +17 pmol/L; placebo,
7 pmol/L; Δ24 pmol/L, P = 0.004; Figure 2). During this time
frame, change scores for [1,25(OH)2D] were correlated with
change scores for [25(OH)D] (r = 0.429, P = 0.006; data not
shown). At Week 13 and 29, the statistical difference in
changes in [1,25(OH)2D] between supplementation arms
had disappeared (Δ11 pmol/L, P = 0.377, and Δ12 pmol/L,
P = 0.224; Figure 2), and the correlation between changes
in [1,25(OH)2D] and [25(OH)D] was no longer evident
(r = 0.169–0.243, P = 0.131–0.298; data not shown). The
initial period of high-dosage vitamin D3 supplementation thus
led to rapid elevations in 1,25(OH)2D levels, which was subse-
quently reversed towards baseline levels during the follow-up
period with maintenance intake (2000 IU/day), although
vitamin D3 supplementation was still associated with
increased numerically values and the levels of individual
variation was large. In all but three samples, measures
of [1,25(OH)2D] were within the normal range for adults
(39–193 pmol/L), as defined by the manufacturer,90 with all
deviating samples being >193 pmol/L (vitamin D3, n = 2;
placebo, n = 1).
At the onset of introduction to training (Week 13) and
throughout the training intervention (Week 17, Week 29),
participants in the vitamin D3 arm were all vitamin D-suffi-
cient, as classified by the National Academy of Medicine
([25(OH)D] > 50 nmol/L),27 while in the placebo arm, 13
(Week 13), 12 (Week 17) and 5 (Week 29) participants were
vitamin D-insufficient. In both supplementation arms, cal-
cium was ingested at 500 mg/day throughout the interven-
tion. Despite this, no changes were seen in calcium or
albumin-corrected calcium levels in blood at any time point
(Supporting Information, Table S11). Levels of the parathyroid
hormone decreased throughout the intervention (P = 0.035;
Supporting Information, Table S11), most likely caused by
an autoregulatory response to increased calcium intake.91
Vitamin D3 supplementation did not alter this response.
Compliance to the supplementation protocol was high in
both intervention arms (vitamin D3, 99.3%; placebo, 99.3%;
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P = 0.998). Together, these observations suggest that vitamin
D3 supplementation led to improved vitamin D-status during
the intervention, measured as 25(OH)D, whereas placebo led
to reduced or maintained levels, with approximately 1/3rd of
placebo-receiving participants showing levels associated with
impaired muscle functionality (<50 nmol/L) at the onset of
resistance training.21,22,92
Effects of vitamin D3 supplementation on
resistance training-associated changes in myofibre
cross-sectional area and proportions (primary
objectives)
In contrast to our main hypotheses, vitamin D3 supplementa-
tion did not enhance resistance training-associated increases
in muscle fibre cross-sectional area or changes in muscle fibre
proportions (Figure 4; pre-defined as primary objectives of
the study), despite clear improvements in vitamin D status
(25(OH)D). The results are presented in more detail in
later sections (Effects of vitamin D3 supplementation on
training-associated changes in maximal muscle strength and
lower-limb muscle mass and Effects of vitamin D3
supplementation on training-associated changes in muscle
fibre characteristics and transcriptomics).
Effects of 12 weeks of vitamin D3-supplementation
only (weeks 1–12) on muscle strength,
performance and characteristics
The main purpose of the initial 12 weeks of vitamin D3
supplementation-only was to ensure physiologically elevated
[25(OH)D] for a prolonged period prior to onset of resistance
training, thus potentially priming muscle cells for plasticity.
Vitamin D3 supplementation itself had no effect on upper-
and lower-body muscle strength and performance, muscle fi-
bre area and characteristics (m. vastus lateralis), or hormone
concentrations in blood compared with placebo (Supporting
Information, Figure S1 and Table S2), showing no interaction
with health status. Surprisingly, the only exception was 1RM
knee extension, for which vitamin D3 led to negative changes
compared with placebo (Δ8.4%; P = 0.008), opposing the
seemingly accepted dogma that vitamin D supplementation
per se exerts positive effects on leg muscle strength.35,93
Notably, for all muscle strength and muscular performance
variables, the initial 12 week supplementation period was
Figure 4 Primary outcome objectives of the study; effects of combined vitamin D3 supplementation and resistance training on changes in muscle fibre
cross-sectional area (A, B) and fibre type proportions (C–E) in older adults. Alpha level at P < 0.05. Data are presented as means with 95% confidence
intervals.
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associated with improved performance in all performance
tests (5–71%; for details, see Supporting Information,
Figure S1). These improvements occurred without any appar-
ent changes in muscle cell characteristics in thigh muscle, in-
cluding muscle fibre CSA (type I, 4%, P = 0.573; type II, 9%,
P = 0.312), muscle fibre type proportions (P = 0.127–0.901),
and total RNA/rRNA expression (P = 0.604–1.000)
(Supporting Information, Figure S1). They were hence likely
caused by technical, psychological and neural learning
effects,94 effectuated by repeated exposure to testing prior
to and during the supplementation period (Supporting
Information, Figure S1), as is typically seen in older
subjects.95 Indeed, dynamic exercises like knee extension
and chest press are associated with lower intra-rater reliabil-
ity than the grip strength test,94 which remains unaffected by
test–retest,94 as was likely the case in the present study.
Overall, the 12-weeks supplementation-only period did
not lead to marked changes in mRNA transcriptome pro-
files in the two supplementation arms combined (vitamin
D3, n = 11; placebo, n = 13). Vitamin D3 supplementation
was, however, associated with differential changes in the
expression of a selected genes compared with placebo; 27
genes ↑ and 27 genes ↓ (Figure 5A and Supporting
Information, Table S7). This included increased expression
of B-cell lymphoma 6 and prolyl 4-hydroxylase subunit
alpha-1 (BCL6 and P4HA1; Figure 5A), both of which are
known to oppose accumulation of reactive oxygen species
(ROS),96–98 and decreased expression of angiopoietin-like
protein 4 (ANGPTL4; Figure 5A), which is closely correlated
with levels of mitochondrial respiration.99 These findings
were reaffirmed by gene enrichment analyses, which
showed a general reduction in the expression of gene sets
relating to both oxidative and glycolytic metabolism in the
vitamin D3 arm (Figure 5B and Supporting Information,
Tables S5–S6). This is in line with previous observations
whereby vitamin D has been shown to counteract ROS
and mitochondrial oxidative stress.100 The seemingly nega-
tive effect of vitamin D3 supplementation for expression
of mitochondrial genes may thus be due to reduced
mitochondrial turnover. Of note, expression of the vitamin
D receptor (VDR) was observed in the data set, but was
not affected by supplementation.
Figure 5 Effects of 12 weeks of vitamin D3 supplementation-only on whole-genome transcriptome profiles in m. vastus lateralis of older adults. After
12 weeks of supplementation-only, numerous genes were differentially expressed between the vitamin D3 and the placebo arm (A); Δ,
pre-introduction to resistance training/pre-RCT). Gene ontology (GO) enrichment analyses showed that these genes were primarily related to mito-
chondrial function and cell cortex/cell-substrate junction (B); positive/negative GSEA-normalized enrichment scores indicates higher/lower expression
of gene sets in the vitamin D3 arm compared with the placebo arm). The seven differentially expressed gene sets were clustered into two distinct
groups of genes (C).
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Introductory observations on the quality and
general efficacy of the resistance training protocol
(weeks 13–28)
Before assessing the effects of combined vitamin D3
supplementation and resistance training, it is vital to reaffirm
that the protocols and methods held sufficient validity and
reliability, including a general assessment of the efficacy of
the resistance training intervention. All training sessions were
supervised by qualified personnel, as suggested by others,46
which likely contributed to the very low drop-out rate
(n = 4 during the training period, ~5%, Table 1), and ensured
high adherence to the protocol (98%, range 81–100%, Table
1) and appropriate training progression throughout the
intervention (Figure 2). Training volume (repetitions x kg)
increased by 20% (knee extension) and 30% (leg press) from
Week 14 (the first week of training) to Week 18 (the 4th
week of training), by 48% and 54% to Week 22 (the 8th week
of training) and by 65% and 68% to Week 27 (the last week of
training) (Figure 2). This resembles or exceeds training pro-
gression seen in similar studies on previously untrained
participants101,102 and was accompanied by progressive
increases in perceived exercise intensities (using the Borg
RPE-scale103) (Figure 2). For these training characteristics,
no differences were observed between supplementation
arms (P = 0.897–0.980). The arguably successful completion
of the resistance training intervention was accompanied
by marked functional and biological adaptations in the
participants, including increased muscle strength and perfor-
mance (e.g. 22% and 72% increases in 1RM and muscular
performance in knee extension, respectively, P < 0.05,
Supporting Information, Figure S1), increased muscle mass
(e.g. 16–24% increases in muscle fibre CSA for m. vastus
lateralis, P < 0.05, Supporting Information, Figure S1),
increases in myonuclei number per fibre (30–37%, P < 0.05,
Supporting Information, Figure S1), alterations in muscle fibre
proportions (e.g. type IIX fibre proportions changed from 10%
to 7%, P < 0.05, Supporting Information, Figure S1), and
robust alterations in muscle transcriptome profiles (499 and
312 differentially expressed genes at post-introduction resis-
tance training and post-RCT, compared with pre-introduction
to resistance training, Figure 11A,B). Importantly, neither of
these muscle fibre characteristics changed from pre-RCT to
before onset of resistance training (Week 13), suggesting
that muscle biopsies sampled before and after the
supplement-only period could be regarded as a sampling-
resampling event (Supporting Information, Figure S1). For
muscle strength, the intervention had relative efficiencies of
0.86% (knee extension) and 1.43% (leg press) increase per
session, which resemble or exceeds expectations based on
previous studies of untrained older adults (0.5–1.0% per
session).104–106
Analytical measures to increase the validity of
vitamin D3-based analyses
To ensure valid analyses of the effects of vitamin D3
supplementation on muscle-related features, two precaution-
ary measures were deemed to be necessary. First, for muscle
strength and muscle performance (apparatus exercises),
we defined baseline levels to be equivalent to values
collected after 3.5 weeks of introduction to resistance
training (main analyses, Figure 2), rather than values
collected before its onset, as noted in the preregistration of
the study (NCT02598830). At this time point, initial adapta-
tions to training were likely to have occurred, preferably
non-hypertrophic effects relating to technical, psychological
and neural learning effects,94 phenomena that are particu-
larly prominent in older subjects.95 Using this time point as
baseline arguably strengthens the association between
changes in muscle strength and muscle mass, which was
the main perspective of our vitamin D3-based analyses. For
other outcome measures, baseline levels were either defined
as values obtained at the onset of introduction to resistance
training (Figure 2, Week 13; muscle biological data, muscle
thickness, body composition, endurance-related outcome
measures) or as values obtained pre-RCT (Week 1, Figure 2;
self-reported health, blood variables, lung function).
To further minimize the confounding effects of
non-hypertrophic increases in strength and performance, all
participants conducted a series of repeated tests prior to base-
line tests, including five repeated 1RM and muscular perfor-
mance tests in knee extension and chest press (Supporting
Information, Figure S1a,b,e,f), respectively, four of which was
conducted prior to onset of introduction to training. As ex-
pected, this led to marked and progressive increases in
strength/performance levels for all test procedures compared
with pre-RCT values (e.g. 4–8 – 14% for 1RM knee extension,
3–5 – 13% for 1RM bench press; the first test was conducted
at ~95% of maximal effort and was thus removed from analy-
ses) (Supporting Information, Figure S1). For leg press, three
tests were performed prior to the defined baseline test at
post-introduction to resistance training, resulting in similarly
scaled improvements as observed for knee extension and
chest press (Supporting Information, Figure S1, 14%; the first
test was conducted at ~95% of maximal effort and was thus re-
moved from analyses). These improvements occurred without
any apparent hypertrophy in m. vastus lateralis of the domi-
nant leg, measured as muscle fibre CSA (pre-RCT vs.
pre-introduction to resistance training; type I, P = 0.573;
type II, P = 0.312), as previously presented (Supporting
Information, Figure S1g), strengthening the notion that the im-
provements were due to other factors. After adopting the
post-introduction-to-training time point as baseline for the
strength outcome measures, the efficiency of the intervention
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on muscle strength was still somewhat higher than expected
based on previous observations104–106 (1RM knee extension,
0.8% per session; 1RM leg press, 1.3% per session). Notably,
while these former studies contained less extensive measures
to ensure reproducibility, they reported low test–retest
variability, which does not concur with our results.104–106
Second, for analyses of the effects of vitamin D3 supple-
mentation on changes in muscle mass, we found it necessary
to reconsider our choice of using changes in muscle fibre CSA
and fibre type proportions in m. vastus lateralis as the pri-
mary objective of the study. These data were associated with
large degrees of sampling-to-resampling variation, as evalu-
ated using repeated muscle biopsies from the dominant leg,
sampled at weeks 1 and 13, i.e. prior to introduction to
resistance training (Supporting Information, Figure S2). Simi-
lar issues have been previously reported for such analyses,107
although not in all studies108,109 and are likely exacerbated in
older adults, for whom larger spatial heterogeneity are pres-
ent in muscle fibre characteristics compared with young
adults,110 possibly relating to the age-related remodeling of
motor units.111 Despite these issues, the data provided
sufficient resolution to disclose marked increases in muscle
fibre CSA and changes in muscle fibre proportions over the
entirety of the training intervention, as previously presented
(Figure 4 and Supporting Information, Figure S1).
In order to achieve reliable assessment of changes in mus-
cle mass, we thus had to take on a different approach. In-
stead of relying on muscle fibre CSA data alone, we
developed a combined muscle mass factor, in which change
scores from a collection of muscle mass-related outcome
measures were combined in a weighted manner (Supporting
Information, Table S4). This factor included data on muscle fi-
bre CSA, leg lean mass (DXA) and muscle thickness (m. rectus
femoris, m. vastus lateralis; ultrasound), all of which are
known to correlate.112–114 Careful investigation of the
computed muscle mass factor suggested that it increased
the biological value of muscle mass-related analyses (for
more information, see Supporting Information, Table S4). As
such, it changed markedly from baseline to post-RCT (9%,
P < 0.001, Supporting Information, Table S4). Following this
logic, combined factors were also computed for other core
outcome domains, including maximal muscle strength and
one-legged and whole-body endurance performance
(Supporting Information, Table S4).
Effects of vitamin D3 supplementation on
training-associated changes in maximal muscle
strength and lower-limb muscle mass
Participants in both vitamin D3 and placebo arms showed
increases for every measure of muscle strength and mass,
assessed from baseline to after finalization of the resistance
training intervention: 12–25% for upper- and lower body
1RM muscle strength, 6–11% for leg muscle torque, 7–26%
for muscle fibre CSA and muscle thickness and 1–3% for leg
lean mass (Figures 6 and 7). Unsurprisingly, after combining
these measures into weighted muscle strength and muscle
mass factors, similarly scaled increases were observed
(13% ± 8% and 9% ± 8%, respectively; Figures 6 and 7), which
was also the case for a calculated score of relative muscle
quality (Δmuscle strength factor/Δmuscle mass factor;
4% ± 10%, Figure 7).
Overall, vitamin D3 supplementation did not affect these
outcome measures compared with placebo in the partici-
pants, primarily evaluated as changes in muscle strength
and muscle mass factors (strength, Δ2.5% (95% CI, 1.0,
6.0), P = 0.194; mass, Δ0.4% (95% CI, 3.5, 4.3), P = 0.940,
Figures 6 and 7), and secondarily as changes in each of the
underlying outcome measures (i.e. seven measures of muscle
strength and three measures of muscle mass; Figures 6 and
7). This lack of a beneficial effect was also evident for changes
in relative muscle quality (Δ1.9% (95% CI, 3.0, 6.8),
P = 0.415; Figure 7). Vitamin D3 supplementation thus had
no main effect on training-associated changes in muscle func-
tionality or gross muscle biology. While this conclusion co-
heres with the few comparable studies assessing the effect
of combined vitamin D3 intake and resistance training,
40,42–44
it contrasts the conclusion drawn in the only available
meta-analysis on this subject, wherein vitamin D3 supplemen-
tation was associated with augmented increases in muscle
strength in older adults.41 Notably, among the selection of
ten specific outcome measures, two did not conform with
the main finding. Vitamin D3 was associated with beneficial
effects for changes in 1RM knee extension (Δ6.8% (95% CI,
1.3, 12.3), P = 0.016; Figure 6) and muscle thickness of
m. rectus femoris (Δ7.5% (95% CI, 1.8, 13.2), P = 0.011; Figure
7). For 1RM knee extension, the effect was interrelated
with the negative development seen from pre-RCT to
pre-introduction to training in the vitamin D3 arm
(Supporting Information, Figure S1). Indeed, when assessing
the effect of vitamin D3 on 1RM knee extension from pre-
to post-RCT (rather than from baseline at post-introduction
to training), no beneficial effect was observed compared with
placebo (Δ2% (95% CI, 12, 7), P = 0.628; Supporting Infor-
mation, Table S2). As for muscle thickness in m. rectus
femoris, we did not collect data pre-RCT and can thus not de-
duce if this variable followed the same pattern as 1RM knee
extension. The observed benefits of vitamin D3 supplementa-
tion for changes in m. rectus femoris thickness contrasts ob-
servations made for m. vastus lateralis thickness (Δ0.3%,
P = 0.838), and even oppose those made for lean mass of
the legs, which tended to increase less in the vitamin D3
arm compared with the placebo arm (Δ1.8%, P = 0.090).
So far, analyses have focused on the main effect of vitamin
D3 supplementation for training-induced development
of muscle strength and mass, and have thus neglected
potential interactions with other independent variables such
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as pre-RCT levels of 25(OH)D, health status (COPD vs. non-
COPD) or training modality (high-load, 10RM, vs. low-load,
30RM). The benefits of vitamin D3 supplementation were
expected to be more pronounced in participants with low
baseline levels of 25(OH)D (ClinicalTrials.gov Identifier:
NCT02598830). This hypothesis was based on observations
made in cohort studies, wherein subjects with levels <30–
50 nmol/L are more likely to show adverse muscle
phenotypes.21–23 To investigate this perspective, participants
in each supplementation arm were divided into quartiles
based on pre-RCT 25(OH)D levels in blood (Supporting
Information, Figure S3). This resulted in two lower quartiles,
one for the vitamin D3 arm (vitamin D3low, [25(OH)D]-
mean = 49.5 nmol/L, n = 8), and one for the placebo arm
(placebolow, [25(OH)D]mean = 47.4 nmol/L, n = 12) (Supporting
Information, Figure S3). At the onset of introduction to resis-
tance training, 25(OH)D levels in vitamin D3low had increased
to 103.3 nmol/L (range 76–138), with all participants being
classified as sufficient (>50 nmol/L),17 whereas 25(OH)D levels
in placebolow remained unchanged (45.5 nmol/L, range
22–71), with 9 out of 12 participants being classified as insuf-
ficient (<50 nmol/L). Within each of the pre-RCT 25(OH)D
quartiles, the effect of vitamin D3 and placebo supplementa-
tion on training-induced changes in muscle strength and mass
(using the combined factors) were assessed. With exception of
one quartile (muscle strength factor, quartile 3, P = 0.048;
Supporting Information, Figure S3), no beneficial effects of
vitamin D3 supplementation were observed in any quartile
(e.g. vitamin D3low vs. placebolow, muscle strength, Δ2.0%
(95% CI, 8.0, 3.9, P = 0.496) (Supporting Information,
Figure S3). Instead, in vitamin D3low, training-associated
changes in muscle mass were reduced compared with
placebolow (Δ6.5% (95% CI, 12.7, 0.27), P = 0.041;
Supporting Information, Figure S3), suggesting that vitamin
Figure 6 Effects of combined vitamin D3 supplementation and resistance training on maximal muscle strength in older adults. Changes in muscle
strength from baseline (after three weeks of introduction to resistance training) to post-RCT (A), and differences in changes between vitamin D3
and placebo arms (B). KE, one-legged knee extension; LP, one-legged leg press; CP, chest press; maximal torque measured using one-legged knee ex-
tension at three velocities; 60, 180, and 240° per second; #, significant difference between vitamin D3 and placebo arms; combined strength factor,
weighted combined strength factor of unilateral strength measures (one-repetition maximum in KE and LP, and KE torque at 60, 180, and 240° per
second). Alpha level at P < 0.05. Data are presented as means with 95% confidence intervals.
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D3 supplementation may even have compromised training ad-
aptations in subjects with low pre-RCT 25(OH)D levels. Adding
to this, participants in the entire spectre of quartiles
responded quite similarly to resistance training, irrespective
of supplementation arms, evident as no interaction between
25(OH)D quartiles/supplementation arm and changes in mus-
cle strength (P = 0.237) or muscle mass (P = 0.159). Arguably,
the statistical power of these analyses were not sufficiently
high to conclude on this perspective.
The impact of vitamin D3 supplementation for
training-associated changes in muscle strength and muscle
mass factors did not interact with health status (COPD
vs. non-COPD) or training modality (10RM vs. 30RM)
(Supporting Information, Table S2). However, it should be
noted that for selected specific outcome measures, interac-
tions were found with both of these independent variables
(summarized in Supporting Information, Table S2), including
an interaction between changes in type II-fibre CSA and
COPD/non-COPD, and between changes in 1RM knee exten-
sion/vastus lateralis thickness and 10RM/30RM. In addition
to these interaction analyses, we also investigated the
potential relation between the effects of vitamin D3
supplementation and baseline body fat proportions, as over-
weight and obese have been shown to have decreased
bioavailability of vitamin D due to deposition of 25(OH)D in
body fat compartments (while concomitantly showing
attenuated anabolic response to resistance exercise115).116
To this end, we performed quartile-based analyses, as previ-
ously described. These analyses did not reveal an effect of
baseline body fat proportions for changes in [25(OH)D] (fat
percentage, P = 0.432; BMI, P = 0.369) or muscle mass factor
(fat percentage, P = 0.355; BMI, P = 0.293) (Supporting
Information, Figure S4). However, it did have an effect on
changes in the muscle strength factor (fat percentage,
P = 0.016; BMI, P = 0.706), that is, in quartilehigh fat percentage,
vitamin D3 supplementation was associated with larger
increases in muscle strength compared with placebo (fat
percentage, Δ 5.8% (95% CI, 0.5, 11.0), P = 0.032; BMI,
Δ7.8% (95% CI, 2.5, 13.1), P = 0.005; Supporting Information,
Figure S4 and Table S2), suggesting beneficial effects of
vitamin D3 supplementations in subjects with high propor-
tions of body fat, opposing our initial expectations.
Figure 7 Effects of combined vitamin D3 supplementation and resistance training on lower-limb muscle mass in older adults. Changes in lower-limb
muscle mass from baseline (before introduction to resistance training) to post-RCT (A), and differences in changes between vitamin D3 and placebo
arms (B). CSA, cross-sectional area (also presented in Figure 4); RF, m. rectusfemoris; VL, m. vastus lateralis; LM per leg, leg lean mass per leg; #,
significant difference between vitamin D3 and placebo arms; combined muscle mass factor, weighted combined muscle mass factor including fibre
cross-sectional area (type I and type II), muscle thickness (RF and VL) and LM per leg; muscle quality, muscle strength factor/muscle mass factor. Alpha
level at P < 0.05. Data are presented as means with 95% confidence intervals.
616 K.S. Mølmen et al.
Journal of Cachexia, Sarcopenia and Muscle 2021; 12: 599–628
DOI: 10.1002/jcsm.12688
Effects of vitamin D3 supplementation on
training-associated changes in one-legged and
whole-body endurance performance
Participants in both vitamin D3 and placebo arms showed im-
provements in one-legged and whole-body endurance perfor-
mance over the course of the resistance training
intervention: 42–74% increases in one-legged muscular per-
formance (Figure 8), 7–9% increases in peak power output
(Wmax) in one- and two-legged cycling (Figure 8), 3–5% reduc-
tions in O2 costs of submaximal one-legged cycling
(Supporting Information, Table S2), and 6–10% increases in
functional performance (1-min sit-to-stand test and 6-min
step test, Figure 8). In accordance with this, marked increases
were observed in weighted one-legged and whole-body en-
durance performance factors (one-legged, vitamin D3
25% ± 19%, placebo 22% ± 11%; whole-body, vitamin D3
9% ± 8%, placebo 7% ± 6%; Figure 8). These effects cohere
well with previously observed benefits of resistance training
for endurance variables in older adults.117–119
Vitamin D3 supplementation had no effect for any of these
outcome measures compared with placebo, neither for
weighted endurance performance factors (one-legged, Δ2%
(95% CI, 5, 10), P = 0.773; two-legged, Δ2% (95% CI, 2,
6), P = 0.636; Figure 8), nor for any of the specific outcome
measures (Figure 8). For combined endurance factors, there
was no interaction between baseline 25(OH)D quartiles
and effects of vitamin D3 supplementation (one-legged,
P = 0.950; whole-body, P = 0.266; Supporting Information,
Figure S3 and Table S2), nor was there any interactions with
health status (one-legged, P = 0.747, whole-body, P = 0.129,
Supporting Information, Table S2) or training modality
(one-legged, P = 0.719, Supporting Information, Table S2).
Effects of vitamin D3 supplementation on
training-associated changes in muscle fibre
characteristics and transcriptomics
Participants in both vitamin D3 and placebo arms showed
marked changes in muscle fibre characteristics over the
course of the training intervention. These included decreased
type IIX muscle fibre proportions from 10% to 7% (Figure 9),
increased type IIA proportions from 26% to 29% (Figure 9),
Figure 8 Effects of combined vitamin D3 supplementation and resistance training on one-legged and whole-body endurance performance in older
adults. Changes in endurance performance from baseline (before introduction to resistance training) to post-RCT (A), and differences in changes
between vitamin D3 and placebo arms (B). 1KE, repetitions to failure in one-legged knee extension (50% of pre-intervention 1RM); CP, repetitions
to failure in chest press (50% of pre-intervention 1RM); Wmax, maximal power output; 6-min step test, maximal number of steps achieved during
6 min; Sit-to-stand, maximal number of sit-to-stands achieved during 1 min; combined 1-leg endurance performance factor, weighted combined
one-legged endurance factor including 1KE muscular performance and one-legged cycling Wmax; weighted combined whole-body endurance factor in-
cluding Wmax bicycling, 6-min step test and sit-to-stand test. Alpha level at P < 0.05. Data are presented as means with 95% confidence intervals.
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increased type IIA/IIX hybrid fibres abundances from 2.6% to
3.2% (Supporting Information, Table S2), and 25–48% in-
creases in myonuclei number per muscle fibre (Figure 9).
Changes in IIX and IIA proportions were verified using qPCR,
showing decreased levels of type IIX mRNA abundance and
increased levels of type IIA (Figure 9), calculated using the
gene family-profiling approach.76 These analyses also re-
vealed increased proportions of type I mRNA after the train-
ing intervention (Figure 9), potentially caused by increased
type I protein turnover. The observed changes in muscle
fibre-type characteristics corroborate well with previous
studies in older adults,120–122 although increased numbers
of myonuclei per muscle fibre are not consistently
reported.123 Vitamin D3 supplementation had no effect on
training-associated changes in muscle fibre proportions or
myonuclei content compared with placebo (Figure 9).
The training intervention resulted in 1.14- to 1.16-fold in-
creases in total RNA per unit muscle tissue weight (Figure
10), a proxy marker for ribosomal RNA content that has pre-
viously been associated with training-induced changes in
muscle growth and strength.67,124 Similar increases were
found for the mature ribosomal species 18 s (1.18-fold) and
28 s (1.16-fold), in addition to the 45 s pre-ribosomal rRNA
(1.19-fold) using qPCR (Figure 10). No changes were observed
for 5.8 s (1.07-fold, P = 0.722) or 5 s (1.06, P = 0.940) follow-
ing the entire training intervention. Notably, for analyses of
total RNA and ribosomal RNA, an additional time point were
included in main analyses, i.e. in muscle biopsies sampled af-
ter introduction to training (3.5 weeks, 7 sessions), as early
increases in total RNA seem to associate with long-term
chronic responses to training, making it a potential hallmark
of muscle plasticity.67 As expected, 3.5 weeks of training led
to marked increases in total RNA (1.10- to 1.21-fold) and
expression of all ribosomal RNA species (1.13- to 1.27-fold)
(Figure 10). Whereas these changes corroborates quite well
with changes observed in healthy, young subjects,67 although
with a notable reduction in the relative increase, they
contradict previous observations of no resistance training-
associated increases in total RNA per unit muscle tissue
weight in older subjects.125 Vitamin D3 supplementation
had no effect on training-associated changes in total RNA or
rRNA expression compared with placebo.
The training intervention led to marked changes in muscle
mRNA transcriptome profiles in the two supplementation
arms combined, with 499 genes being differentially
expressed (DE) after 3.5 weeks of resistance training
Figure 9 Effects of combined vitamin D3 supplementation and resistance training on muscle fibre type proportions and myonuclei per fibre in m.
vastus lateralis of older adults. Muscle fibre type proportions (A–F) at baseline (before introduction to resistance training) and post-RCT measured
using immunohistochemistry (A–C) and qPCR (gene family profiling (GeneFam)-normalized myosin heavy chain mRNA expression, (D–F), and changes
in myonuclei count per type I and type II fibre from baseline to post-RCT (G). Significant changes were observed for fibre type IIA and IIX using both
methods (significant increase and decrease, respectively; P< 0.05). For fibre type I, an increased expression was present using qPCR (P< 0.05), but no
change was observed for immunohistochemistry (P = 0.322). P-values denotes the statistical difference between the supplementation arms. RT, resis-
tance training. Data are presented as means with 95% confidence intervals.
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(post-intro RT; 436 genes ↑, 63 genes ↓, Figure 11A) and
312 genes being DE after 13 weeks of resistance training
(post-RCT; 255 genes ↑, 57 genes ↓) (Figure 11A,B). VDR
was expressed, but unaffected by combined vitamin D3
supplementation and resistance training, contradicting
previous observations of a positive association between
supplementation-induced improvements in 25(OH)D
status and leukocyte,126 myoblast/myotube127 and skeletal
muscle128 VDR expression. GO enrichment analyses revealed
increased expression of gene sets associated with extracellu-
lar matrix, blood vessel morphogenesis and leukocyte migra-
tion at both 3.5 and 13 weeks (Figure 11C, Supporting
Information, Table S8), as well as increased expression of
the inflammatory response gene set at 3.5 weeks (Supporting
Information, Table S8). Conversely, decreased expression was
observed for gene sets involved in ribosomal functions at
both 3.5 and 13 weeks (Figure 11C). This could be interpreted
as contradicting the likely important role of de novo
ribosomal biogenesis for training-associated muscular
adaptations.67,124 Notably, as these analyses were performed
using traditional library size-based normalization, which
basically provided target gene expression relative to the
expression of all other genes.129 In an alternative set of
transcriptome analyses, which rather included normalization
that corrected for muscle sample weight and thus provided
gene expression analyses per sample size (tissue-offset
normalization),129 the negative effects of resistance training
on ribosomal gene expression was not evident (data not
shown). This was the only major difference between library
size and tissue-offset normalization in the present study
setting.
Vitamin D3 supplementation had no effect on
training-associated changes in gene expression, neither at
3.5 weeks (Figure 11D) nor at 13 weeks (Figure 11E), suggest-
ing that no single gene was differentially affected by
combined vitamin D3 supplementation and resistance
training and resistance training-only. In contrast to this,
enrichment analyses showed traces of vitamin D3-sensitive
changes in expression at both 3.5 and 13 weeks of resistance
training (Figure 11F and Supporting Information, Tables
S9–S10). After 3.5 weeks of training, there was differential
expression of gene sets involved in cell junctions, blood
vessel morphogenesis and muscle cell differentiation. These
initial responses to resistance training should be interpreted
with caution, as they were only evident in one of the two
analyses (GSEA or rank-based analyses; Figure 11F and
Supporting Information, Tables S9–S10). After 13 weeks
of resistance training, the vitamin D3 arm showed
increased expression of gene sets involved in endothelial
proliferation and blood vessel morphogenesis compared with
placebo (Figure 11F). This agrees with the previously
observed positive relationship between 25(OH)D-status and
endothelial function, potentially interacting through the
endothelium-derived vasodilator, nitric oxide.100 Indeed, this
coheres well with a recent study, which showed favorable ef-
fects of combined vitamin D3 supplementation and resistance
Figure 10 Effects of combined vitamin D3 supplementation and resistance training on total RNA abundances and rRNA expression inm. vastus lateralis
of older adults. Total RNA (A), 18 s rRNA (B), 28 s rRNA (C), 5.8 s rRNA (D), 5 s rRNA (E), and 45 s pre-rRNA (F) abundances at baseline (before intro-
duction to resistance training) and post-RCT. Significant increases from baseline–post-introduction to resistance training were present for all variables
(P < 0.05). From baseline–post-RCT significant increases were present for all variables (P < 0.05), with the exception of 5.8 s rRNA (P = 0.722) and 5 s
rRNA (P = 0.940). RT, resistance training. P-values denotes the statistical difference between the supplementation arms. Alpha level at P < 0.05. Data
are presented relative to amounts of tissue weight. Data are presented as means with 95% confidence intervals.
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Figure 11 Effects of 3.5/13 weeks of resistance training-only (A–C) and 3.5/13 weeks of combined vitamin D3 supplementation and resistance training
(D–G) on mRNA transcriptome profiles in m. vastus lateralis of older adults. Resistance training-only led to robust changes in gene expression at both
3.5 weeks (A; post-intro resistance training – pre-intro resistance training) and 13 weeks (B; post-RCT – pre-intro resistance training), including in-
creased expression of collagen type IV α1 and α2 genes (COL4A1 and COL4A2, respectively) and decreased expression of the myosin heavy chain
IIX gene (MYH1). The three most enriched gene sets with increased and decreased expression, in addition to the ‘blood vessel morphogenesis’ gene
set are shown in C (light blue, 3.5 weeks; dark blue, 13 weeks; according to the GSEA enrichment score). Combined vitamin D3 supplementation and
resistance training did not lead to differential changes in expression for a singular gene compared with placebo at neither 3.5 weeks (D; Δ, post-
introduction to resistance training - pre-introduction to resistance training) nor 13 weeks of resistance training (E; Δ, post-RCT - pre-introduction to
resistance training; orange dots/genes denotes leading edge genes from the ‘blood vessel morphogenesis’ GO gene set, that is, the most highly
enriched gene set between supplementation arms after 13 weeks of resistance training). GO enrichment analyses of differentially regulated gene sets
between the vitamin D3 and the placebo arms following 3.5 weeks (left panel, F) and 13 weeks of resistance training (right panel, F; positive/negative
GSEA-normalized enrichment scores indicates higher/lower expression of gene sets in the vitamin D3 arm compared with the placebo arm). (G) Time-
line for the 10 most affected genes between vitamin D3 and placebo arms belonging to the ‘blood vessel morphogenesis’ GO gene set. RT, resistance
training; Consensus, when both the non-directional rank-based enrichment test and the directional gene-set enrichment analysis (GSEA) turned out
significant. In Figure 11C,F, circle sizes of gene sets are relative to P-values, i.e. larger circles indicate lower P-values (see Supporting Information,
Tables S5–S10 for exact P-values).
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training on flow-mediated dilation of blood vessels and blood
pressure in postmenopausal women.130 Unfortunately, endo-
thelial function was not assessed in the current study.
Effects of vitamin D3 on hormones in blood and
health-related outcome measures
In general, the intervention was associated with beneficial
changes for several health-related variables, including
reduced levels of lipids (triglycerides and low-density lipopro-
tein/LDL), reduced levels of fat mass (total and visceral fat)
and improved self-reported health (Supporting Information,
Table S11). Conversely, a small but undesirable decrease
was observed in lung capacity, measured as forced
ventilatory capacity (FVC) (Supporting Information, Table
S2). The intervention was not associated with changes in
whole-body bone mineral density or changes in serum levels
of hormones, except for decreased levels of parathyroid
hormone (Supporting Information, Table S11), as previously
presented. For most of the health variables, there was no ef-
fect of vitamin D3 supplementation (Supporting Information,
Tables S2 and S11), with exception of cortisol levels in blood,
which increased more in the vitamin D3 arm (Table S11), and
lung function measured as FEV1/FVC-ratios, which declined in
subjects with COPD in the vitamin D3 arm (Supporting
Information, Table S2).
Sarcopenia
The intervention proved effective for treating age-related loss
in muscle mass, leading to 1.4% increases in total lean body
mass (P < 0.001) (Supporting Information, Table S11). This
reduced the number of participants that could be defined
as sarcopenic from 16% (11 subjects) to 12% (8 subjects),
with sarcopenia being defined as appendicular lean mass
(kg)/m2 greater than two standard deviations below the
sex-specific means of young adults.61 Speculatively, the
increase in total lean mass was supported by increased levels
of serum creatinine in both supplementation arms (+6%;
Supporting Information, Table S11). Although serum creati-
nine is generally used for evaluation of renal function,131
creatinine production and levels also increases with increases
in total muscle mass.131,132
Steroid hormones
Vitamin D3 supplementation did not affect levels of anabolic
steroid hormones such as testosterone. This was in discor-
dance with our initial hypothesis, as we presumed a positive
association between vitamin D levels (measured as 25(OH)D)
and testosterone levels, based on previous observations from
vitamin D3 supplementation studies
52 and cohort studies.133
Despite this, our finding is in line with several other vitamin
D supplementation studies, which has reported no effect
on testosterone in blood.134,135 Conversely, vitamin D3
supplementation seemed to affect serum cortisol levels com-
pared with placebo (Δ48 nmol/L, P = 0.038; Supporting Infor-
mation, Table S11), although no main effect of time was
observed (i.e. the observed increase in the vitamin D3 arm
was not statistically significant, P = 0.374) and there was no
statistical difference between supplementation arms at the
end of the intervention (P = 0.053).
Lung function
The small 1.95% reduction in FVC seen after the 28 week
long RCT (P = 0.006; Supporting Information, Table S2) was
surprising, as exercise is generally accepted to be beneficial
for lung functionality, including resistance training.136,137
Notably, other measures of lung function, such as forced
ventilatory volume in one second (FEV1 and predicted FEV1)
and FEV1/FVC, were not affected by the intervention
(Supporting Information, Table S2).
The negative effects of vitamin D3 on lung function, mea-
sured as FEV1/FVC (Δ2.9% points, P = 0.012; Supporting
Information, Table S2), were also surprising. This effect
showed a clear interaction with health status, and as such
was only evident in COPD patients in the vitamin D3 arm,
which showed Δ8.4% reductions compared with placebo
(Supporting Information, Table S2). This subgroup analysis
was however clearly weakened by the small sample size
(COPD, n = 9 vs. n = 11, vitamin D3 vs. placebo). The negative
effect of vitamin D3 on FEV1/FVC did not interact with
pre-RCT levels of FEV1/FVC, but surprisingly, in another sub-
group-analysis, the pre-RCT 25(OH)D vitamin D3low quartile
was associated with larger decrement in FEV1/FVC than
placebolow (Δ5.4% points, P = 0.009; data not shown). This
observation is difficult to explain, as it indirectly opposes the
notion that vitamin D deficiency leads to impaired lung
functions.138 More research is clearly needed to elucidate
on the consequences of resistance training and vitamin D3
supplementation for lung functionality.
Adverse effects of the intervention
Overall, neither vitamin D3 supplementation nor resistance
training was associated with adverse effects or events during
the intervention, with potential exception of certain aspects
of lung function, as previously discussed, and iron biology
(see Supporting Information, Table S11).
Primarily, a health survey was administered to the partici-
pants on a weekly basis. This included rating of 11 potential
discomforts relating to digestion problems, sleep problems,
issues with the urinary system, issues with the vestibular
system and dermal irritations (Supporting Information, Table
S2). No effect of vitamin D3 supplementation was found for
any of these variables. In the health survey, participants were
also asked to rate their experienced health on a point-scale
from 0–10. This self-reported conception of health
improved from 6.3 ± 1.6 to 7.1 ± 1.6 (P < 0.001, Supporting
Information, Table S2), with no difference between
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supplementation arms (P = 0.433, Supporting Information,
Table S11).
The intervention was not associated with
training-associated injuries, with only five participants (6%)
reporting discomforts with training towards the end of the in-
tervention and only four participants (5%) withdrawing from
study during the resistance training intervention, neither of
which were due to injuries associated with the training. As
such, serum levels of markers of muscle tissue damage
(creatine kinase and aspartate aminotransferase) even
decreased during the intervention, with no effects of vitamin
D3 supplementation (Supporting Information, Table S11).
Supervised resistance training can safely be advocated for
both healthy older adults and persons with COPD.
Concluding remarks
The study was conducted as a double-blinded RCT, address-
ing the effects of 12 weeks of vitamin D3 supplementation
only (i.e. two weeks of 10 000 IU/day, followed by ten weeks
of 2000 IU/day), and 13 weeks of combined vitamin D3
(2000 IU/day) and resistance training on functional measures,
health markers and muscle biology in a mixed population of
older adults. Vitamin D3 supplementation is often hailed as
an ergogenic aid for optimizing the outcome of resistance
training, and is recommended for a variety of human
populations, ranging from healthy subjects to athletes and
chronically diseased subjects.7,20 Vitamin D is thus presumed
to play an important role in training-associated muscle plas-
ticity. Despite this, its importance for humans remains largely
elusive, with current knowledge stemming predominantly
from animal research,55 and the few existing human studies
providing limited, uncertain and contradicting results.41–44 In-
deed, the present data do not support a role for vitamin D in
training-associated muscle plasticity and functionality, at
least not in older adults (with and without moderate COPD)
with suboptimal to adequate baseline levels of 25(OH)D.
More precisely, vitamin D3 supplementation had no effect
on core outcome domains such as changes in muscle
strength, muscle mass, endurance performance and general
muscle cell characteristics, and its effects on the muscle
transcriptome was largely limited to gene sets relating to
endothelial and cardiovascular functions. The validity of this
insight is fortified by the thorough methodological and
analytical approach. This included accounting for previous
methodological issues such as a lack of a pre-training supple-
mentation period, low vitamin D dosages, and neglecting to
standardize test/training routines such as supervision of
training sessions, test–retest analyses of functional and
biological outcome measures, familiarization to training and
a low reproducibility of singular outcome measures. The ana-
lytical approach also accounted for the potential confounding
effects of the heterogeneity of the study population, as no
interaction was found between effects of vitamin D3
supplementation and disease status (healthy vs. COPD), or
differences in pre-RCT vitamin D status, as all [25(OH)D]-
baseline quartiles responded in similar manners.
Despite our substantial efforts to strengthen the ecological
value of the data set, there are aspects of vitamin D biology
that remain unresolved, and that may have affected the con-
clusions and outcomes of the study. First, in skeletal muscle,
adequate vitamin D signaling may occur at 25(OH)D levels
lower than the defined cutoff (insufficient, <50 nmol/L).27
Speculatively, all participants in the placebo arm may thus
have been vitamin D-sufficient at the onset of resistance
training, leaving our quartile-based analyses with limited bio-
logical value. Indeed, studies have suggested that vitamin D
insufficiency will affect human muscle in an adverse manner
only at concentrations <30 nmol/L.139 Second, although se-
rum 25(OH)D level is widely regarded as an adequate mea-
sure of vitamin D status,63 it may be a poor proxy marker
for vitamin D biology, as it largely fails to reflect 1,25(OH)2D
levels, the metabolically active form of vitamin D.140 In line
with this, in the present study, [25(OH)D] was not correlated
with [1,25(OH)2D] at baseline (data not shown) and was not
increased by long-term vitamin D3 supplementation (at
weeks 13 and 29). Such decoupling of 25(OH)D and 1,25
(OH)2D levels have several potential explanations. These in-
clude feedback-mediated regulation of vitamin D biology,
which is largely affected by PTH levels,141 as well as impaired
25(OH)D → 1,25(OH)2D conversion in individuals with patho-
physiological indications such as renal dysfunction.142 The lat-
ter is unlikely to explain the lack of increases in [1,25(OH)2D]
in the present study, as only two participants were indicated
with renal dysfunction (estimated based on levels of
creatinine in serum; Table 1). Rather, the initial two weeks
of high-dosage vitamin D3 supplementation did lead to
marked increases in [1,25(OH)2D], emphasizing that
supplementation is indeed capable of increasing levels of
metabolically active vitamin D, at least at high doses and
within a short time frame. At weeks 13 and 29 were the
PTH levels suppressed for both supplementation arms
compared with pre-RCT levels. This was possibly related to
the calcium supplement, and may have contributed to the
unaltered 1,25(OH)2D levels at these time points. Third,
muscle cells may themselves possess the apparatus to
convert 25(OH)D into 1,25(OH)2D, as they express the
25-Hydroxyvitamin D 1-alpha-hydroxylase (CYP27B1) protein.
Indeed, in in vitro experiments on murine myoblast and
myotubes, 25(OH)D and 1,25(OH)2D treatment seem to lead
to similar increases in the expression of vitamin D markers
such as VDR, suggesting that peripheral regulation of vitamin
D biology is a biological opportunity.127 Fourth, while 25(OH)
D was assessed as [25(OH)D]total in the present study, levels
of unbound 25(OH)D (i.e. not bound to vitamin D binding
protein or albumin; ~0.03%) may represent a more accurate
measure of vitamin D status in a clinical setting.143 Indeed,
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in mice lacking vitamin D binding protein, and therefore
displaying very low [25(OH)D]total (~8 nmol/L), no signs of vi-
tamin D deficiency are seen unless they are put on a vitamin
D deficient diet.144 Fifth, in the present study, the resistance
training intervention lasted for only 13 weeks. Speculatively,
this may have been too short for vitamin D3 supplementation
to manifest its potential benefits for muscle plasticity, despite
the presence of a 12-week lead-in supplementation period.
Arguably, however, if vitamin D status and signaling is indeed
important of muscle biological adaptations to training, even
shorter interventions should lead to detectable changes in
muscle biology, such as its transcriptome. This was not
observed, neither in general, nor for specific vitamin
D-responsive genes such as VDR.128 Sixth, the study protocol
was unavoidably associated with large interindividual
variation in responses. This variation may have been related
to vitamin D3 supplementation per se, resistance training
per se or to a combination of both, and may have affected
groupwise comparisons. More research is clearly needed to
elucidate on these perspectives.
Despite these uncertainties, it seems clear that vitamin D3
supplementation did not affect muscle biological characteris-
tics in the present study, particularly those measured using
RNA-seq. Indeed, in our transcriptome analyses, not a single
gene was found to be vitamin D3-sensitive after a period of
resistance training, which is surprising given the accepted
dogma that vitamin D primarily acts as a transcriptional
regulator,55 and that the VDR was rather highly expressed
in the data set, although it did not change with vitamin D3
supplementation. Moreover, gene sets that were identified
as vitamin D3-sensitive in gene enrichment analyses were
largely associated with vascular function rather than muscle
cell biology.
Despite the general lack of effects of vitamin D3 supple-
mentation on muscle mass and phenotype (primary objec-
tives of the study), as well as the lack of effects on other
muscle functional and biological traits, the data set
contained a couple of interesting observations. First, in
the muscle transcriptome data, the effects of vitamin D3
supplementation per se on expression of mitochondrial
genes and the effects of combined vitamin D3 supplemen-
tation and resistance training on biomarkers of endothelial
and vascular biology calls for further study. Arguably, these
biological features would be more decisive for adaptations
to endurance-like training, posing the intriguing possibility
that vitamin D3 supplementation may be beneficial for
the outcome of such training. Second, in participants with
high baseline fat proportions/high BMI, vitamin D3 supple-
mentation led to increased training-associated changes in
muscle strength. In these participants, the bioavailability
of vitamin D may have been compromised by the high fat
content (in the placebo arm, although they did not exhibit
lowered 25(OH)D levels), corroborating with previous ob-
servation of interactions between vitamin D biology and
fat mass.116 While this may indicate that vitamin D exerts
direct effects on muscle biology, as muscle strength is
predominately defined by muscle mass,145 this still seems
unlikely as no such vitamin D3-effect was seen for other
muscle-specific outcome measures (e.g. muscle mass and
phenotype). The causality may thus involve other physio-
logical adaptations such as motoneuron function,146 which
has indeed been suggested to be affected by vitamin D
supplementation in rodents.147
In retrospect, the pre-identified primary objectives of the
current study were not ideal (i.e. the effects of vitamin D3
supplementation on muscle fibre CSA and proportions). The
underlying rationale behind this choice was to investigate
the effects of vitamin D3 supplementation on a set of unbi-
ased biological variables (not prone to test–retest fluctua-
tions), adhering to the existing notion that vitamin D may
affect muscle fibre size and fibre type proportions (e.g.
elucidated in the review from Ceglia, 2009148). This clearly
underestimating the reliability issues associated with
histological measures, which were indeed evident in the data
set (Supporting Information, Figure S2). Importantly, vitamin
D3 supplementation was not associated with beneficial
effects for any of the investigated primary or secondary
outcome measures, hence leaving the overall conclusion as
unambiguous.
In conclusion, in older adults with or without COPD,
vitamin D3 supplementation efficiently improved vitamin
D-status without any adverse effects, but did not lead to ben-
eficial effects in resistance training-associated changes in
muscle function or characteristics. This rejects the notion that
vitamin D3 supplementation is necessary to obtain adequate
muscular responses to resistance training in the general older
population. Secondary analyses revealed positive effects of
vitamin D3 supplementation for participants with high
proportions of fat mass and for gene sets involved in vascular
functions, advocating further research to elucidate on these
specific biological characteristics. Finally, the training
programme was well-tolerated and associated with pro-
nounced effects for a variety of health variables, emphasizing
the potency of resistance training for relieving sarcopenia
and maintaining functional capacity in older adults with and
without COPD.
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A standardized pipeline for analysis of RNA-seq dataset from human skeletal 
muscle was developed. For pre-processing of data, trimmomatic was found 
to be a better choice than trim galore. For read alignment and quantification, 
RSEM proved to be a better tool having less variation between replicates and 
increased biological relevance. In addition, the effects of using different 
normalization strategies for analysing and interpreting skeletal muscle trans- 
criptome responses to resistance training was explored. Analysis of data from 
this model showed that the choice of the normalization model affected down-
stream data interpretations. While all normalization models arguably remove 
technical biasness, our results suggest that it may be necessary to account 
for biological biasness caused by global changes in total RNA population  
(i.e., total RNA per tissue mass) to increase the biological relevance of tran-
scriptome analyses from resistance-trained skeletal muscle. This perspective 
and considerations is applicable to all sequencing technologies to have 
results with better biological relevance. In addition, the vitamin D3 supple-
mentation and chronic obstructive pulmonary disease diagnosis during 
training linked to some molecular change in skeletal muscle seen in transcrip-
tome responses with improvement in lung function but does not account for 
significant phenotypic change as muscle growth.
